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Abstract
Glycosylation is im portant for m any m olecular processes, although how 
glycosvlation contributes to g lycoprotein structure and function is not entirely clear. 
O ther than that, the study o f  m any of these events is com plicated  by the fact that natural 
glycoproteins norm ally  occur as mixtures of glycoforms, therefore the isolation or 
synthesis of hom ogenous  glycoproteins is an im portant task. Previous studies on 
deglycosylated proteins have shown that glycosylation reduces their catalytic activity and 
increase therm al stability. Therefore, we hypothesize that similar effects may be observed 
in the naturally unglycosylated  dihydrofolate reductase from  E scherich ia  coli (EcDHFR).
Four different surface-exposed sites for the incorporation of a single cysteine 
residue were selected based on the protein crystal structure, which may or may not affect 
its dynamics. H om ogeneous  glycoproteins have been synthesized via chemoselective 
ligation o f  a glycosyl ha loacetam m ide with the thiol of a cysteine, to produce site- 
selectively glycosylated  form s of EcD H FR. Techniques such as mass spectrometry, 
circular dichroism  (CD ) spectroscopy, fluorescence spectroscopy, ultraviolet (UV) visible 
spectroscopy and s topped-flow  spectrophotom etry  have been used to identify and study 
the physical properties o f  d ifferent g lycoform s of DHFR.
Although there were some changes of the kinetic activity o f  the mutants of 
EcDH FR. the values were com parable  to those of the wild-type protein. Interestingly, in 
four of the five cases studied. E cD H F R dm D87C, there was an increase in thermal 
stability upon site-selective glycosylation. The other mutants showed no effect. With the 
exception o f  the effect seen for the thermal stability o f  the D 87C mutant, this is not in 
accordance with the original hypothesis. This suggest that the effect seen in the D87C
mutant may be due to specific interactions of the carbohydrate moiety at certain points on 
the protein. An increase in resistance to thermal denaturation observed for proteins in 
sugar solutions may therefore also be due to binding of the sugars to specific sites on the 
protein.
In conclusion, an effective method for the synthesis of homogeneous glycosylated 
and non-glycosylated proteins has been developed and applied to the site selective 
glycosylation of EcDHFR. The results also suggested that the kinetic properties of 
EcDHFR are not significantly affected by glycosylation. It may be the large effects in 
terms of protein stability which due to glycosylation only occur in naturally glycosylated 
proteins, and not in the naturally unglycosylated EcDHFR.
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Chapter 1 
Introduction
1.1 Preface
The study of glycobiology has been carried out for decades to study the biological 
functions of the carbohydrate moieties in term of stability, catalytic activity, regulation of 
intracellular traffic and localization of glycoproteins, modulation of enzymatic and 
hormone activity, modification of immunological properties, participation cell-cell 
interaction and many other effects. Although much was known about the structure and 
biosynthesis of oligosaccharides in glycoproteins, the central question of how 
glycosylation contributes to glycoprotein structure and function is not entirely clear. 
Other than that, the study of many of these events is being complicated by the fact that 
natural glycoproteins normally occur as mixtures of glycoforms, therefore the making of 
homogenous glycoproteins has been an important task for glycobiology. Many 
techniques from biological methodology to chemical synthesis have been introduced, 
however most of them have the disadvantages of reductions in site-selectivity and yields. 
However, such disadvantages have been overcome through a combination of the 
introduction of unique cysteine residues at required sites using a selective chemical 
derivatisation strategy. This methodology has been proven by the synthesis of 
homogeneous glycoforms of the human glycoprotein hormone, erythroprotein.
One example of a glycoprotein that has been extensively studied is the enzyme 
ribonucleases (RNase), which exists in vivo both in non-glycosylated and glycosylated 
forms, the two molecules being named as RNase A and B. The oligosaccharide moiety of 
RNase B shields a large section of the protein from interactions with other molecules. 
Thus, glycosylation contributes to the stability of RNase against proteases, but also 
decreases its activity because binding to the substrate (RNA) is hindered. Other than that,
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the effect of decrease in thermal stability due to deglycosylation has been observed in 
yeast external invertase, bovine serum fetuin, and glycoamylase from Aspergillus niger.
These studies have shown that the carbohydrate moiety does have an effect on the 
thermal stability of the glycoproteins. However it is not known whether these effects can 
be observed in a naturally non-glycosylated protein? In this work, the effect of site- 
specific glycosylation on the structural conformation, thermal stability and kinetic 
activity of the naturally non-glycosylated enzyme, dihydrofolate reductase (DHFR), will 
be described.
1.2 The importance of glycoproteins
Until about 1960, carbohydrates were thought to be rather uninteresting 
compounds and they have been considered as a nuisance that complicated protein 
purification by the protein chemist. Research of the last 30 years or so, however, has 
demonstarated that most proteins are, in fact, glycoproteins. The term ‘glycobiology’, 
introduced in 1988, focused on the role of oligosaccharides in the context of the proteins 
to which they were attached. Almost all the secreted and membrane-associated proteins 
of eukaryotic cells are glycosylated and protein glycosylation is one of the most abundant 
forms of covalent protein and lipid modification in eukaryotic cells [1-3]. There are two 
main types of protein glycosylation: A-glycosylation (Asn-X-Ser (or Thr), where X^Pro 
and possibly Asp), in which the oligosaccharide is attached to the NH2 group of 
asparagine (Asn) side chains (Figure 1.1a), and O-glycosylation, in which the 
oligosaccharide is attached to the OH groups of serine (Ser) or threonine (Thr) side chain 
(Figure 1.1). Inspection of the protein databases suggests that as many as 70% of proteins
3
have potential A-glycosylation sites. Unfortunately, glycoproteins often refuse to 
crystallize and NMR techniques do not allow unambiguous determination of the 
complete conformation of the sugar part, due to the glycan heterogeneity and flexibility. 
Therefore, time-consuming complex simulation methods are often used to explore the 
conformational space of N-glycans [4, 5].
OH
HO'
HO
NH
O
Polypeptide chain
N NH
Asn
x
GlcNAc Ser or Thr
OH
Polypeptide chain
HO'
HO NH
NH
Polypeptide chain
GlcNAc
Ser (R = H) /
Thr (R = CH3)
Figure 1.1: Structures o f  oligosaccharide linkages, (a) N-linked glycosidic bond between 
GlcNAc and an Asn residue, (b) O-linked glycosidic bond between GlcNAc and Ser (Thr) 
residue.
1.3 Synthesis of O-linked oligosaccharides
The synthesis of O-linked oligosaccharides occurs by the sequential addition of 
monosaccharide units to the newly synthesized protein as it passes through the Golgi 
complex. First, A-acetylgalactosamine (GalNAc) is transferred to the relevant Ser or Thr
4
residue of the protein by GalNAc transferase, an enzyme that uses uridine diphosphate- 
A-acetylgalactosamine (UDP-GalNAc) as the precursor (Figure 1.2). Other 
monosaccharides such as galactose (Gal), A-acetylglucosamine (GlcNAc), sialic acid, 
and fucose are then added using the corresponding sugar nucleotides as precursors. The 
exact type and number (up to about 10) of monosaccharides added depends on the protein 
substrate [6].
Figure 1.2: (a) Synthesis o f  O-linked oligosaccharide. The example shown is an O-linked 
oligosaccharide in human immunoglobulin A (IgA). (b) The chemical structure o f uridine 
diphosphate.
1.4 Synthesis of TV-linked oligosaccharides
The synthesis of A-linked oligosaccharides is much more complex than the O- 
linked oligosaccharides because they are not synthesized by adding monosaccharides 
directly to the protein but instead the oligosaccharide is made on a lipid carrier called
GalNAc GalNAc
UDP-
GalNAc
o
(b)
HO------
OH OH
5
dolichol phosphate (Figure 1.3). Dolichol phosphate consists of 14-24 isoprene (C5) units 
(17-21 unis in animals and 14-24 units in fungi and plants) with a terminal phosphate 
group and it is anchored to the RER membrane. Involvement of lipid-linked 
oligosaccharides in N-linked glycoprotein synthesis was first demonstrated in 1972 by 
Armando Parodi and Luis Leloir, who showed that, when a lipid-linked oligosaccharide 
containing [14C]glucose is incubated with rat liver microsomes (vesicular fragments of 
isolated ER), the radioactivity becomesw associated with protein. All N-linked 
oligosaccharides are based on a common pentasaccharide core structure consisting of 
three mannose (Man) residues and two N-acetylglucosamine (GlcNAc) residues (Figure
1.3).
(a)
R------ Man—O
OHOH
HO'
N NH
HOMan
NH
Man
x
GlcNAc
(b)
O  P  O-
Figure 1.3: Figure (a) show the structure o f the common pentasaccharide core o f N- 
linked oligosaccharides, and figure (b) show the structure o f dolichol phosphate (n = 12- 
22 units).
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There are two different types of AMinked oligosaccharides; high mannose type 
oligosaccharides, where the R group in Figure 1.3 is consist of variable number of 
mannose residues, and complex type oligosaccharides, where the R group consists of a 
variety of other sugars such as GlcNAc, galactose, sialic acid and fucose.
Synthesis of the oligosaccharides is initiated by the dolichol phosphate (Dol-P) 
accepting monosaccharides from the cytosolic face of the RER membrane but when the 
(Man)5(GlcNAc)2 -dolichol phosphate intermediate has formed, this will flip orientation 
to the luminal side of the RER membrane for accepting further monosaccharides (Figure
1.4). All of these subsequent transfers are from dolichol phosphate-linked 
monosaccharides that are made on the cytoplasmic side of the RER membrane then 
likewise flipped across to act as donors [7-10]. The final oligosaccharide, which is known 
as G-oligosaccharide [composed of (Glc)3(Man)9(GlcNAc)2] is linked to the dolichol by a 
pyrophosphate bond. This provides the energy for transfering the oligosaccharides to the 
protein by a membrane-bound oligosaccharides transferase enzyme and which occurs in 
the RER (Figure 1.4). This reaction is also known as core glycosylation. Whilst the 
protein is still in the RER, the three glucose residues and a mannose residue will be 
removed. However, if the protein is unfolded or in a wrongly folded conformation, the 
glucose residues will be added back to the protein until a correctly folded form is 
achieved.
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CY IU S O L RER MEMBRANE LUMEN
UDP — GlcNAc 
UMP
UDP — GlcNAc—  p _ p
UDP — GlcNAc
UDP 
(GlcNAc)2—  p
5GDP—  Man
5GDP 
(ManXGIcNAc)2 -
X = 4Man-P-dolichol 
3Glc-P-dolichol
Dolichol
Dolichol
Dolichol
Do ichol
Dolichol
Dolichol
Flips cwientation 
across RER membrane
P _  P—  (GlcNAc)2(Man)
X
7P— dolichol 
P _ P  — (GlcNAc)2(Man)5(Glc)3
Figure 1.4: Synthesis ofN-linked oligosaccharides on a dolichol phosphate carrier in the 
RER membrane.
Once the three glucose residues are finally removed, the protein may continue 
along the modification pathway transported to the Golgi complex via vesicles. As it 
moves through the Golgi complex, the ‘trimming’ or ‘processing’ of the oligosaccharide 
continues by removing another five mannose residues (Figure 1.5). Finally, mannose 
residues and other monosaccharides will be added to the oligosaccharides via a process 
known as terminal glycosylation to generate either the high mannose or complex type of 
oligosaccharides.
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G-oiigosacchande -  P -  P -  Doi
PROTEIN G-oligosaccharide
PROTEIN
P -  P -  Dol
Occurs in RER 
(core glycosylation)
3Glu / 6Man
GDP-Man
Pentasaccharide core 
PROTEIN
UDP-GlcNAc 
UDP-Gal 
CMP-sialic acid
UDP +
Simple type 
N-linked 
Oligosaccharide Complex type 
protein N-linked
Oligosaccharide
protein
Occurs in Golgi apparatus 
(terminal glycosylation)
Figure 1.5: Transfer o f the oligosaccharides to the protein and further processing in the 
RER and Golgi.
1.5 Importance and function of glycoproteins in eukaryotic cells
Glycoproteins have a wide range of important functions within eukaryotic cells. 
One type of glycoprotein found in the body is the mucins, which are secreted in the 
mucus of the respiratory and digestive tracts. The sugars attached to mucins give them 
considerable water-holding capacity and also make them resistant to proteolysis by 
digestive enzymes, which may be important in maintaining mucosal barriers.
Another important function of glycoproteins is immune cell recognition, 
especially in mammals [11]. Examples of glycoproteins in the immune system are the 
immunoglobulins (Ig) and the major histocompatibility complex (or MHC), which are
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expressed on the surface of cells and interact with T-cells as part of the adaptive immune 
response.
Immunoglobulins (Ig) are large Y-shaped proteins used by the immune system to 
identify and neutralize foreign objects like bacteria and viruses. Each antibody recognizes 
a specific antigen unique to its target [12]. In binding their specific antigens, the 
antibodies can cause agglutination and precipitation of antibody-antigen products primed 
for phagocytosis by macrophages and other cells, block viral receptors, and stimulate 
other immune responses such as the complement pathway [13]. The complement 
pathway/system is a biochemical cascade of the immune system that helps clear 
pathogens from an organism, and promotes healing. It is derived from many small plasma 
proteins that work together to form the primary end result of cytolysis by disrupting the 
target cell's plasma membrane [1 2 ].
The major histocompatibility complex (MHC) is a large genomic region found in 
most vertebrates, especially in human. It is the most gene-dense region of the mammalian 
genome and plays an important role in the immune system, autoimmunity, and 
reproductive success. The MHC region encodes integral membrane proteins which are 
found on the surface of cells in all jawed vertebrates, and the function of these proteins 
are display the fragments of molecules from invading microbes or dysfunctional cells (e.g. 
tumor cells) to a particular type of white blood cell called a T cell that has the capacity to 
kill or co-ordinate the killing of the microbe, infected cell or malfunctioning cell.
Other examples of glycoproteins include components of the zona pellucida, which 
surrounds the oocyte, which is important for sperm-egg interaction, and structural 
glycoproteins, which occur in connective tissue. These help bind together the fibers, cells,
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and ground substance of connective tissue. They may also help components of the tissue 
bind to inorganic substances, such as calcium in bone [14, 15].
Recent studies on the enzymes RNase, yeast external invertase, bovine serum 
fetuin, and glucoamylase have shown that glycosylation has a general stabilization effect 
on protein thermal stability and conformation [16]. The non-glycosylated protein and 
glycosylated protein, shows a difference in their thermal stability. Glycosylation appears 
to have an effect on stabilizing the protein. This similar phenomenon has also been 
observed in studies of the two heavily glycosylated P-l,3/l,4-glucanases by Olsen and 
co-workers [17]. They found that the glycosylated enzymes which were expressed in 
Saccharomyces cerevisiae were considerably more heat stable than their unglycosylated 
counterparts which are expressed in E. coli.
It is important to note that all the heavily glycosylated proteins, whether TV- 
glycosylated or <9-glycosylated or both, are thermally destabilized by removing their 
carbohydrate. If the results from the present study can be generalized, then we may 
expect that stabilization of protein conformation and thermal stability are common 
general properties conferred by the covalent attachment of carbohydrates to the 
polypeptide and are closely related to the extend of glycosylation.
However, due to the distinct differences in heat stability values were observed in 
those glycoproteins, these results do not explain the molecular basis by which 
carbohydrate affects the glycoprotein properties. One possible way for the attached 
carbohydrate moieties to stabilize the protein conformation is to form hydrogen bonds 
with the polypeptide. Studies of the crystal structure of glucose oxidase (GO) by Hecht 
and co-workers have shown that the TV-linked mannose residues form strong hydrogen
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bonds with the backbone nitrogen and the carbonyl oxygen of glutamic acid [18]. In 
addition, carbohydrate moieties may stabilize protein conformation simply by steric 
interactions of the carbohydrate with the adjacent peptide residues [19, 2 0 ].
Other example of glycoprotein that has been extensively studied is the 
mammalian ribonucleases (RNases) which has been regulate many important biological 
functions by catalyzing the degradation of single- and double-stranded ribonucleic acids 
(RNAs). Bovine pancreatic RNase is a mixture of unglycosylated RNase A (Mw = 13,682) 
and a collection of glycoforms (designated RNase B Man-5,-6 ,-7, - 8  and -9) in which the 
oligomannose series, Man-5 to Man-9, is associated with the single N-glycosylation site 
at Asn34LeuSer. Various spectral properties (circular dichroism, optical rotatory 
disperson, and ultraviolet denaturation difference spectroscopy) of the glycosylated form, 
RNase B have been measured and were in good agreement with similar datas on the non­
glycosylated form, RNase A. Other than that, the amino acid composition of RNase B is 
identical with that of RNase A and presumably the amino acid sequence of the two 
proteins is identical (ref)- Previous studied of the ID and 2D 1H NMR spectra of RNase 
A and the gly coforms of RNase B have showed no significant different too [21]. Previous 
studies by Dwek and co-workers have shown that the carbohydrate moieties that are 
attached on the protein were able to affect the enzymatic activity of the protein [19, 2 0 ]. 
The RNase A was more than three times as active as the glycosylated form, RNase B. 
The different size of the carbohydrate moiety attached to the protein may also affect the 
enzymatic activity.
In addition studies on the glucose oxidase (GO) in protein catalysis have shown 
that carbohydrate moieties have an effect on the kinetic properties of GO. GO catalyses
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the oxidation of glucose to gluconolactone and the subsequent reduction of oxygen to 
hydrogen peroxide according to a ping-pong steady-state kinetic mechanism [22, 23]. 
Three glycoforms of GO, which vary in their degree of glycosylation have been 
characterized according to their molecular weight by Kohen and co-workers to 
investigate the kinetic properties of the enzyme, with the goal of determining the 
contribution of H-tunneling to the C-H bond cleavage step [22-24].
The properties of glucose and 2-deoxyglucose oxidation by GO have been 
investigated using both steady-state and pre-steady-state kinetic methods and have shown 
that 2 -deoxyglucose is an ideal probe for their studies due to its sensitivity towards 
hydrogen transfer step [25, 26]. Focusing on 2-deoxyglucose to probe the chemical step, 
Kohen and co-workers measured the temperature dependence of competitive H/3H and
 ^ -j
H / H kinetic isotope effects on the enthalpy of activation using [1- H]-2-deoxyglucose. 
Apparently, less glycosylation results in more tunneling and a lower enthalpy of 
activation. Interestingly, the crystal structure, kinetic analysis, and other studies suggest 
that the enzyme active site is not conformationally changed by the degree of 
glycosylation [18, 20, 27-31]
An alternative explanation for the effect of glycosylation on GO catalysis is 
through changes in protein dynamics. Recently, several works have reported that 
glycosylation can modify the dynamic stability and functional activity of an enzyme [2 0 , 
31]. In the latter studies, comparative X-ray crystallographic studies, circular dichroism 
(CD) and nuclear magnetic resonance (NMR) techniques, and NH-N H exchange data 
were used to demonstrate that the three-dimensional structure of RNase was unaffected 
by glycosylation whereas dynamic fluctuations were changed. In the studies of GO, the
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enzyme activity was found to correlate with decreased glycosylation and protein rigidity 
which is due to the masses/sizes of the carbohydrate moieties attached on the surface of 
the protein. It was also shown that glycosylation had an effect on the isotopically 
sensitive hydrogen transfer step of the enzyme. This implied that protein dynamics may 
be involved in the transition state of the bond cleavage step.
In these experiments, two interesting questions arise: first, how glycosylation 
could modify protein dynamics; and second, how does such a change in protein dynamics 
affect tunneling in an enzymatic reaction?
A possible answer to the first question might lie in the relationship of surface 
changes to internal protein dynamics. Recent studies by Yedgar and co-workers provided 
direct evidence that viscosity decreases the specific volume and the adiabatic 
compressibility of the protein interior [32]. Based on the kinetics of tryptophan 
phosphorescence decay, Cioni and Strambini hypothesized that viscosity and hydrostatic 
pressure act similarly in decreasing internal free volume and increasing protein rigidity 
[33]. Studies by Rudd (1994) and Mer (1996) described a similar phenomenon where 
glycosylation decreased dynamic fluctuations throughout the molecule [20, 31]. It is 
possible that protein glycosylation leads to a change in solvation at the protein surface 
that resembles the effects of viscosity, and hydrostatic pressure.
As for the second question, many models connecting protein dynamics to its 
function have been described and reviewed [34-38]. Several investigators have simulated 
hydrogen transfer processes incorporating both protein dynamics and quantum- 
mechanical tunneling [39-42]. These models demonstrate that hydrogen tunneling in 
enzymatic systems may be mediated by thermal fluctuations, leading to a decrease in the
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tunneling distance and disruption of the tunneling coherence with a concomitant 
localization of the particle to the product side. This process is also known as dissipative 
tunneling. From the studies of GO, there is evidence that the hydrogen transfer step in an 
enzyme-catalyzed reaction is modified by remote changes in glycosylation on the surface 
of the protein [24, 43].
As previously described, the native conformation of many proteins can be 
stabilized against thermal denaturation through glycosylation, however the mechanism of 
such stabilization is less clear [44-46]. The removal of carbohydrates from naturally 
glycosylated proteins through the use of glycosidases [47] or by mutagenesis of 
glycosylation sites [48, 49] can lead to decreased thermal stability of the protein. This is 
often accompanied by an increased tendency towards protein aggregation. Due to the 
heterogeneous nature of protein glycosylation both in vivo and in vitro, a comprehensive 
study if its effect on thermal stability has been elusive. However, studies of the stability 
of several unglycosylated proteins in the presence of high concentrations of saccharides 
such as glucose, sucrose, galactose and a,a-trehalose have led to the conclusion that these 
glycans stabilize the folded protein due to preferential binding of the native states [50-53]. 
Such observations suggest that glycosylation of natural proteins could establish a 
microenvironment that resembles that of unglycosylated proteins in solutions of high 
carbohydrate content.
Through these examples, we knew that at the cellular level, N- and O-glycans 
have been shown to contribute to a myriad of functions, including cell-adhesion events 
[54-57] during immune surveillance, inflammatory action, viral and bacterial infections 
[58]. There are other effects of glycosylation on protein such as participating in protein
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folding [59], thermal stability [16], protection against proteolytic degradation [57, 60-63] 
and the protein catalytic activity [24, 43], Glycoproteins usually exist as mixtures of 
various ‘glycoforms’ that differ in the structure of the oligosaccharides. In order to 
understand their function precisely, it is desired that glycoproteins are homogeneous and 
the oligosaccharide structure is well defined. Isolation of homogeneous glycoprotein is 
difficult; therefore various approaches to synthesise artificial glycoprotein have been 
developed [64]. These include modification of natural glycoproteins using glycosidases 
and/or gly cosy ltransferases [65], ligation of synthetic gly copeptides with expressed 
protein [6 6 ], and introducing synthetic sugar derivatives using a chemoselective ligation 
(e.g. coupling of a sugar bearing an haloacetamide group with a thiol of a free cysteine 
moiety) [67-71] (Scheme 1.1).
Recently, a full chemical synthesis of a large glycopeptide has been relatively 
successful [6 8 , 72]. However the purity of the synthesized glycoproteins is paramount, 
and the yields of the product were low, and the synthesis was expensive. Therefore 
alternative methods are required to overcome these problems. The methodology of 
combination of the introduction of unique cysteine residues at required sites and a highly 
flexible but selective chemical derivatisation strategy allowed us to systematically study 
the effect of site-specific glycosylation on the thermal stability and catalytic activity of 
the naturally nonglycosylated enzyme, dihydrofolate reductase (DHFR).
16
OH
HO'
HO
OH
+ HS
Polypeptide chain
NH
O
Polypeptide chain
Polypeptide chain
N NH
Polypeptide chain
Scheme 1.1: Chemoselective ligatiom o f a glycosyl haloacetamide (X=Cl, Br, or I) with 
the thiol o f a cysteine residue [67].
1.6 Overview of dihydrofolate reductase (DHFR)
Dihydrofolate reductase (DHFR) is a ubiquitous enzyme which catalyses the 
reduction of 7,8-dihydrofolate (H2F) to 5,6,7,8-tetrahydrofolate (H4 F) using nicotinamide 
adenine dinucleotide phosphate (NADPH) as a cofactor (Figure 1.6 ; also see Scheme 1.2). 
The reaction occurs by stereospecific hydride transfer of the pro-R hydrogen of NADPH 
to the C6  atom of the pterin ring with concurrent protonation of N5 of the substrate [73- 
75] (Figure 1.6). Both H2 F and H4 F are reduced derivatives of folate (folic acid). In many 
organisms, DHFR is also capable of catalyzing the reduction of folate to H2 F, although 
less efficiently [76]. H2F is composed of a pterin ring linked via the 6 -methyl group to a 
/xzra-aminobenzoic acid moiety which is connected to one or several glutamate (Glu) 
residues through its a-amino group. The /?ara-aminobenzoic acid and the glutamate
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groups of the molecule are often referred to as the para-aminobenzoylglutamate (pABG) 
portion (Scheme 1.2). DHFR plays a central role in maintenance of the intracellular pool 
of H4F in prokaryotes and eukaryotes, which is essential for the biosynthesis of 
thymidylate, purines, several amino acids (e.g. serine), and hence for cell growth and 
proliferation [75, 77, 78].
HN
NADPH
I R'
Pterin ring
Nicotinamide
DHFR H+
HN
NADP
I R*
NHz
R' =
4 — ^
■i H
. 0  Ribose
■p— o ■p—o
R =
o= p— o
2'-Phosphoribose
pABG
Scheme 1.2: The reaction catalysed by DHFR and the structure o f  cofactor (NADPH) 
and substrate (H2F).
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DHFR is the sole source of H4 F, and its low molecular weight (Mw-18,000) 
coupled with a lack of disulfide bonds or metal ion requirements, makes it an ideal 
subject for kinetic measurements, X-ray crystallography, NMR spectroscopy, and site- 
directed mutagenesis studies [79-82]. DHFR is an important target for several anticancer 
and antibacterial drugs such as methotrexate (MTX), trimethoprim (TMP) and 
pyrimethamine (PMA), which act by inhibiting the enzyme in malignant cells (Figure 
1.6). Trimethoprim, for example, binds to bacterial DHFRs 105 times tighter than it does 
to vertebrate DHFRs, [83] and the antimalarial agent pyrimethamine targets DHFR from 
Plasmodium falciparum [84]. The inhibition effects of MTX towards DHFR [79], have 
been demonstrated by Futterman [79, 85] and similar observation had been dicovered by 
Zakzewski and Nichol [79, 8 6 ]. After more than 40 years of studies, MTX remains one of 
the most potent chemotherapeutics in the treatment of leukaemia and lymphoma. DHFR 
is also the likely target in the treatment of rheumatoid arthritis by MTX.
Figure 1.6: Inhibitors o f  the reaction catalysed by DHFR. (1) is methotrexate (MTX), (2) is 
trimethoprim (TMP) and (2) is pyrimethamine (PMA).
(1)
.0
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1.7 The importance of folic acid or folate
Folic acid or folate is a water-soluble B vitamin and occurs naturally in food and 
can also be taken as supplement. Folate gets its name from the Latin word folium 
meaning leaf, and it tends to be used as a general term referring to all forms of folate (i. e. 
H2F, H4F and their methylated forms). Leafy vegetables such as spinach, turnip greens, 
fortified cereal products, and certain other fruits and vegetables are discovered to be rich 
sources of folate.
A key observation by researcher Lucy Wills in 1931 led to the identification of 
folate as the nutrient needed to prevent anaemia during pregnancy. Dr. Wills 
demonstrated that anaemia could be reversed with brewer’s yeast. Folate was identified 
as the corrective substance in brewer’s yeast in the late 1930s and was extracted from 
spinach leaves in 1941. It was synthesized in 1964 by Yellapragada Subbarao.
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Figure 1.7: Structures o f one carbon unit carriers, derivedfrom H4F: N5 -methyl- H4F (4), 
N5 1 0-methylene- H4F  (5), N5’10-methenyl- H4F (6 ), N5 -formyl- H4F  (7), NI0-formyl- H4F  
(8 ), and N5-formimino- (9).
Folate is necessary for the production and maintenance of new cells [87] 
especially during periods of rapid cell division and growth such as infancy and pregnancy. 
Folate is needed to replicate DNA, this is because H4F, is a precursor of cofactors 
required for the production of purines, pyrimidines, and several amino acids [8 8 ].
H4F is a carrier of one-carbon units, such as methyl (-CH3), methylene (-CH2-), 
methenyl (-CH=), formyl (-CHO) and formimino (-CH=NH) groups. These are carried by
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H4F bound to its N5 and N10 nitrogen atom (denoted as N5 and N10) (Figure 1.7). These 
folate derivatives are interconvertible and serve as substrates in a number of single- 
electron-transfer reactions. N5-Methyl-tetrahydrofolate is known to be the source of the 
terminal methyl group of the amino acid methionine. N5,10-Methylene-tetrahydrofolate is 
required by thymidylate synthase as a methyl group donor for the synthesis of dTMP (2’- 
deoxythymidine-5’-phosphate) from dUMP (2’-deoxyuridine-5’-phosphate) (Scheme 1.3) 
[8 8 , 89].
dUMP dTMP Folate
NADPH
NH NH
NADP
HN.
HNHN
Thymidylate
synthase
Serine
hydroxy lmethyl 
.transferase
Dihydrofolate,
reductase NADPHGlycine
HN
NADPSerine
HN
H2N
Scheme 1.3: Schematic o f the biosynthesis o f dTMP from dUMP involving DHFR.
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1.8 Kinetic mechanism of DHFR
As a result of the biological and pharmacological importance of DHFR, this 
enzyme has been the subject of intensive kinetic and structural investigations for many 
years. For the past decades, several sources of DHFR have been investigated for the 
reaction mechanism. Most recent advances include the elucidation of a full kinetic 
pathway for DHFRs from E. coli (EcDHFR) [74], Lactobacillus casei (LcDHFR) [74], 
Pneumocystis carinii [90], mouse [91] and human [92].
The complex catalytic cycle for EcDHFR has been reported by Benkovic and co- 
workers (Scheme 1.4) [74]. Under steady-state turnover conditions, with physiological 
concentrations of substrate and cofactor, the catalytic cycle is composed of five 
kinetically observable intermediates, dominated by a rapid hydride transfer from NADPH 
to H2F and a slow release of the H4 F from the ternary product complex 
NADPH:DHFR:H4 F [74].
An important aspect for this cycle is that the chemical step of hydride transfer is 
not followed immediately by the release of the product. Following hydride transfer, the 
product (H4F) is released only after the release of oxidised co-factor (NADP+) and 
subsequent rebinding of NADPH into the active site. This step is also known as the rate- 
determining step (12.5 sec'1). Thus, free enzyme will not be generated under 
physiological conditions, remaining primed for the next round of catalysis. The 
coordination of the ligand binding and release is maintained by a synergistic interaction 
between the substrate and co-factor binding site, in which the ofif-rates of oxidised 
cofactor (NADP+) are elevated in the presence of bound product, and the off-rates of the 
product is elevated in the presence of reduced cofactor (NADPH). The chemical step is
23
associated with a pKa of 6.5 and becomes the rate-determining step above pH  9 [93].
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Scheme 1.4: The catalytic cycle o f EcDHFR. It shows the five primary imtermediates and 
the rate constant for DHFR catalysis pathway at pH  7 (2, 26). E = Enzyme, NH = 
NADPH, N* = NADP+, H2F = Dihydrofolate, and H4F  = Tetrahydrofolate.
There are two different proposed mechanisms that explain the pH  dependence of the 
hydride transfer reaction at the active site of EcDHFR. In both mechanisms the 
protonation of N5 atom of H2F is very important for the rate of hydride transfer. In the 
first mechanism, Asp27 has been shown to play a major role as a proton acceptor. From 
the studied of crystallography [94], Raman spectroscopy [95] and computational analyses 
[96, 97] support a keto-enol tautomerization of the pterin substrate. The enol form is 
stabilized as a consequence of the expulsion of most of the water molecules on substrate 
binding leading to a significantly reduced dielectric environment and an increased /?Ka of 
N5 atom, thereby making its protonation feasible [93, 98]. An alternative mechanism 
suggests that the N5 atom is protonated directly by the solvent, recently receiving support 
from Molecular Dynamics (MD) calculations [99].
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1.9 Structure of DHFR
The biological importance of DHFR in many biosynthetic pathways has prompted 
numerous structural studies. The first crystal structure of a DHFR enzyme was published 
26 years ago from E. coli [100]. Since then, structural models based on X-ray 
crystallographic data have been constructed for the DHFR enzymes from Lactobacillus 
casei [100], chicken [101], human [102], mouse [103], Pneumocystis carinii [104] and 
Leishmania maior [105]. However, the most extensive structural characterisation has 
been done on EcDHFR, including different substrate, inhibitor and cofactor complexes 
(for an extensive list of DHFR structures see [99] and references therein.
DHFRs are relatively small monomeric enzymes with molecular weights (Mw) 
normally ranging from 18,000 - 25,000. EcDHFR contains 159 amino acid residues and 
its molecular structure consists of a central eight-stranded beta-sheet (composed of P- 
strands A-H) and four flanking a-helices (designated as as, ac, aE, and ap) (Figure 1.8) 
[106]. The active site cleft divides the protein into two structural domains: the adenosine 
binding domain (residues 38-88, ABD) and the major domain. The adenosine binding 
domain is the smaller of the two domains and provides the binding site for the adenosine 
moiety of the cofactor. The major domain is dominated by three loops [Met20 (residues 
9-24), F-G (residues 116-132), and G-H (residues 142-150)] on the ligand binding face, 
surrounding the active site. These loops make up approximately 40-50% of the major 
domain, hence it is sometimes called the loop domain. Met20 and F-G loops are also 
referred as loop 1 and loop 2. X-ray crystal structures and NMR studies show that upon 
the binding of the enzyme to various ligands, Lys38 and Val8 8  perform a hinge-bending
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motion, allowing the adenosine binding domain to move relative close to the major 
domain resulting in closure of the active site cleft [107],
Adenosine 
Binding .
Domain 
(ABD)
Loop Domain 
(LD)
Figure 1.8: Structural overview of EcDHFR. The major domain loops are indicated in 
green (Met20), orange (F-G), and yellow (G-H). The adenosine binding domain is red. 
Folate and NADP+ are drawn in stick format and indicated in blue and yellow 
respectively in the ternary complex (1RA2). The structure is oriented so that the co-factor 
nicotinamide ring is in the plane of the paper [78, 108].
Comparison of the various structures of DHFR from various species seems to 
adopt similar secondary and tertiary structural arrangements. The DHFR isolated from 
the hyperthermophilic bacterium Thermotoga maritima (TmDHFR) is the only 
hyperthermophilic DHFR isolated to date. Its X-ray crystal structure (Figure 1.9b) 
revealed similarity of the overall fold and tertiary structure with EcDHFR (Figure 1.9a).
26
TmDHFR has a size of approximate twice the size of the EcDHFR, because it is 
composed of two monomeric forms of EcDHFR. The dimeric form of TmDHFR most 
likely plays a central role in the thermostabilisation of the enzyme, as indicated by 
biophysical [109] and computational studies [110]. In the literature an increasing number 
of hyperthermophilic enzymes have been described, three of which have been isolated 
from T. maritima, namely phosphoribosyl anthranilate isomerase [111], glutamate 
dehydrogenase [1 1 2 ] and xylanase [113].
TmDHFR secondary structures consists of four a-helices and eight P-sheets in the 
same relative positions to the other DHFRs. The one significant difference is the addition 
of a ninth p-sheet in each monomer. In the dimer structure, these two extra strands form 
an antiparallel p-sheet interaction at the dimer interface. The loop regions corresponding 
to the Met20 and G-H loops in EcDHFR are shortened in the T. maritima structure and 
exhibit less mobility as judged by comparison of the B-factors of their relative 
conformations between the apoenzyme and ternary structure [110]. The CD loop region 
remains of similar length and mobility to the mesophilic bacterial enzymes, the F-G loop 
on the other hand is elongated in the T. maritima structure. However, the residues of the 
loop can be seen to be involved in the dimer interface and to be forming two inter-subunit 
salt bridges between lysine 129 from one subunit and two glutamate residues (136 and 
138) from the other.
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(a)
Figure 1.9: Crystal structure of DHFR from E. coli (a) and T. maritima (b). MTX and 
NADP+ are drawn in stick format and indicated in blue and yellow respectively in the 
ternary complex. The structure of EcDHFR and TmDHFR dimmer were taken from the 
PDBfiles 1RX3 and 1D1G, respectively [99, 110].
1.10 The chemical step during the catalysis
As mention above, the DHFR-catalysed reduction of H2 F involves protonation of 
N5 of H2 F and hydride transfer from NADPH to C6 of H2F. The source of the proton 
transferred to N5, by contrast to the source of the hydride, has been the major subject of 
debate. In EcDHFR, extensive crystallographic and nuclear magnetic resonance (NMR) 
studies of the apo-enzyme and various binary and ternary complexes have revealed the 
relative orientation of H2 F and NADPH in the active site. Through extensive 
investigation, the presence of the conserved ionisable amino acid residue Asp27 in the
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active site and a water molecule within hydrogen bonding distance to N5 of H2F are 
assumed to be mechanically important for the reaction (Figure 1.10) This water molecule 
could be either part of a hydrogen shuttle from the conserved Asp or as a direct donor 
from solvent [95, 96, 99, 114, 115].
H
Figure 1.10: Partial scheme o f the active site o f EcDHFR, indicate the location of Asp27 
and a water molecule within H-bonding distance to N5 o f H2F.
In an investigation by Koshland and co-workers, the angle and the distance between 
hydride donor and acceptor were shown to be the critical determinants of the rate of the 
hydride transfer [116]. From ab initio calculations the optimal C-C bond distance of the 
transferring and accepting carbons was determined to be 2.6 A [117]. In the model of 
productive substrate binding [118] shown in Figure 1.12, Asp27 forms hydrogen bonds 
with Trp22, with Thrll3, and with both the 2-amino and 3-amino groups of the pterin 
ring. Substitution of Asp27 with asparagine or serine generates a mutant form of 
EcDHFR that is 300 times slower and binds the substrate 20 times more weakly [93]. 
Thrll3 hydrogen bonds indirectly to the pterin ring system through a fixed water 
molecule. Loss of the hydroxyl group, by substitution of Thrll3 with valine, results in a 
200 and 50 fold decrease in the affinity for H2F and H4F respectively [119]. The rate of 
the hydride transfer in the Thrll3Val mutant enzyme decreases only six fold, which is 
consistent with the minor role for Thrl 13 in the proton transfer step.
H O
H
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Leu-
HN
Figure 1.11: The hydrogen bond network of the substrate in the active site, as derived 
from the crystal structure of the EcDHFR. NADP+. H2 F ternary complex [118].
Residue Trp22 coordinates the pterin ring system through hydrogen bonding with 
another fixed water molecule and it has been proposed that the hydrogen bonds formed 
by this residue are more important for binding substrate rather than for coordinating and 
orienting putative fixed water involved in the chemical step [120]. When Trp22 is 
substituted with phenylalanine, substrate affinity decreases six fold, but the hydride 
transfer rate decreases only three fold. The hydride transfer step for the EcDHFR 
catalysed reaction is pH dependent and the rate decreased with increasing pH showing an 
inversion point at pH 6.5. This apparent pKa was attributed to Asp27 [121], since it is the 
only residue in the active site that seems to be able to protonate the substrate. Asp27 is
o
more than 5 A away from N5 of the pterin ring. The protonation of N5 was therefore 
proposed to occur by an indirect mechanism involving an adjacent water molecule, which
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was stabilised in the active site by the enol tautomer of the substrate's pterin ring (Figure 
1.11) [96].
The water molecule at the position site B (Figure 1.12) has only been observed in 
EcDHFR structures when the Met20 loop is in the open conformation, which is contrary 
to the proposal that such a water molecule may be involved in the reaction. An alternative 
mechanism has been suggested, in which protonation of the N5 atom of H2F directly 
from solvent is responsible for the pH dependence [95]. This mechanism has received 
support from recent theoretical calculations by Brooks III and co-workers [115].
Site A
H O
HN
Figure 1.12: The mechanism of the substrate protonation as proposed by Miller and 
Benkovic [98].
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1.11 Active site loop conformations
Within the active site, the substrate and cofactor bind in a hydrophobic cleft at the 
juncture of the two structural domains. In the ternary complex with NADP+ and folate, 
the pterin ring (H2F) and the nicotinamide ring (NADPH) bind in close proximity in the 
active site via van der Waals contact [118]. The Met20 loop lies directly over the active 
site protecting it from the solvent, and helps determine the active site’s architecture. Part 
of the loop domains, which are the F-G and G-H loops, also play a stabilizing role of 
hydrogen bonding interactions with the Met20 loops.
Extensive X-ray studies of EcDHFR have provided evidence of how the enzyme 
changes its conformation to facilitate the reaction; it shows the Met20 loop appears in 
four characteristic conformations: occluded, closed, open, and disordered conformations 
(Figure 1.13) [108]. The occluded and closed conformations have also been observed in 
solution NMR experiments, and chemical shifts sensitive to the conformational change 
have been identified [115]. The open conformation has been observed only in certain 
crystal forms and seems to be stabilised by crystal lattice contacts [99, 115]. The Met20 
loop is disordered in X-ray structures of the apo-enzyme and of the MTX complex. The 
electron density maps suggest that the disorder may result from the time-averaged 
fluctuations between the occluded and closed conformations [108].
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(b)
Figure 1.13: X-ray structure of EcDHFR, showing the three conformations of the Met20 
loop. The substrate and cofactor is showed in blue and yellow, respectively. The protein 
structure is showed in grey with the Met20 loop in green. The loop is closed over the 
active site in 1RX2 (a), open away in 1RA2 (b) and occluded into the nicotinamide 
binding site in 1RX6 [108].
Changes in the conformation of the active site loops depend on the binding of 
ligands at the substrate and co-factor binding sites. If substrate is bound, the Met20 loop 
assumes the occluded loop conformation. Binding of the NADPH will lead to the 
formation of the closed conformation, in which the Met20 loop is closing the active site 
and protects it from solvent. Thus, loop movement is coordinated with the stages of the 
catalytic cycle. It is important to note that only the closed conformation allows 
positioning of the co-factor and substrate reactive centre in close proximity within the 
active site pocket, as observed, in the structures of the E:folate:NADP+ and 
E:MTX:NADPH complexes, believed to be good models of the Michaelis complex and 
transition state, respectively [108J.
The comparison between the occluded and closed conformations shows difference 
in structure in the central portion of the Met20 loop and in the pattern of hydrogen bonds
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formed between the Met20 loop and the F-G and G-H loops (Figure 1.14). In the 
occluded state, the central region of the Met20 loop forms a 3io-helix, with Met 16 and 
Glul7 projecting into the active site, thereby occluding the binding site for the 
nicotinamide ring of the NADPH co-factor [108]. The occluded conformation is 
stabilized by hydrogen bonds between Asn23 (backbone CO and NH) in the Met20 loop 
and Serl48 (NH and Oy ) in the G-H loop. In the closed conformation, residues 16-19 
form a type IIP (3-hairpin. Metl6 and Glul7 are flipped out of the active site, thereby 
allowing nicotinamide binding, while the side chains of Asnl8 and Met20 pack down 
over the bound substrate and cofactor. The Asn23/Serl48 hydrogen bonds are disrupted, 
and new hydrogen bonds are formed between the backbone NH and 05 of Asp 122 in the 
F-G loop and the backbone CO and NH of Glyl5 and Glul7, respectively. The magnitude 
of the structural rearrangement is large; the hydrogen bond donors and acceptors in the
o o
closed complex are more than 9 A (Aspl22 to Glyl5) and 11 A (Aspl22 to Glul7) apart 
in the occluded conformation [78]. A NMR study by Osborne and co-workers monitored 
the chemical shifts of the characteristic interactions between the Met20 loop and the 
ligands and concluded that the open conformation is in fact an intermediate between the 
closed and occluded forms of the Met20 loop. When the Met20 loop is in the open 
conformation, it extends away from the reactants, allowing the nicotinamide-ribose 
portion of NADPH and the pterin ring of H2F in or out of the active site.
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Figure 1.14: Diagram of the Met20 loop and its integrations with the F-G loops in an 
overlay o f the a-carbon traces for the closed (red) and occluded (green) conformations of 
EcDHFR. The positions of the folate and NADP+ ligands in the ternary complex (1RX2) 
are shown in blue and yellow respectively [78].
1.12 Loop and sub-domain movement during the catalytic cycle
A proposed detailed structural model for the conformational changes during the 
catalytic cycle was described by Sawaya & Kraut [99], based on the analysis of 
isomorphous crystal structures of E. coli DHFR complexes analogous to the five kinetic 
intermediates and to the transition state for hydride transfer, suggested that the Met20 
loop is in the closed conformation in the holoenzyme, the Michaelis complex, and the 
transition state, but occludes the nicotinamide binding pocket in the three product 
complexes (Scheme 1.5).
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In the Michaelis complex and transition state, the nicotinamide-ribose moiety 
occupies its binding pocket within the active site, in close proximity to the pterin ring of 
the substrate. However, in the occluded E:H4F:NADP+ and EitUFiNADPH product 
complexes, this moiety projects into the solvent. Movement of the adenosine binding sub- 
domain relative to the major sub-domain at different stages of the catalytic cycle 
modulates the width of the p-aminobenzoylglutamate binding cleft. This cleft is 
narrowest in the structures that model the Michaelis complex and transition state and 
becomes wider in the occluded product complexes. The domain rotations may play a role 
in transition state stabilization and cofactor-assisted H4F release [78, 108].
Closed
E:H2F:NADPH
Michaelis
Complex
Closed
E:NADPH
Holoenzyme
Occluded
E:H4F:NADPH
Product Release 
Complex
Occluded
E:H4F:NADP+
Product Ternary 
Complex
Occluded
E:H4F
Product Binary 
Complex
Scheme 1.5: Schematic diagram indicating conformational changes in the active site 
loops through the catalytic cycle o f DHFR.
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1.13 Loop dynamics
Given the important contacts made with substrate and cofactor and the compelling 
evidence for loop conformational changes during the catalytic cycle, much effort has 
been focused on the role of Met20 loop dynamics in ligand binding and catalysis. The 
existence of two isoforms of apo-EcDHFR (El and E2) was discovered by Dunn and 
King from their kinetic studies with trimethoprim (TMP) [122-124]. The second isomer 
was detected as a slow ligand-independent phase that followed an initial ligand- 
dependent burst phase in stopped-flow fluorescence kinetics. Interconversion between the 
isoforms occurs at a rate of 0.035 s '1 [125].
For the E. coli apo-enzyme, a second conformational equilibrium, faster than that 
between El and E2, is detectable by NMR spectroscopy within the Met20 loop. When 
magnetization transfer between the pair of resonances observed for the side chain imino 
proton of Trp22 was measured, the rate of fluctuations in the Met20 loop was estimated 
at -35 s 1 [114]. This rate is comparable to the rate of product dissociation (12 s'1) from 
the E:THF:NADPH ternary complex [74]. Conformational exchange on a similar 
timescale was also observed for the Met20 loop in the MTX [126] and folate [127] binary 
complexes.
The existence of slowly interconverting conformational states in DHFR from 
several sources has been demonstrated by NMR spectroscopy [127-129][references 
within [78]}. Because the chemical shift is a highly sensitive probe of structure, a single 
spin giving rise to multiple peaks in an NMR spectrum is indicative of a conformational 
process that is slow on the NMR chemical shift timescale. Although a direct link is 
difficult to establish, the conformational exchange that gives rise to splitting of
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resonances occurs on a slow timescale and is likely related to interconversion of the El 
and E2 isoforms that were identified from the biphasic substrate and cofactor binding 
kinetics. As in the case of the E1/E2 interconversion, binding of folate or NADPH to the 
apoenzyme appears to stabilize a single conformer, resulting in a single set of resonances 
in the NMR spectrum.
In a mutagenesis study, substitution of the central portion of the Met20 loop 
(residues 16-19) with a single glycine residue slows hydride transfer by more than 500- 
fold without significantly affecting the Michaelis constants (K m ) for substrate (H2F) or 
cofactor (NADPH) [130]. Coincidentally, the mutation results in a single set of NMR 
peaks and disappearance of the slow ligand-independent phase observed in fluorescence 
quenching experiments. On the basis of these observations, Met20 loop movement may 
be a limiting factor in substrate turnover [114].
Recent studies by Benkovic and co-workers at the central portion of the Met20 
loop for determine the relationship between the dynamic of the loop with the catalytic 
reaction of the DHFR by substituting with a single cysteine residue at the position 18 of 
the loop and the results showed not much affects in kinetic measurements. However 
when they acylated that site with a large hydrophobic fluorophore, ALEXA 488 there is a 
significant difference in kinetic activity and affinity for binding with NADPH (K d) [126].
Although NMR experiments on the folate binary complex of E. coli DHFR failed 
to reveal any resonance splitting [131, 132], evidence for an equilibrium between two 
conformational substates has recently come from high-pressure 15N/!H 2D NMR studies 
in the pressure range between 30 and 2000 bar [127, 133, 134]. Upon increasing the 
pressure to 2000 bar, several resonances in the spectrum of the folate complex split or
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broaden, revealing a second conformational state whose population is strongly 
temperature dependent. The second conformer appears to be more open and more 
hydrated than the first, and Akasaka and coworkers [127] proposed that it might represent 
an open conformation of the Met20 loop comparable to that observed in X-ray structures. 
The population of the secondary conformer is estimated to be 10% at 1 bar and 15 °C, 
and it lies about 5 kJ/mol in energy above the occluded ground state conformer. Its low, 
temperature-dependent population probably explains why it was not observed in NMR 
experiments at normal pressure.
Kraut and co-workers measured fluorescence decay for 13 EcDHFR mutants with 
slower rates of catalysis [135]. Excluding mutations at the critical Asp27, they found a 
striking correlation between dynamically quenched fluorescence and the rate of hydride 
transfer in the NADPH holoenzyme. From the loss of electron density in X-ray structures 
of the wild-type enzyme, they postulated that motions in the Met20 loop and the 
nicotinamide ring are primarily responsible for fluorescence quenching.
There has thus been a lot of evidence showing flexibility of the Met20 loop on a 
timescale (-2—40 s '1) relevant to processes of substrate and cofactor binding and product 
release. This may also contribute to catalysis through active site compression and 
stabilisation of the transition state [96]. In the closed conformation inferred for the 
Michaelis complex and the transition state, the side chain of Met20 is directed towards 
the active site and packs against the nicotinamide and pterin rings by shielding the active 
site from solvent, generating a low dielectric and raising the pKa of the putative proton- 
donating aspartate residue [96].
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1.14 Changes in protein flexibility during the catalytic cycle
Variations in crystallographic temperature factors (B-factors) for EcDHFR 
suggested that the amplitude of motions varies along the polypeptide chain, as well as 
between different liganded complexes of the enzyme [99, 107, 118]. The variation 
between structures was largely in the Met20 and F-G loops, which exhibited low B- 
factors (suggesting little motion) in the closed complexes and higher B-factors (implying 
more motion) in the occluded complexes. In the extreme case, the Met20 loop in the apo- 
enzyme had no observable electron density (indicating that it is completely disordered). 
Thus, it was suggested that loop flexibility, as well as structure, depends on ligand 
binding and therefore varies during the catalytic cycle [99].
B-factors reflect only amplitudes of motion, not timescales, and cannot 
discriminate time-dependent motions from static disorder. A more detailed picture of 
protein dynamics at the level of individual residues is obtained using solution NMR spin- 
relaxation methods. Insights into molecular motions that occur on timescales faster than 
the overall tumbling of the macromolecule can be derived from the longitudinal (Ri) and 
transverse (R2) nuclear spin-relaxation rates, and the [H]-15N heteronuclear NOE. The 
relaxation data are commonly treated using the Lipari-Szabo model-free analysis [136, 
137].
NMR studies provided a dynamic description of the structural elements of 
EcDHFR. The first comprehensive NMR study of dynamics in EcDHFR focused on the 
amide backbone and tryptophan side chain motions of the folate binary complex [131]. A 
full model-free analysis of the longitudinal (Ri) and transverse (R2) nuclear spin- 
relaxation rates, and [H]-15N heteronuclear NOE values gave a highly detailed view of
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the magnitude and timescale of motions in DHFR [138]. The study identified several 
regions with below-average S2 order parameters, indicative of large-amplitude motions 
on the picosecond-nanosecond timescale that are independent of the molecular tumbling. 
These included the hinge residues Lys38 and Val8 8 , residues Gly67 and Asp69 in the 
adenosine binding loop, and several residues in the Met20 loop and the F-G loop. The 
decreased order parameters for residues in these regions are associated with internal 
correlation times on the order of 1 - 2  nanoseconds, significantly shorter than the overall 
rotational correlation time of the molecule, around 9 ns [138].
NMR measurements were extended to complexes that model intermediates in the 
catalytic cycle [138]. The ternary complex with folate and 5,6-dihydroNADPH 
(E:folate:DHNADPH) assumes an occluded loop conformation in which the adenosine 
ring of the cofactor is bound, but the nicotinamide ring is flipped out from the active site 
pocket into the solvent [108, 138]; this complex is a model for both the ternary product 
complex (E:H4F:NADP+) and the product release complex (E:H4F:NADPH). In the 
ternary complex with folate and NADP+ (E:folate: NADP+), the Met20 loop is in the 
closed conformation and both the substrate pterin ring and the cofactor nicotinamide ring 
are inserted into the active site pocket; this complex is a model for the Michaelis complex 
formed during the catalytic cycle [99]. Finally, the folate binary complex was used as a 
model for the H4F product binary complex [138]. A details of the studies has been 
reviewed in the paper published by Osborne MJ, Wright PE and co-workers [78].
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1.15 Dynamics of protein
The rate enhancement exhibited by enzyme catalysed reactions is not fully 
understood. It is commonly accepted that the observed rate enhancement occurs mainly 
through transition state stabilisation. However, the contribution of protein dynamics has 
been shown to have a major role [78]. Numerous mutations have been introduced into 
EcDHFR to probe the role in catalysis of flexibility and conformational change in the 
Met20 and distal loops. The role of the hydrogen bonding networks formed between the 
Met20 and F-G loops and the Met20 and G-H loops in the closed and occluded 
conformers, respectively, has been investigated by Benkovic and co-workers [70, 75, 
126].
As describe above, mutation of Glyl21 to valine (G121V) results in a 40-fold 
decrease in NADPH binding affinity and a striking 200-fold decrease in the hydride 
transfer rate [75]. Furthermore, the G121V mutation introduces a new step into the 
catalytic cycle that reflects a slow (3.5 s '1) conformational change prior to hydride 
transfer. This step has been interpreted as the exchange of the nicotinamide ring of the 
NADPH into the active site to form the reactive Michaelis complex. Deletion of Glyl21 
has shown similar effects on the kinetics [139]. This is rather surprising, since mutations 
far from the active site are expected to cause only slight alterations in the active site 
geometry by communicating structural changes through intervening residues. However, if 
protein fluctuations are involved in catalysis, mutations far from the active site could 
affect the catalytic rates by simply changing the global dynamic of the protein.
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In order to support this theory, Rajagopalan et al. measured the rate for the 
forward and reverse hydride transfer step for the M42F, M42W, G121A, G121S and the 
four possible double mutant combinations [140]. They observed that while all the single 
mutations severely reduced the hydride transfer rate, the double mutation displayed non­
additive effects {i.e., the effect of double mutation is greater than the effect of the single 
mutation). This suggested a coupling of the F-G loop to distant regions of the enzyme. It 
is important, however to mention that recent experimental evidence seems to lead to 
different conclusions. Swanwick et al. used CD spectroscopy and stopped flow 
fluorescence refolding from the urea-denatured state to investigate the structure of the 
G121V mutant. In this study, G121V appears to be trapped in a highly fluorescent state; 
suggesting that the reduced catalytic activity of G121V is the consequence of non-local 
effects on the structure of the enzyme [77].
Earlier studies by Brooks and coworkers, using MD simulations, suggest that 
distant residues are coupled, exhibiting so called ‘correlated motions’ and these studies 
attempt to understand the effect of distal mutation on the chemical transformation step 
via thermodynamic factors [115]. It also showed that mutants can perturb the active site 
structurally, even if it is distant from the active site, thus rationalizing the observation by 
Benkovic and coworkers that distal mutation does affect the rate [75].
A portion of the network of coupled promoting motions in DHFR between Met20 
loop and pF-PG loop is shown in Figure 1.15. When the H2F substrate and NADPH co- 
factor are bound to the EcDHFR, the Met20 loop adopts the closed conformation, in 
which the Met20 loop is interacting strongly with NADPH. As mentioned above, the 
closed conformation is stabilized by H-bonding interactions with the pF-pG loop (residue
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117-131). Specifically, the amide backbone of both Ilel4 and Glyl5 in the Met20 loop 
will form hydrogen bonds with Aspl22 and Thrl23in the pF-pG loop. These hydrogen 
bonds are not present in occluded and open conformation of the Met20 loop. Thus, a pre­
organised structure that juxtaposes the substrate and coenzyme in an orientation 
conductive to reaction is been provided by the closed conformation [141].
Hybrid quantum/classical molecular dynamics (MD) simulations for the G121V 
mutant indicate that this is due to an increase in the ffee-energy barrier and suggest that 
the mutation may disrupt the network of coupled transition state promoting motions [142]. 
Therefore, we observe a dramatic decrease in the hydride transfer rate for the mutant 
EcDHFR [75]. This interpretation has however recently been questioned by two recent 
independent MD simulations for wild-type (WT) and mutant forms of EcDHFR [77, 143], 
suggesting that non-additivity in the kinetic effect of double mutants at these sites might 
have in origin on long range structural perturbation.
Previous studies on the Met20 loop by Benkovic and co-workers have shown that 
when a large hydrophobic compound (i.e. Alexa 488) was attached at position 18, there 
was an effect in the DHFR enzymatic reactivity [126]. However, the structure of the 
protein is similar to the wild-type protein. The attachment of the hydrophobic molecule 
seems have affected the dynamic of the protein, which led to the decrease of the 
enzymatic activity of the protein. A similar observation has been observed in the 
mammalian RNases and GO, where attachment of different carbohydrate moieties was 
able to affect their enzymatic activity but not their structures.
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Figure 1.15: A portion of the network o f coupled promoting motions in DHFR, which 
proposed by Agrawal et al. [ 141 ]. The red arrows indicate the direction of promoting 
motion.
Therefore, we have selected four different individual exposed sites for attachment 
of a carbohydrate moiety to study whether there is any effect on the protein stability and 
enzymatic reactivity. Four different types of carbohydrate moieties vary from 
monosaccharide to trisaccharides have been used in our experiments and the results of 
these studied will be discuss in following chapters.
45
Chapter 2 
Materials and Methods
2.1 Materials
Oligonucleotide primers for site-directed mutagenesis were purchased from Alta 
Biosciences (University of Birmingham) and Operon Biotechnologies GmbH (Germany). 
Pyrococcus furiosus (Pfu) DNA Polymerase was purchased from Promega. DNA markers 
solution was from New England Biolabs (NEB). N,N’-methylene-bis-acrylamide and 
N,N,N’,N’-tetramethylenediamide (TEMED), and AG® 501-X8 ion exchange resins were 
purchased from BIO-RAD. The DNA template of cysteine free EcDHFR (DM EcDHFR) 
DNA (C85A/C152S) was previously synthesized in our lab by Dr. Richard Swanwick and 
Dr. Masood Javeed The miniprep mutagenesis kit was obtained from Qiagen. E. coli 
BL21(DE3) cells were from Novagen. Micro size pore syringe filters were purchased 
from Millipore. Glycosyl iodoacetamides were contributed by Professor Sabine Flitsch 
(University of Manchester) and Dr. Nicola J. Davis. All other chemicals were purchased 
from Fluka, Sigma-Aldrich, Merck, Fisher or Melford, unless otherwise stated
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2.2 Preparation of culture media
All media described in this chapter have been prepared according to Sanbrook et al. 1989 
[144].
2.2.1 Luria Bertani (LB) medium
To prepare 1 litre (L) of media, the following were dissolved in 950 ml of deionised 
water;
10 g Bacto-tryptone/peptone
10 g NaCl
5 g Yeast extract
The pH  was adjusted to 7.5 with NaOH, the volume adjusted to 1 L, and sterilised in an 
autoclave at 121 °C, 15 lb.inch' 2 for 20 minutes.
2.2.2 LB Ampicillin/Agar plates
For the preparation of agar plates 15 g of agar powder was added to 1 L of LB media 
prior to sterillisation. After cooling to -55 °C, ampicillin was added to a concentration of 
100 pg/ml via aseptic technique and the solution carefully mixed and poured into Petri 
dishes. After solidification, plates were stored inverted at 4 °C.
48
2.2.3 2xYT medium
To prepare 1 L of media, the following were dissolved in 950 ml of deionised water;
16 g Bacto-tryptone
5 g NaCl
10 g Yeast extract
The pH was adjusted to 7.5 with NaOH, the volume adjusted to 1 L, and sterilised in an 
autoclaved at 121 °C, 15 lb.inch'2  for 20 minutes
2.3 The strains of E. coli
2.3.1 Expression strains
2.3.1.1 E.coU BL21(DE3)
The designation DE3 indicates that the strains contain the ADE3 lysogen that carries the 
gene for T7 RNA polymerase under control of the lacUV5 promoter. Isopropyl-P-D- 
thiogalactopyranoside (IPTG) is required to induce expression of T7 RNA polymerase.
2.3.1.2 E. coli BL21(DE3) pLysS
The pLysS plasmid produces T7 lysozyme, an inhibitor of T7 RNA polymerase which 
functions to lower the basal levels of recombinant protein which may be toxic to the cells 
or lower cell growth and viability prior to induction.
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2.3.2 Cloning strains
The E. coli XLl-Blue strain was used for the preparation of high-quality plasmid DNA 
due to its ability to repair nicks in the transfected plasmid following site directed 
mutagenesis. These cells have high transformation efficiency and are supplied with the 
Quick-site directed mutagenesis kit.
2.4 Preparation of sterile solutions
2.4.1 Ampicillin solution (50 mg/ml)
Ampicillin sodium salt (100 mg) was dissolved in 2 ml sterile deionised water, filter 
sterilised using a 0.22 pm syringe filter, aliquoted and stored at -20 °C.
2.4.2 Chloramphenicol solution (34 mg/ml)
Chloramphenicol (34 mg) was dissolved in 1 ml ethanol (EtOH) and filter sterilised using 
a 0.22 pm syringe filter, aliquoted and stored at -20 °C.
2.4.3 Isopropyl-p-D-thiogalactopyranoside (IPTG) solution (0.2 g/ml)
EPTG (2 g) was dissolved in 10 ml sterile deionised water and filter sterilised using a 0.22 
pm syringe filter, aliquoted and stored at -20 °C. IPTG working concentration for large 
scale expression was 0 . 1 2  mg/ml.
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2.4.4 Competent Cell Buffer A
A 100 mM solution of calcium chloride (CaCb) was prepared in deionised water, 
sterilised in an autoclave at 121 °C, 15 lb.inch'2 for 20 minutes and stored at 4 °C.
2.4.5 Competent Cell Buffer B
A solution of 100 mM CaCl2/15 % glycerol was prepared in deionised water, sterilised in 
an autoclave at 121 °C, 15 lb.inch'2 for 20 minutes and stored at 4 °C.
2.5 Preparation of non-sterile solutions
2.5.1 DNA Loading buffer (Agarose Gels)
The following reagents were added to 847.5 pi of deionised water;
2.5 pi 0.25% w/v Bromophenol blue
2.5 mg Xylencyanol FF
150.0 pi Glycerol
Solutes were fully dissolved and the solution, stored at room temperature (RT).
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2.5.2 50x TAE electrophoresis buffer (Agarose Gels)
A solution of 50x TAE electrophoresis buffer was prepared as follows;
242.0 g Tris Base
100.0 ml EDTA (0.5 M, pH  8.0)
57.1 ml Glacial acetic acid
Solutes were fully dissolved, the volume adjusted to 1 L with deionised water and stored
atRT.
2.53 Ethidium Bromide solution (EtBr)
Ethidium bromide solution was prepared as follows. 10 mg of EtBr was dissolved in 1 ml 
of deionised water. Solutes were fully dissolved, the tube/sample wrapped with foil to 
prevent light exposure and stored at 4 °C.
2.5.4 MTEN buffer
The following solutes were dissolved in 150 ml deionised water to prepare the final 
concentration of each solute;
1.95 g 2-[N-morpholino]ethanesulfonic acid (MES) (50 mM)
0.66 g Tris-base (25 mM)
0.30 ml Diethanolamine (25 mM)
1.17 g NaCl(lOOmM)
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The pH was adjusted to pH 7.0 with 1 M NaOH/HCl and the total volume taken to 200 
ml with deionised water and stored at RT.
2.5.5 Phosphate buffer
Phosphate buffers at different pH  values were prepared from 1 M stock solutions of 
potassium phosphate (KiHjPC>4, see table 2.1) and sodium phosphate (NaiHjPCU, see table 
2.2) buffers, and stored at RT. The total volume at the required pH  was taken to 1 L with 
deionised water to prepare a working concentration of 100 mM phosphate buffer.
Table 2.1: Proportions o f K2HPO4 and KH 2P04for the preparation o f KiPO4 buffers at 
given pH.
pH Volume of 1 M K2HPO4 (ml) Volume of 1 M KH2P 0 4 (ml)
6 . 0 13.2 8 6 . 8
6.4 27.8 72.2
6 . 8 49.7 50.3
7.0 61.5 38.5
7.2 71.7 28.3
7.4 80.2 19.8
7.6 8 6 . 6 13.4
7.8 90.8 9.2
8 . 0 94 6 . 0
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Table 2.2: Proportions o f Na2HP0 4 <md NaHfPOtfor the preparation o f buffers at given 
pH.
pH Volume of 1 M Na2H P04 (ml) Volume of 1 M NaH2P0 4  (ml)
6 . 0 1 2 . 0 8 8 . 0
6.4 25.5 74.5
6 . 8 46.3 53.7
7.0 57.7 42.3
7.2 68.4 31.6
7.4 77.4 2 2 . 6
7.6 84.5 15.5
7.8 89.6 10.4
8 . 0 93.2 6 . 8
2.5.6 Tris buffer
To 950 ml of deionised water the following was added to prepare the final concentration 
of each solute;
6.06 g Tris-base (50 mM)
1.80 g EDTA (5mM)
Solutes were fully dissolved, the pH  adjusted to 8.0 with 1 M NaOH/HCl and the volume 
was taken to 1 L with deionised water. For preparation of 0.15 M NaCl -  Tris buffer (50 
mM), 8.76 g of NaCl was added per 1 L buffer.
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2.5.7 SDS-PAGE Solutions
2.5.7.1 Buffer 1 (1.5 M Tris-HCl,/iH 8.8)
Tris-base (27.5g) was dissolved in 80.0 ml deionised water. The pH was adjusted to pH
8 . 8  with 5 M HC1, the total volume was taken to 150 ml with deionised water and stored 
at 4 °C.
2.5.7.2 Buffer 2 (0.5 M Tris-HCl,/>H 6.8)
Tris-base (6.0 g) was dissolved in 60.0 ml deionised water. The pH was adjusted to pH
6 . 8  with 5 M HC1, the total volume was taken to 100 ml with deionised water and stored 
at 4 °C.
2.5.7.3 SDS solution 10 % (w/v)
Sodium dodecyl sulphate (SDS, 10.0 g) was dissolved in 100.0 ml deionised water. The 
solution was stored at RT.
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2.5.7.4 Protein loading buffer
Protein loading buffer consisted of:
1.25 ml Tris-HCl (0.5 M, pH  6 .8 )
2.50 ml Glycerol
0.20 ml 10% (w/v) Bromophenol blue
2.00 ml 10% (w/v) SDS
3.55 ml Deionised water
The solution was stored at RT. Immediately prior to use, P-Mercaptoethanol (P-ME) was 
added to a final concentration of 5 % (v/v). Protein samples were diluted 1:2 with the 
loading buffer and heated at 90 °C for 5 min.
2.5.7.5 lOx Electrode (Running) buffer,pH  8.3
The following was dissolved in 950.0 ml deionised water;
30.3 g Tris-base
144.0 g Glycine
10.1 g SDS
The pH was adjusted to 8.3, the total volume taken to 1 L and stored at RT. Immediately 
prior to running a gel, lOx electrode buffer was diluted to lx buffer via addition of 
deionised water.
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2.5.7.6 Staining solution
SDS-PAGE staining solution comprised;
0.25 ml Coomassie Brilliant Blue (1.25 g/500 ml)
90.00 ml Ethanol: deionised water (1:1. v/v)
10.00 ml Glacial acetic acid
The solution was stored at RT. Staining solution was used to stain SDS-PAGE gel at RT 
for 2 0  minutes whilst stirring.
2.5.7.7 De-stain solution
SDS-PAGE de-stain solution comprised;
100 ml Glacial acetic acid
120 ml Isopropanol
800 ml Deionised water
The solution was stored at RT. De-stain solution was used to destain Coomassie Brilliant 
Blue stained SDS-PAGE gels at RT whilst stirring.
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2.5.8 Tannic Assay
It is an alternative method for determine protein concentration and this method was 
developed by Mejbaum-katzenellenbogen & Dobryszycka et al. 1959 [145]
2.5.8.1 Tannic reagent
The following reagents were added to 196 ml 1 M HC1 and dissolved by heating to 80 °C;
4 ml Phenol
20 g Tannic acid
The solution was stored at RT.
2.5.8.2 Gum Arabic solution
0.4 g of gum arabic was added to 200 ml deionised water and dissolved by heating to 30 
°C. The solution was stored at RT.
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2.6 Site-directed mutagenesis
2.6.1 Primer design
Primers were designed as per manufacturer’s instructions {QuickChange™ Site-Directed 
Mutagenesis Kit [146]}. Primers (forward and reverse) containing the desired mutation 
must anneal to the same sequence on complementary strands of the DNA, which should 
contain between 25 and 45 bases and the desired mutation should be positioned in the 
middle of the primer sequence. Guanine and cytosine bases should compromise at least 
40% of the primer sequence, with the melting temperature (Tm) being at least 78 °C. The 
Tm for each primer was calculated using the following formula:
Tm= 81.5 + 0.41 (%GC) -  675/N - %mismatch Equation 2.1
(N is the length in bases and %GC and %mismatch are whole numbers)
Primers sequences used for the production of the desired mutants described within this 
work were as follows:
D87C Forward: 5’ -CGCGGCGGCGGGTTGCGTACCAGAAATCATGG- 3’
D87C Reverse: 5’ -CCATGATTTCTGGTACGCAACCCGCCGCCGCG- 3’
N18C Forward: 5’ -CGCGTTATCGGCATGGAATGCGCCATGCCGTGG- 3’
N18C Reverse: 5’ -CCACGGCATGGCGCATTCCATGCCGATAACGCG- 3’
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R52C Forward: 5’ -CTGGGAATCAATCGGTTGCCCGTTGCCAGGAC- 3’
R52C Reverse: 5’ -GTCCTGGCAACGGGCAACCGATTGATTCCCAG- 3’
D132C Forward: 5’ -CCGGATTACGAGCCGGATTGCTGGGAATCGG- 3’
D132C Reverse: 5’ -CCGATTCCCAGCAATCCGGCTCGTAATCCGG- 3’
(Text in bold indicates the position of the desired cysteine mutation)
2.6.2 dNTP mix
To prepare a stock solution of 2 mM dNTP mixture solution, 2 pi each of 20 mM of dATP, 
dGTP, dCTP, and dTTP were mixed. The total volume was taken to 20 pi with sterile 
deionised water, the solution was mixed thoroughly and stored at -20 °C.
2.6.3 Mutagenic polymerase chain reaction (PCR) protocol
The reactions were set up in 0.5 ml sterile Eppendorf tubes where the following was 
added;
lp l DNA template (5 -  50 ng)
4 pi Forwards primer (125 ng)
4 pi Reverse primer (125 ng)
lp l dNTP mix (2 mM)
5 pi Pfu DNA polymerase buffer (0.5 U)
1 pi Pfu DNA polymerase
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The total volume was taken to 50 p.1 with sterile deionised water, the reaction mixture was 
covered with mineral oil and ready for Section 2.6.4.
2.6.4 Mutagenic PCR procedure
The polymerase chain reaction (PCR) was carried out according to the recommended 
thermal cycling conditions for Pfu DNA polymerase [“XLl-Blue competent cells”, 
Instruction manual [146]], summarized in Table 2.3.
Table 2.3: Recommended thermal cycling conditions for Pfu DNA polymerase-mediated 
PCR amplification.
Step Temperature (°C) Time (sec) Number of cycles
Initial Denaturation 95 30 1
Denaturation 95 30
Annealing 55 60 16
Elongation 6 8 300
Final Extension 6 8 60 1
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2.6.5 Agarose gel electrophoresis
To prepare 1% agarose gel, 1.0 g of agarose powder was dissolved in 100 ml of 0.5x TAE 
buffer (dilute 1 ml 50x TAE buffer with 99 ml of deionised water) by heating in a 
microwave oven for 1 min. EtBr (0.2 mg/ml) was added and the mixture poured into a 
Mini Gel Kit Tray (CBS Scientific) to solidify. The gel was covered in lx TAE buffer. 
DNA samples were prepared by mixing 5 pi PCR product with 1 pi of DNA loading 
buffer. The gel was run for 30 min at 8  volts/cm. EtBr fluorescence was visualised using 
an ultraviolet (UV) lamp at 245 nm [147].
2.6.6 Digestion with Diplococcus pneumoniae restriction endonuclease 
(Dpnl)
Restriction digestion with Dpnl was carried out immediately following site-directed 
mutagenesis in order to remove template DNA. Site directed mutagenesis products were 
incubated with Dpnl for 1 h at 37 °C as according to manufacturers’ instructions. Dpnl 
recognizes and digests methylated sequences only (Figure 2.1). Dpnl functions by 
reading the methylation status of its recognition sequence, comparing the methylation 
status of the two adenines within the recognition sequence. If both adenines are 
unmethylated (a signal that the DNA is not host DNA) the enzymes avoids the restriction 
site. The enzyme acts as an endonuclease secondary to a maintenance methylase, thus 
template DNA gets digested and the newly synthesized (mutant) DNA is.untouched.
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CH-
5'...GA
3'...CT
TC...3' 
AG...5'
CH.
Figure 2.1: Methylated sequence recognized by Dpnl.
2.7 Experimental protocols
2.7.1 Preparation and storage of DNA constructs
This section describes the procedures and materials required for the construction, 
manipulation, and storage of the DNA construct used during the course of this research. 
All DNA constructs including primers and plasmids were stored at -20 °C.
2.7.1.1 Purification of plasmid DNA
Plasmid DNA was purified according to manufacturers instructions from transformed E. 
coli strains (XLl-Blue) using a QLAGEN Miniprep Kit (QLAprep® Spin Miniprep Kit). A 
single colony was picked from a LB ampicillin agar plate and grown in 5 ml LB- 
ampicillin medium overnight (-10 h) at 37 °C, 160 rpm. The cells were harvested by 
centrifugation (3,430 g) and the manufacturer’s protocol followed based on the Bimboim 
and Doly method [148]. Eluted DNA was stored at -20 °C.
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2.7.1.2 Quantification of oligonucleotides and plasmid DNA
Quantification of all oligonucleotides and plasmid DNA was performed using a 
Shimadzu Biospec-mini spectrophotometer. Optical density (OD) measurements were 
taken at 260 nm and 280 nm. An OD2 6 0  value of 1.0 equates to 50 pg/ml of double 
stranded DNA (dsDNA), 30 pg/ml of oligonucleotide, or 40 pg/ml of single stranded 
DNA (ssDNA). The value derived from the ratio of OD2 6 0/OD2 8 0  gave an indication of 
the purity of the DNA sample. An observed value between 1.8 and 2.0 indicates the DNA 
sample was pure and free from protein contamination.
2.7.1.3 Sequencing of plasmid DNA
DNA at a concentration between 200-500 ng/pl was added to 3.5 pi of 1 pM T7 primer. 
The total volume was brought to 10 pi with sterile deionised water. DNA sequencing was 
performed at the University of Birmingham Genomics Laboratory, Birmingham, UK. 
Alternatively 15 pi of 100 ng/pl DNA was sequenced by Lark Technologies, Essex, UK.
2.7.1.4 Cleavage of plasmid DNA using restriction enzymes
Plasmid DNA were restriction digested to check for the presence of a particular insert 
(without the need for sequencing) and allow the sub-cloning of inserts between various 
vectors. In all cases the manufacturer’s procedures were followed; 0.3 pg of plasmid 
DNA (10 pi) was mixed with 1-5 U (~1 pi) of restriction enzyme, lOx buffer (~1 pi) and 
sterile deionised water. The reaction mixture was incubated at 37 °C for a defined period 
of time varying from an hour to overnight (o/n). In the case of double digests, where the 
plasmid DNA was simultaneously cut by two different restriction enzymes, a buffer
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compatible with both enzymes was used as specified by the manufacturer.
2.7.1.5 DNA purification and visualisation
Double stranded DNA (dsDNA, >100 base pairs) was visualised by agarose gel 
electrophoresis (Section 2.6.5). DNA of different sizes run at different speeds through the 
agarose gel and separate according to their size and shape (i.e. supercoiled or linear). 
PCR products were compared directly to a DNA ladder (Bioline) to verify they were at 
the correct size.
2.7.1.6 DNA ethanol (EtOH) precipitates
Following sequencing of plasmid DNA, EtOH precipitates and glycerol stocks were 
made of all new constructs. Procedures described in this section were carried out at rt and 
cell solutions were centrifuged at 3,430 g in Eppendorf® 5415R centrifuge using aseptic 
technique. Once the standard plasmid DNA preparation was complete (Section 2.7.1.1), 
EtOH precipitates were prepared by eluting the bound DNA from the QIAprep column 
into 100 pi of sterile deionised water. 7.5 M ammonium acetate (50 pi) and 100% 
absolute EtOH (375 pi) were added to the DNA eluent and incubated for 10 minutes 
followed by centrifugation at 3,430 g, 15 minutes. The supernatant was carefully 
removed and the DNA pellet washed with 250 pi of 80% EtOH (v/v in deionised water) 
followed by centrifugation at 3,430 g, 10 minutes and stored at -80 °C.
65
2.7.1.7 Glycerol stocks
Glycerol stocks were prepared by incubating E. coli XL 1-Blue competent cells 
containing the plasmid of interest at 37 °C, 180 rpm until an OD6 0 0 °f ~0.6 was reached. 
A small volume of the culture (1 ml) was then aseptically mixed with 100 pi of 80% 
sterile glycerol (v/v deionised water), mixed and stored at -80 °C. Glycerol stocks could 
then be streaked on a pre-warmed agar plate containing the appropriate antibiotic and 
incubated o/n at 37 °C.
2.7.1.8 Preparation of competent cells
*E. coli competent cells were streaked on a sterile LB agar plate and incubated at 37 °C 
o/n. A single colony was picked and grown o/n in 5 ml of LB medium at 37 °C, 180 rpm. 
The following day, the o/n culture was incubated in 50 ml 2x YT medium at 37 °C, 180 
rpm until an OD6 0 0  of 0.5 was reached. The culture was then centrifuged for 10 min at
8,000 g, the supernatant discarded, and the pellet re-suspended in 20 ml of pre-chilled 
Competent Cell Buffer A (See Section 2.4.4) on ice for 20 min. The solution was 
centrifuged as before and the supernatant discarded. The pellet was re-suspended in 5-10 
ml of Competent Cell Buffer B (See Section 2.4.5) and placed on ice for 1 h. The 
competent cells were aliquoted into 100 pi, fast-frozen in liquid nitrogen, and stored at 
-80 °C.
*XL1-Blue competent cells used to extract DNA and BL21(DE3) competent cells used to extract protein.
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2.8 Protein purification and characterization
This section describes the procedures and materials required for the production, 
purification and analysis of EcDHFR wild-type (WT) and mutants. All enzymes were 
stored at 4 °C and assays at 20 °C unless otherwise stated.
2.8.1 Transformation of DNA constructs into competent cells
Plasmid DNA containing the required DNA construct was transformed into E. coli 
BL21(DE3) cells. 0.1 pg plasmid construct (1 pi) was added to 100 pi of cell suspension 
previously thawed on ice, and then incubated on ice for 30 minutes. The mixture was heat 
shocked via water bath at 42 °C for 30 sec. Preheated LB medium (1 ml) was added to the 
cell suspension and incubated at 37 °C, 180 rpm for 1 hour, followed by centrifugation 
(3,430 g) for 2 min. The pellet was re-suspended with 100 pi LB-medium and plated on a 
preheated sterile LB agar plate containing the appropriate antibiotic (See Ssection 2.2.2). 
Inverted plates were incubated o/n at 37 °C then stored at 4 °C.
2.8.2 Test induction
Test inductions were carried out to determine if the cells were producing the protein of 
interest. Two colonies were picked and grown o/n in two separate sterile tubes containing 
5 ml LB medium and 10 pi 0.27 M ampicillin. From each tube, 100 pi was grown in 5 ml 
fresh LB medium containing 10 pi 0.27 M ampicillin and incubated at 37 °C, 180 rpm 
until an OD6 0 0  of 0.5 was reached; 1 ml of the solution was then removed for SDS-PAGE 
analysis. The remaining culture was then induced with 40 pi of 0.4 mM IPTG and
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incubated for 3 h at 37 °C, 180 rpm. A sample (1 ml) of the incubated mixture was taken 
every hour for SDS-PAGE analysis, centrifuged (3,430 g) and the supernatant discarded. 
Protein loading buffer (100 |il) was added and heated to 90 °C for 5 min. SDS-PAGE 
analysis was performed to test for cellular expression of protein (Section 2.5.7). Protein 
identification will be discussed at Section 2.8.4.
2.8.3 Large scale expression
A sterile 100 ml flask containing 60 ml of LB medium, 180 fil of 0.27 mM ampicillin, 
was inoculated with a single cell colony and grown o/n at 37 °C, 180 rpm. The cell 
culture was divided equally into six flasks containing 500 ml of sterile LB medium, 1 ml 
of 0.27 mM ampicillin and incubated further until an OD6 0 0  of 0.5 was reached. A 1 ml 
sample was removed from each flask for SDS-PAGE analysis. Protein expression was 
induced with 1.0 ml (60 mg/ml) IPTG for 3 to 4 h at 37 °C, 180 rpm. The cells were 
harvested at 11,000 g, for 10 minutes in Sorvall® RC-5B centrifuge. The supernatant was 
discarded and the pellet stored at -20 °C.
2.8.4 Protein identification using SDS-PAGE
The Mini-PROTEAN™ 3 cell (BioRad) was used to identify the protein of interest and to 
monitor its purification. The stacking gel was used to concentrate the samples and the 
resolving gel was used to separate the proteins by their molecular weight (Mw). The 
following solutions were prepared [Table 2.4] [149].
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Table 2.4: Solutions for SDS-PAGE.
dH20 30 % Acrylamide * Buffer 10 % w/v SDS
(ml) (ml) (ml) (ml)
Stacking (5 %) 5.7 1.7 2.5 0.1
Resolving (15 %) 2.4 5.0 2.5 0.1
♦Resolving Gel buffer -  1.5 M Tris-HCl (pH 8.8); Stacking Gel buffer -  0.5 M Tris-HCl (pH 6.8). See 
Section 2.5.6 for buffer preparation.
to pouring the gel, the following reagents were added;
100 pi 10 % APS 
10 pi TEMED
Stacking Gel: 50 pi 10 % APS
10 pi TEMED
Samples were mixed with protein loading buffer (1:2) and heated to 90 °C for 5 min. The 
samples were loaded into the gel wells and run for 50 min at 180 V in lx running buffer 
(See Section 2.5.7.5). Gels were stained with staining solution followed by incubation 
with the de-stain solution to visualise protein bands (See Section 2.5.7), via UV light.
Immediately prior 
Resolving Gel:
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2.8.5 Purification of EcDHFR
As previously stated, BL21(DE3) E. coli cells were used for large scale expression of all 
proteins mutants. Frozen cells previously harvested during large scale expression were 
thawed on ice and re-suspended in 50 mM Tris buffer (pH 8.5, 15 ml). The suspension 
was sonicated for 5 min on ice and centrifuged at 27,000 g, 20 minutes in Sorvall® RC- 
5B. The filtered supernatant (0.22 pm filter, Millipore) was applied to a column contained 
immobilized methotrexate (MTX) resin (5 ml bed volume, Amersham Pharmacia Biotech 
AB), pre-equilibrated with lysate buffer (50 mM Tris buffer, pH 8.5) and washed (4x 
column volume) with the same buffer with 0.15 M NaCl. The column was extensively 
washed (20x column volume) with the same buffer. Bound protein was eluted with a 
buffer containing 50 mM Tris buffer (pH 8.5), 0.15 M NaCl, and 5 mM folic acid. The 
eluted protein was analysed by SDS-PAGE (Section 2.8.4). EcDHFR was dialysed o/n 
against 3 L of 5 mM phosphate buffer (pH 7.0) containing 5 mM EDTA with two changes 
of buffer. Dialysed protein was lyophilised to reduce the total volume of buffer. Two 
different methods have been used for further purification EcDHFR from folic acid (See 
Section 2.8.5.1 and Section 2.8.5.2).
2.8.5.1 DEAE anion exchange chromatography
A diethylaminoethyl (DEAE) sepharose column (15 ml bed volume, Amersham 
Pharmacia Biotech AB) was pre-equilibrated with lysate buffer. The column was 
extensively washed (lOx column volume) with the same buffer. The lyophilised protein 
was dissolved in a small volume (~ 2 ml) of fresh dialysis buffer and applied to the 
DEAE-sepharose column. Bound protein was eluted with three column volumes of buffer
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with a 0 to 1 M NaCl gradient in 50 mM of Tris buffer (pH 8.3) containing 5 mM EDTA. 
EcDHFR fractions were identified using SDS-PAGE and absorbance measured at 280 nm. 
Fractions containing EcDHFR were dialysed o/n against 3 L of dialysed buffer containing 
5 mM EDTA with two changes of buffer. The flow rate was 2 ml/min.
2.8.5.2 SEPHADEX G-100 size exclusion chromatography
SEPHADEX G-100 contains beads for gel filtration prepared by cross-linking dextran 
with epichlorohydrin, and used to fractionate proteins from 4000 to 150,000 Mw. The 
lyophilised protein was dissolved in a small volume (~ 2 ml) of fresh dialysis buffer and 
applied to the SEPHADEX G-100 column (15 ml, Sigma-Aldrich) which has pre- 
equilibrated with lysate buffer. Bound protein was eluted with 50 ml 0.5 M NaCl in 50 
mM of Tris buffer (pH 8.3) containing 5 mM EDTA. EcDHFR fractions were identified 
using SDS-PAGE and their absorbance measured at 280 nm. Fractions containing 
EcDHFR were dialysed o/n against 3 L of dialysed buffer containing 5 mM EDTA with 
two changes of buffer. The flow rate was 1.5 ml/min.
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2.8.6 Protein identification using mass spectrometry
The mass of EcDHFR was determined by matrix assisted laser desorption ionization 
time-of flight mass spectrometry (MALDI-TOF) using a Bruker Biflex IV machine. The 
matrix used was *sinapic acid (10 mg/ml in 1:1, 1:2, 1:4 ratio dilution deionised water). 
Myoglobin (Mw~ 16,952) at a concentration of 10 pmol/pl was used to calibrate the 
machine.
♦Alternative matrix such as a-cyano-4-hydroxy-cinnamic acid was used for analysis of peptides (Mw < 
6,000).
2.8.7 Determine of protein concentration
Three alternative methods were used to determine the EcDHFR concentration. The 
accuracy of the protein concentration is very important prior for further analysis.
2.8.7.1 Absorbance measurement
The concentration of the WT EcDHFR enzyme was calculated using Shimadzu UV- 
2401PC, UV/Vis spectrophotometer using an extinction coefficient at 280 nm (£28 0) of 
31,100 cm ’M '1 [74]. To determine presence of contaminating nucleic acids, if a ratio of 
the absorbance value at 280 nm compared to 260 nm <1.6 (A2 8 0/A2 6 0  <1.6) indicated a 
low level of contamination.
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2.8.7.2 Micro-tannin Assay
The concentration of solutions of EcDHFR mutant proteins was determined using the 
micro-tannin assay calibrated against a standard concentration of bovine serum albumin 
(BSA) [150]. Optical density measurements were taken at 500 nm using a Shimadzu Bio- 
Spec-mini spectrophotometer. The accuracy for this assay was assumed to be between 10 
and 80 pg of protein.
In a water bath, 1 ml of protein solution and the BSA solution was incubated for 5 min at 
30 °C. Pre-warmed tannic reagent (1 ml) was added and the mixture incubated for a 
further 10 minutes. The solution was removed from the waterbath and 1 ml of gum arabic 
solution added and allowed to cool to RT (Section 2.5.8). An OD5 0 0  was taken to measure 
protein concentration.
2.8.7.3 Methotrexate (MTX) titration
The concentration of the EcDHFR mutant proteins was also calculated by observing the 
quench of the intrinsic tryptophan within the protein via MTX titration using a 
PerkinElmer LS 55 Luminescence spectrometer. The fluorescence emission spectrum of 
DHFR showed a maximum at 345 nm when excited at 290 nm. The total volume of MTX 
to quench the protein was used to determine the protein concentration;
MjVi = M2V2 Equation 2.2
Where Mi is the initial concentration of sample, M2 is the final concentration of sample, 
Vi is the initial volume used, and V2 is the final volume used.
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2.8.8 Protein cleavage using trypsin digestion
EcDHFR was digested into polypeptides with the acetylated protease trypsin. EcDHFR 
protein (100 pi, 10 pM) in 100 mM ammonium hydrogen carbonate (pH 8 -  8.5) buffer 
was prepared. Trypsin (0.2 unit, 1 pi) was added to the protein sample, gentle mixed and 
incubated o/n at 37 °C. The protein sample was then lyophilized to remove the 
ammonium salt and stored at -20 °C. Prior to use, the protein was dissolved in 10 pi of 
deionised water or matrix for MALDI-TOF analysis (Section 2.8.6).
2.8.9 Protein storage
EcDHFR could be stored as a lyophilized product and its catalytic activity had no 
significant difference with protein solution, stored at -20 °C. EcDHFR could be stored at 
-20 °C for several months without any loss in activity.
2.9 Synthesis and purificatioin of glyco-EcDHFR
The methodology for derivatisation of the desired mutated glycosylated EcDHFR 
cysteine mutant (glycosyl haloacetamide) will be discussed in this section.
Protein sample (50 pi, 50 mM) was diluted with 150 pi of 50 mM phosphate buffer (pH 
8.5), 1 mM TCEP, and incubated at 20 °C for 10 min. Glycosyl haloacetamide (5 mg) was 
dissolved in 100 pi of 50 mM phosphate buffer (pH 8.5) and mixed with the protein 
sample. The mixture was incubated in the dark at 4 °C for 36 h. The glycol-EcDHFR
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protein was dialysed against 3 L of dialysis buffer containing 5 mM EDTA o/n and the 
protein sample was analysed using MALDI-TOF (Section 2.8.6) to determine any 
presence of free protein (unglycosylated protein) within the sample. For example, the 
unglycosylated DM-D87C EcDHFR with glucose-N-acetamide (GlcNAc) haloacetamide 
shows a molecular weight (Mw) at 17,989. Upon glycosylation, a peak indicating the Mw 
18,237 is observed due to addition of one GlcNAc acetamide (Mw~248).
Purification of the glycol-EcDHFR was performed when at least 15 % of the protein 
sample contained sugar free proteins via MALDI-TOF analysis (Section 2.8.6). Mixtures 
of glycosylated and unglycosylated proteins were treated at pH 7.0 with 2-[(biotinoyl)- 
amino]-ethyl methanethiosulfonate (MTSEA) to produce mixtures of proteins that were 
either glycoslyated or biotinylated on the mutated Cys site. The sample mixture was 
incubated in 25 mM MES pH 7.5, 100 mM NaCl at 4 °C for 12 h. Reaction products were 
dialysed against dialysis buffer containing 5 mM EDTA o/n. The mixture was applied to 
avidin immobilized on agarose (-30 nmol avidin per ml of resin, Promega) and 
unbiotinylated proteins were eluted with 10 mM phosphate buffer (pH 7.5), 100 mM 
NaCl (Elution buffer). The overall yield varied from 25 -  65% [71].
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2.10 Techniques for protein analysis
2.10.1 Circular dichroism (CD) spectroscopy and thermal denaturation
CD spectroscopy is a common technique used to characterise a protein’s secondary 
structure and thermo-stability. In this work, CD spectroscopy was used to measure the 
melting temperature (thermo-stability) of EcDHFR and its glycosylated forms.
Experiments were performed using a Jasco 815 or Applied Photophysics Chirascan CD 
spectrometer. The resulting milli-degree values (0) were converted to mean residue 
ellipticity (MRE or [©]) expressed as deg cm2/dmol/residue. The value of the MRE was 
calculated using Equation 2.3;
[0] MRE = [0] / (10 * m * c * 1) Equation 2.3
where [0] is the measured ellipticity in mdeg, m is the number of residues, c is the 
concentration in M, and 1 is the path-length of the cuvette in cm.
EcDHFR (10 pM) in 5 mM phosphate buffer (pH 7.0) was placed in a stopped-lid quartz 
cuvette (10 mm path-length, Helman). Wavelengths were measured at every 1.0 nm 
ranging from 280.0 -  200.0 nm with a bandwidth of 1 mm, and a time per nm wavelength 
of 4 s used to obtain a far UV-CD spectrum of the enzyme.
In the temperature denaturation experiments, the temperature was increased at 0.4 °C/min. 
The temperature range used was from 20.0 -  80.0 °C. The unfolding of the protein was 
monitored at 222.0 nm and the melting temperature was taken as the midpoint of the 
observed transition. MRE2 2 2 was determined using Equation 2.3.
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2.10.2 Kinetic assays
2.10.2.1 Preparation of substrates and co-factor
The preparation of 7,8-dihydrofolate (H2F) was performed as previously described by 
Blakley (1984) [8 8 ]. Folic acid (38.2 mg) was dissolved in a freshly prepared, filtered 
solution of ascorbic acid (1.0 g/10 ml) and the pH was taken to 6.0 by drop wise addition 
of 1 M NaOH. The folate solution was reduced to tetrahydrofolate (H4F) by addition of 
sodium dithionite (400 mg) at 4 °C. The formation of H2F was achieved by slowly ( 1  
ml/min) adding glacial acetic acid until the pH was 2.8. The solution was centrifuged at 
27,000 g for 5 min at 4 °C. The white precipitate of H2F was then re-suspended in 10 ml 
ascorbate solution (pH 6.0) and re-precipitated as described above. H2F was re-suspended 
and washed with acetone and diethyl ether. All operations were performed anaerobically 
under nitrogen and all buffers were degassed before use. The presence of H2F was 
confirmed by NMR and UV/Vis spectrophotometry by comparison with a known 
standard.
(4R)-[2H]-NADPH (NADPD) was synthesised by reduction of NADP+ (35 mg) using the 
NADP+ dependent alcohol dehydrogenase from Thermoanaerobium brokii (3.8 units) and 
dg propan-2-ol (1.2 ml) [151]. The mixture was incubated in 25 mM ethanolamine (pH
7.8) at 42 °C. The reaction was completed in less than 1 h by monitored the absorbance 
reading at 340 nm. Purification of NADPD was achieved using anion exchange 
chromatography (Mono Q™ HR 5/5, Pharmacia) [152], using 25 mM ethanolamine (pH
7.8) as a calibrating buffer and eluting with a 75% gradient of NaCl over 10 min. 
Fractions that showed an absorbance ratio at 260 and 340 nm (A260/A3 40) of 2.4 or less
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were collected, aliquoted and stored at -20 °C as lyophilized products.
NADPH and NADPD concentrations were determined by spectrophotometer using an 
£340 of 6,220 cm ^M'1 [74]. Similarly the concentration of H2F was determined using an 
6 2 8 2  of 28,000 cm ’M'1 at pH 7.4 [153].
2.10.2.2 Pre-steady state measurement of EcDHFR
Pre-steady state kinetic experiments were performed on an Applied Photophysics 
stopped-flow spectrophotometer using 2.5 ml syringes. Using the difference between the 
absorption and emission spectra of the co-factor in its reduced and oxidised forms, the 
loss of a hydride in NADPH was monitored during the reaction catalysed by DHFR. The 
nicotinamide ring of NADPH has a maximum fluorescence absorption at 340 nm and a 
maximum emission at 450 nm. However the oxidized form, NADP+ has no adsorption or 
emission at these wavelengths. Therefore conversion of NADPH to NADP+ resulted in a 
decrease in the relative fluorescence intensity at 450 nm upon excitation at 340 nm. A 
450 nm cut off filter was used.
Pre-steady state kinetic measurements were monitored by measuring the fluorescence 
resonance energy transfer (FRET) between the protein and the reduced co-factor 
(NADPH). This technique relies on two important factors: 1) the overlap between the 
emission spectrum of tryptophan and the absorption spectrum of NADPH, and 2) the 
distance of the two chromophores (-10 to 100 A). EcDHFR has a tryptophan residue in 
the active site, therefore exciting the reaction mixture at 292 nm results in the 
fluorescence resonance energy transfer (FRET) at 340 nm between the tryptophan and 
NADPH. This reaction can be followed by observing the decay of fluorescence of the 
reduced co-factor at 450 nm. EcDHFR (8 pM) solution was pre-incubated with NADPH
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(4 jiM) for at least 15 min at 20 °C to avoid hysteretic behavior [74]. As mentioned 
previously, a 450 nm cut off filter was used The reaction was initiated by rapidly mixing, 
at a controlled temperature, an equal volume of H2F (100 pM) solution. The reaction 
buffer used was 100 mM MTEN (pH 7.0, Section 2.5.4). The reaction was monitored 
using a 400 nm cut-off filter. The dead time of the experiment was 2 msec. The observed 
kinetic traces were fitted to single or double exponential decay using the provided 
software (Applied PhotoPhysics)
2.10.2.3 Steady state measurement of EcDHFR
Turn-over rates were measured spectrophotmetrically following the decrease in 
absorbance at 340 nm during the reaction ( 8 3 4 0 , n a d p h  + t h f  = 11,800 M^cm'1 [74, 154]. 
The temperature was held constant at 20 °C and pH 7.0 for steady state measurement. The 
enzyme (10 pM) was pre-incubated with NADPH (20 pM) for 15 min at RT to avoid 
hysteretic behavior [74]. The enzyme-NADPH mixture solution (5 pi) was added to 950 
pi of 100 mM MTEN (pH 7.0) buffer. NADPH/D (100 pM final concentration) was 
added to the solution and the reaction was started by adding 10 pi of H2F (100 pM final 
concentration). The rates were calculated from the linear fittings of the initial velocities 
(from 10 -  40 sec). Each experiment was performed in triplicate and average values were 
used for calculations. Plotting a graph using the average activities against corresponding 
concentration of NADPH/D / H2F, the Michaelis constant (Km ) and the rate constant (kcat) 
were able to be determined. The cuvette used had a 10 mm path-length (Helman). Pre- 
warming the buffer and utilising a temperature controlled cuvette holder carefully 
controlled the temperature through the reaction.
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2.10.3 Equilibrium dissociation constants
The equilibrium dissociation constants (Kd) between ligands (folate or NADPH) and 
EcDHFR and its derivatised glycoforms were measured by monitoring the quenching the 
intrinsic tryptophan fluorescence as a function of ligand concentration by PerkinElmer 
LS 55 Luminescence spectrometer at 25 °C [123]. The solvent conditions were 50 mM 
NaCl /50 mM phosphate buffer (pH 7.0) containing 0.1 mM EDTA and 0.1 mM DTT. 
The protein concentration was 0.05 to 0.5 pM.
The fraction of protein bound to the ligand was calculated by dividing the observed 
fluorescence intensity of the protein-ligand complex by the sum of the intensities of the 
protein-ligand complex and free protein from the ligand titrations (Equation 2.4). By 
plotting the fraction of bound protein against the concentration of unbound (free) ligand 
[L], the concentration where half of the protein binding sites are occupied {[L] 1/2 } can be 
calculated. The data were fit to the Langmuir isotherm (Equation 2.5).
®  =  I l p  /  ( I p +  I l p )  Equation 2.4
<D = l / ( l + K Dn/[L]n) Equation 2.5
Where O is the fraction of protein bound, I is the intensity of the protein only (Ip) or of 
protein-ligand complex (Ilp); [L] is the concentration of free ligand that is not bound to 
the protein.
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2.10.4 Equilibrium unfolding
Equilibrium unfolding of EcDHFRs and its derivatised glycoforms in the presence of 
urea were monitored by the intensity of fluorescence at 345 nm and 20 °C with a 
PerkinElmer LS 55 Luminescence spectrometer [155-157]. The solvent conditions were 
10 mM KiP04 (pH 7.0) containing 0.1 mM EDTA and 0.1 mM DTT. The protein 
concentration was maintained at about 2 pM and freshly prepared urea solution was pre­
treated with AG® 501-X8 ion exchange resin (BIO-RAD) to remove the formation of 
cyanate and ammonium ions from decomposition of urea [158]. All samples were fully 
equilibrated at each denaturant concentration by incubated for o/n at RT before the 
fluorescence intensities were measured. A minimum of 10 to 15 data points were required 
to adequately define the denaturation curve.
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2.11 Errors and their propagation
2.11.1 Standard errors of the mean
The errors in this work are expressed as standard error of the mean ( o s e m )  defined as the
standard deviation (a) of the observations divided by the square root of the sample size:
Standard deviation Standard error of the mean (SEM)
a = [£ (X -  M)2 / (n -  1)2]1/2 aSEM = a / n1/2
Where X is the value of the population, M is the mean of the population, and n is the 
number of samples within the population. The accuracy of the SEM value was dependent 
on the sample size. With bigger sample sizes, the sample mean becomes a more accurate 
estimate of the parametric mean, so the standard error of the mean becomes smaller.
In this work, if not otherwise stated, the errors are given as two standard errors of the 
average mean, indicating an accuracy of 95%.
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2.11.2 Propagation of errors
The propagation of the errors for all calculations were as follows,
Function Error (A)
Sum Z = X + Y AZ = (AX2 +AY2)1'2
Subtraction N II X 1 AZ = (AX2 +AY2)1/2
Multiplication N II X * >-< AZ = Z[(AX/X)2 + (AY/Y)2]172
Division Z = X /Y AZ = Z[(AX/X)2 - (AY/Y)2]1/2
Logarithm Y = In X AY = (AX) / X
Exponential Y = ex
X<L>*IIX<
Where X and Y represent a variable and AX and AY represent their errors, respectively. 
The measurement X and Y must be independent from each other. The calculated value is 
Z and its error is AZ.
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Chapter 3 
Wild-type (WT) and 
cysteine free (DM) EcDHFR
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3.1 Introduction
In order to understand the effect of site-specific glycosylation on the physical and 
chemical properties of the naturally nonglycosylated enzyme dihydrofolate reductase, a 
site-directed mutagenesis approach was followed. Stability and kinetic parameter studies 
of the glycosylated proteins and the site-specific cysteine mutant EcDHFR were used to 
identify the effects of the presence of sugars on the protein. However, the interpretation 
of those results required the determination of reference values obtained from the wild- 
type enzyme and the nonglycosylated site-specific cysteine mutant EcDHFR. Therefore 
wild-type and the site-specific cysteine mutant EcDHFR protein were expressed, and the 
protein purified to analyse their stability and kinetic parameters. The X-ray structure of 
EcDHFR reveals two cysteine residues located at position 85 and 152 [118]. In order to 
synthesise a desired site-selective homogeneous glycosylated EcDHFR, the two cysteine 
residues at position 85 and 152 were required to be replaced.
The cysteine free double mutant EcDHFR has been made and investigated by 
Iwakura and co-workers [159]. They successfully replaced the Cys85 and Cysl52 with 
various amino acid residues. They showed that the Cys85Ala and Cysl52Ser double 
mutant (DM) or also known as the free cysteine mutant of EcDHFR has catalytic activity 
(kcat = 9.4 ± 0.4 s"1) and thermal stability (T m = 50.9 ± 0.9 °C) comparable to the wild- 
type enzyme. Therefore in our work, we selected the cysteine free double mutant 
C85A/C152S (DM)-EcDHFR as the base template for synthesizing single site-specific 
cysteine mutants of EcDHFR via site-directed mutagenesis techniques.
This chapter presents a detailed description of the entire study of wild-type (WT) 
and the cysteine free double mutant C85A/C152S (DM)-EcDHFR (Figure 3.1), which
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was used as the DNA template for synthesizing site-specific cysteine mutants for 
obtaining results that were taken as reference values in the following chapters.
Figure 3.1: Structural overview of EcDHFR. The two cysteine residues are labeled in red. 
Folate and NADP+ are drawn in stick format and indicated in blue and yellow 
respectively in the ternary complex (1RA2). The structure is oriented so that the co-factor 
nicotinamide ring is in the plane of paper [78, 108].
3.2 Expression of wild-type and cysteine free double m utant (DM) 
EcDHFR
A single E. coli BL21(DE3) colony containing WT or DM EcDHFR, was used to 
grow a culture to express the protein. These cells contain the ADE3 lysogen that carries 
the gene for T7 RNA polymerase under control of the lac\JW5 promoter. Isopropyl-P-D-
C85A
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thiogalactoside (IPTG ), w hich binds to the lac repressor, can be used to induce 
production o f the T7 R N A  polym erase from  the lac\JV5 promoter. A fter induction with 
IPTG, T7 R N A  polym erase transcribes the target gene carried in the plasm id. T7 RNA 
polym erase is prom oter-specific, therefore it is com m only used to transcribe D N A which 
has been cloned into vectors. O ver-expression o f the DH FR protein was followed by 
sodium  dodecyl sulfate polyacrylam ide gel electrophoresis (SDS-PAGE) for visualization. 
The recom binant W T and D M  EcD H FR  proteins have a calculated m ass about 18,000 
m olecular w eight, therefore a band will show ed at betw een the region o f M w -2 0 ,GOO- 
14, 000 by the pro tein  m arkers at the SDS gel (See Figure 3.2).
Mw 1 2 3 4 5
83.000
62.000
47.500
32.500
25,000
16.500
Figure 3.2: SD S-PA G E for large-scale expression of EcDHFR. Lane I indicates the 
molecular weight marker; Lane 2 indicates the cells before induction with IPTG; and 
Lane 3-5 indicate the cells after induction with IPTG for 1, 3, and 4 h.
Mw-18,000 
EcDHFR
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3.3 Purification of EcDHFR
Initial purification o f W T  and D M  EcDHFR was carried out using m ethotrexate 
(M TX) affinity chrom atography. The colum n was pre-equilibrated using lysate buffer and 
the protein was eluted w ith lysate buffer containing 0.15 M NaCl and 5 m M  folic acid. 
The eluted protein fraction from  the M TX  colum n was visualized by SDS-PAGE (Figure
3.3).
Mw 1 2 3 4 5 6 7
M* -18.000 
EcDHFR
Figure 3.3: SDS-PAGE purification of EcDHFR via MTX column. Lane 1 indicate the 
protein standard molecular weight, crude extract (lane 2 and 3), flow  through from MTX- 
agarose column before folate wash (lane 4 and 5) and the eluent after the folate wash 
(lane 6) Lane 7 is a sample ofW T EcDHFR after purify via MTX-agarose column.
The eluted protein  was dialyzed extensively w ith 5 m M  o f phosphate buffer (pH 
7.0) to decrease the NaCl concentration and applied to a colum n contained 
diethylam inoethyl (D EA E) sepharose for further purification. The colum n was pre­
equilibrated using colum n-lysate buffer (See Section 2.8.5.1) and the protein was eluted 
using a salt gradient (0 - 1.0 M NaCl) at a rate o f 2 m l/m in. Fractions were tested for 
protein by the absorbance at 280 nm. A  typical elu tion profile o f  EcDH FR is shown
below in Figure 3.4. Two maxima in the absorbance were observed corresponding to a 
concentration of NaCl of 0.2 - 0.3 M and 0.4 -  0.5 M, respectively.
2.0  -
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Figure 3.4: Purification o f EcDHFR via DEAE sepharose column. The two maxima in 
the absorbance at 280 nm denote the presence o f DHFR with folic acid and non-folic 
acid complexes (— denotes pooled fractions).
As high absorbance at 280 nm can be produced by the presence of contaminating 
proteins and folate in addition to EcDHFR, several fractions corresponding to the two 
peaks of absorbance were analysed by SDS-PAGE (Figure 3.5). The aim of this 
experiment was to identify which protein fractions were least contaminated with folic 
acid. Other than that, through the observation of the color of the protein solution within 
the fractions, fractions between 20-30 contained least folic acid (colourless) and the 
fraction between 40 to 50 contain the most folic acid solution (yellow).
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Figure 3.5: Purifiation o f  EcDHFR by DEAE sepharose chromatography. Lane 9 is a 
sample o f previously purified WT EcDHFR; Lane 1-8: fractions 8, 12, 16, 20, 25, 30, 35, 
and 40 respectively from the elution profile shown at Figure 3.4.
O nce the protein  fractions that contained least contam inated w ith folic acid had 
been separated and identified the presence o f  protein w ithin the solution by SDS-PAGE, 
further dialysis w ith 5 m M  phosphate buffer (pH  7.0) was carried out. D ialyzed protein 
was lyophilized and stored at - 2 0  °C. T he concentration o f EcD H FR protein solution was 
m easured by the U V -absorbance m easurem ent, tannin assay using BSA  solutions as the 
standard curve, or M TX  titration (Section 2.8.7).
3.4 C h a rac te risa tio n  o f E cD H FR
The far-UV CD  spectrum  o f W T EcD H FR showed a m inim um  at 222 nm and a 
m axim um  at 195 nm  at 25 °C (Figure 3.6). In good agreem ent w ith the values published 
previously [77, 160, 161], the m ean residue ellipticities at 222 nm  and 195 nm  were 
-7 ,3 9 9  ± 1 8 2  deg cm 2 d m o l'1 and 9,856 ±  94 deg cm 2 d m o l 1 respectively. The far-UV
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spectrum of EcDHFR indicated that the recombinant protein adopted the proper 
secondary structure.
The far-UV CD spectrum of DM EcDHFR which was very similar to the WT 
EcDHFR was also in good agreement with the values published by Iwakura and co­
workers [159], the mean residue ellipticities at 222 nm and 195 nm were -7,689 + 84 deg
 ^ I 0 1
cm dmol' and 10,010 + 60 deg cm' dmol' respectively.(Figure 3.6).
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Figure 3.6: Far-UV spectra of WT and DM EcDHFRs. All protein concentrations were 
10 pM and the spectra were recorded by using a JASCO-815 spectrometer at 25 °C with 
a pathlength of 1 mm in 5 mM K,P04 (pH 7.0).
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3.5 Thermal denaturation of EcDHFR
Thermal denaturation was used to measure the unfolding process of DHFR by a 
change in the CD signal at the wavelength of 222 nm as a function of temperature. This is 
also described as the melting temperature of a protein. The melting temperature (T m) is 
where 50% of the population is unfolded (denatured) and the other half folded (native or 
non-denatured). The Tm of EcDHFR was measured at 222 nm (Figure 3.7). At this 
wavelength the CD spectra are dominated by the strong n-7c* transitions of the backbone 
amide bonds involved in a-helices and, to a lesser extent in (3-sheets. By monitoring the 
change in the CD signal at 222 nm it is therefore possible to observe the disruption of the 
protein secondary structure, and thus the unfolding of the enzyme.
The temperature dependencies of the CD profile of EcDHFR exhibited a linear 
variation of the signal between 20 and 37 °C, corresponding to the native baseline, and a 
sharp cooperative loss of secondary structure between 37 and 57 °C (Figure 3.7). 
Thermal denaturation of WT and DM EcDHFR were reversible from 80 to 20 °C at a 
temperature gradient of 24 °C h '1. The CD transitions recorded for both species of 
EcDHFR were similar and their midpoints were within the experimental error of 
measurements (50.7 ± 0.2 °C for WT and 50.9 ± 0.9 °C for DM EcDHFR). This shows 
that replacement of the two cysteine residues of EcDHFR caused no significance 
difference in thermal stability.
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Figure 3.7: Thermal denaturation of WT and DM EcDHFR. All protein concentrations 
were 10 pM and the spectra were recorded by using a JASCO-815 spectrometer from 20 
to 80 °C with a pathlength of 1 mm in 5 mM KjP04 (pH 7.0), and the scan rate was 24 °C 
K1.
3.6 Steady state kinetics studies for EcDHFR
The velocity of the DHFR-catalysed turn-over rates of NADPH and H2 F were 
measured by UV spectroscopy. This relies on the difference of the absorbance maxima of 
the oxidised and reduced forms of the cofactor at 340 nm. At this wavelength NADPH 
showed a large peak while NADP+ showed a very small peak. The steady state kinetics of 
the oxidation of NADPH to NADP+ was therefore monitored by measuring the initial 
linear decrease of absorbance at 340 nm. The oxidation of the cofactor could be 
quantified by using the extinction coefficient for the reaction 8 3 4 0 =  11,800 M'1 cm'1 [74, 
154]. The specific activity, which is defined as the number of molecules of substrate(s) 
turned over by one molecule of enzyme per unit of time, was calculated per second. The
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steady-state rate of the reduction of H2 F by NADPH catalysed by EcDHFR at pH 7.0 was 
calculated by measuring the specific activity of the enzymes at high concentration 
(usually lOOOx fold excess compared with protein concentration) of substrate and 
cofactor. Under these conditions, the specific activity of the reaction is within good 
approximation the turn-over rate, kcat (Section 3.8). The KmNADPH value for each protein 
can be determined from the graph of rate against concentration of NADPH used (Figure 
3.8). At 25 °C the turn-over rate of DM EcDHFR was not significantly different than WT 
EcDHFR at the same temperature (Table 3.1). The experiment was carried out with a 
minimum of three repeats under the same conditions (Section 2.10.2.3).
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Figure 3.8: A plot of rate of reaction o f the WT and DM EcDHFRs against concentration
of NADPH used. KmNADPH for each protein can be determined from the half of the 
maximal rate o f reaction for each protein.
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Table 3.1: Steady state kinetic parameters of WT and DM EcDHFRs. Kinetic 
measurements were carried out at 25 °C as previously described [162].
EcDHFR v NADPH, XynKm (pM) kcat (S ) , NADPH ,  -1 , . w - kkcat/K M  (s pM )
WT 1.6 ±0.1 12.2 ± 0.7 7.6
DM 2.1 ±0.1 9.4 ± 0.4 4.5
3.7 Pre-steady state kinetics studies for EcDHFR
Stopped flow fluorescence can be used to measure the DHFR-catalysed hydride 
transfer. Similar to steady state kinetics, the ability of stopped flow to monitor the hydride 
transfer relies on the differences between the adsorption spectra of the reduced and 
oxidized cofactor. This technique relied additionally on the overlap of the maximal 
emission of the tryptophan residue of DHFR at 340 nm and the maximal excitation of the 
reduced nicotinamide moiety of NADPH. The emission maximum of NADPH is 450 nm 
while the oxidised nicotinamide moiety of NADP+ displays no emission at this 
wavelength. Therefore oxidation of NADPH to NADP+ resulted in a decrease of 
fluorescence emission at 450 nm upon excitation at 292 nm. In a typical an experiment 8 
pM of DHFR solution (expressed as number of active sites) was incubated with 4 pM 
NADPH and then quickly mixed with a large excess of substrate (H2F, 100 pM). The 
change in fluorescence was followed as a function of time and fit to a single exponential 
(Figure 3.9). Varying the concentration of NADPH (from 2 to 10 pM) did not affect the 
reaction rate [74]. The reaction catalysed by DM EcDHFR occurred at a rate of 191 ± 6 s' 
1 at pH 7.0 and 25 °C, similar to the hydride transfer rate for WT EcDHFR at the same 
temperature (Table 3.2). The experiment was carried out with a minimum of three repeats 
under the same conditions.
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Figure 3.9: Stopped flow fluorescence energy transfer experiment o f EcDHFR with 
catalysed hydride transfer from NADPH to DHFR. The enzyme ( 8  pM) was preincubated 
NADPH (4 pM) in MTEN buffer (pH 7.0) and the reaction was initiated by the addition 
of an equal volume o f H2F (100 pM) at 25 °C (Section 2.10.2.2).
Table 3.2: Pre-steady state kinetic parameters o f WT and DM EcDHFR. Kinetic 
measurements were carried out at 25 °C.
EcDHFR kH (s ')
WT 223 ± 5
DM 191 ± 6
3.8 Estimate for ka*, KM and catalytic efficiency for the EcDHFR 
catalysed reaction
The Michaelis-Menten model (Equation 3.1) is widely used to provide a
phenomenological description of enzyme catalysis
k i  kcat
E + S ,—  -------   ES    E + S
. Equation 3.1
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Where E represents the enzyme, S the substrate, ES the enzyme substrate complex and P 
is the reaction product. The rate constants ki, k2, and kcat indicate the rate associated with 
each step of the catalytic process (note that kcat is not hydride transfer, but it includes all 
the kinetic steps of the catalytic mechanism). The velocity of the reaction (V), expressed 
as rate of breakdown of the complex ES, can be expressed as a function of the reaction 
constants, the maximum velocity (Vmax) and the concentration of the substrate ([S]) 
(Equation 3.2), where kcat = Vmax /[E]T and KM = (k2 +kcat)/ki
V = (Vm„.[S ])/(K M+[S])
Equation 3.2
kcat is the turnover number of the enzyme and represents the maximum number of 
substrate molecules converted to product per active site per unit of time, while Km is 
defined as the concentration of the substrate at which the velocity of the reaction is half 
the maximum velocity and is generally a good indication of the affinity of the enzyme for 
the substrate. In these reactions, the Michaelis-Menten equation is used and the 
parameters kcat and Km indicate the speed of the reaction and the affinity for the enzyme 
to the substrate/cofactor, respectively. In the EcDHFR case, these catalytic parameters 
(kcat and Km) were calculated under pseudo first order conditions [74], by measuring the 
steady state reaction rate at saturating concentration of NADPH (or H2F) and varying the 
concentration of the H2F (or NADPH). From a previous study at pH 7.0 and 25 °C the 
values of Km for H2F and NADPH were 1.0 and 5.0 pM respectively, and the kcat 10.1 
and 12.2 s '1 respectively [74].
The calculated catalytic efficiency (kcat/KM) of DM EcDHFR for NADPH was 
slightly lower but not significantly different to that of WT EcDHFR at 25 °C (Table 3.1) 
and these results are comparable to those reported by Iwakura and co-workers [159].
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3.9 Urea denaturation/equilibrium unfolding of EcDHFR
Previous studies showed that denaturing agents such as urea and guanidium 
hydrochloride (GdnHCl) exhibit favourable interactions with non-polar solutes and 
substituent groups, and polar groups of amides and peptides [155, 163]. Both polar and 
non-polar interactions provide the driving force for the denaturation of proteins by urea 
and related compounds. The nature of its interactions of denaturation with amine and 
peptide groups has been discussed elsewhere [164, 165].
A typical urea denaturation curve is shown in Figure 3.10a. When a protein 
unfolds by a two-state mechanism, the equilibrium constant, K, can be calculated from 
the experiment data by using:
K -  [<yV-  (y) ] !  KyMyW E q u a t io n  3 J
Where (y) is the observed value of the parameter used to follow unfolding, and (y)w and 
(y)o are the values (y) would have for the native state and the denatured state under the 
same conditions where (y) was measured. In the original analyses of urea denaturation 
curves [166, 167], log K was found to vary linearly as a function of log [urea], and the 
slope of the plot was denoted by n, and the midpoint of the curve by [urea] m (where log 
K = 0). These parameters could than be used to calculate the dependence of the standard 
free energy of denaturation, AG° (= -RT In K), on urea concentration with [156]:
rf(AG°Murea] = RTW[urea]1/2 Equation 3.4
This equation was used by Alexander and Pace [166] to estimate the difference in 
stability among three genetic variants of a protein for the first time, and was the 
forerunner of the linear extrapolation method.
The linear extrapolation method (LEM) was first used to analyze urea and
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GdnHCl denaturation curves by Greene and Pace [168]. When AG° is calculated as a 
function of urea concentration by using data such as those shown in Figure 3.10a, AG° is 
found to vary linearly with urea concentration as shown in Figure 3.10b. Based on results 
such as these for several proteins, this equation was proposed for analyzing the data:
AG° = AG°(HzO) -  m[urea]
Equation 3.5
where AG°(H2 0 ) is an estimate of the conformational stability of a protein that assumes 
that the linear dependence continues to 0 M denaturant (i.e. urea) and m is a measure of 
the dependence of AG on urea concentration, i.e., the slope of the plot shown in Figure 
3.10b. The same approach has been proposed for measuring the stability of RNA 
molecules [169].
The linear extrapolation method is now widely used for estimating the 
conformational stability of proteins and for measuring the difference in stability between 
proteins differing slightly in structure.
Equilibrium urea titrations were performed on EcDHFR and monitored by 
tryptophan fluorescence emission (Figure 3.9). This studied can be determined by 
titrating these EcDHFR with urea while monitoring the absorbance spectrum at 292 nm 
[160]. The observation of inflections in the fluorescence titration curves at ~2 M urea 
implies that DHFR undergoes a two-state unfolding transition. The difference in free 
energy, as determined by global fitting of the fluorescence data, between the native and 
denatured states of DM EcDHFR, 5.2 kcal mol*1 (Table 3.3), is similar to that for WT 
EcDHFR, 5.9 kcal mol"1 [159, 170]. This shows that the stability of the cysteine-free 
variant, DM EcDHFR, is similar to the WT protein, an observation previously reported 
by Iwakura and coworkers [159].
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Figure 3.10: Urea titration ofWT and DM EcDHFR monitored by fluorescence, (a) Urea 
denaturation profile of the WT and DM EcDHFRs at 340 nm. All protein concentration 
were 2 pM and the spectra were recorded by using a PerkinElmer LS 55 Luminescence 
spectrometer at 20 °C in 5 mM KiPC> 4 (pH 7.0). (b) Plot of the free energy of unfolding in 
the presence of urea versus the urea concentration.
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Table 3.3: Thermodynamic parameters obtained from equilibrium urea denaturation of 
EcDHFR
EcDHFR AG ° (kcal mol*1) m (kcal mol^M"1) Cm (M)
WT 5.9 ±0.3 2.1 ±0.1 2.8 ±0.1
DM 5.2 ±0.3 1.6 ±0.1 3.1 ±0.1
3.10 Equilibrium dissociation constants (KD) of EcDHFR complexes
The quenching of the enzyme fluorescence at 340 nm was used to determine the 
equilibrium dissociation constants of enzyme-NADPH and enzyme-folate complexes and 
the results of such experiments performed at 25 °C and pH 7.0 are shown in Figure 3.11. 
The Kd of these ligands were calculated (Section 2.10.3) and are listed in Table 3.4.
Previous studies on site-directed mutagenesis at specific areas of DHFR have 
shown a dramatic change in Kd values for NADPH and folate. For example studies 
carried out by Gekko and co-workers, where Met42 was replaced with a trytophan 
residue, showed an decrease in the enzyme affinity towards folate and NADPH by 5- and 
11- fold respectively (KDNADPH = 0.5 pM; Kd**"  = 21.8 pM) [171], Met42 is located in 
the adenosine binding domain and its side chain is buried in the hydrophobic core. This 
residue is distal to the active site of EcDHFR [126, 172]. Within their experiments, 14 
different mutants of Met42 were tested, and they suggested that the introduction of a 
hydrophilic side chain at residue 42 disrupts the hydrophic interaction with the side chain 
of Ile50 (which comes directly into contact with the p-aminobenzoyl moiety of the 
substrate), consequently decreasing the affinity of the substrate. Thus the side-chain 
hydrophobicity at residue 42 would enhance the enzyme function mainly by decreasing 
the affinity of the substrate. These results showed that the affinities for coenzyme and
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substrate may be influenced by the selected site of mutation.
From the results shown in Table 3.4, DM-EcDHFR has a similar Kd values for 
NADPH and folate to WT EcDHFR. These suggest that the affinities for coenzyme and 
substrate are not significantly changed in DM-EcDHFR.
The binding of the EcDHFR with its coenzyme and folate appears to be with a 1:1 
stoichiometry, and this has been investigated by Dunn and coworkers [123]. Therefore we 
were able to use this technique to determine the equilibrium dissociation constants 
between the ligands and enzyme.
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Figure 3.11: NADPH (a) and folate (b) concentration dependence of the fluorescence 
intensity' at 340 nm of WT and DM EcDHFRs. All protein concentrations were 0.05 pM 
(a) and 0.5 pM (b) and the spectra were recorded by using a PerkinElmer LS 55 
Luminescence spectrometer at 25 °C in 50 mM KiPC>4 (pH 7.0) containing 50 mM NaCl, 
0.1 mM EDTA and 0.1 mM dithiothreitol (DTP). Curves are theoretical fits to Equation 
2.5 (Section 2.10.3) with the parameter values listed in Table 3.4.
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Table 3.4: Equilibrium dissociation constants of NADPH and folate parameter values of 
the WT and DM EcDHFRs at 25 °C and pH 7.0
EcDHFR KD(pM) KD(pM)
NADPH Folate
WT 0.1 ±0.0 2.1 ±0.1
DM 0.1 ±0.0 2.1 ±0.2
3.11 Summary
In this chapter, recombinant WT and DM EcDHFRs have been expressed and 
purified. Determination of their secondary structure by CD spectroscopy showed similar 
results in good agreement with the literature values. Thermal denaturation studies and 
kinetic analysis studies showed DM EcDHFR has a similar stability and catalytic activity 
as WT DHFR. We therefore reasoned that DM EcDHFR could be used as a base template 
to synthesise site-specific cysteine mutant DHFR, for glycosylated with glycosyl 
haloacetamides. Results of these studies will be discussed in Chapter 6.
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Chapter 4 
Synthesis and Analysis of EcDHFR
triple mutants
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4.1 Introduction
Following the successful preparation of the DM EcDHFR and a comparison of its 
stability with the WT protein (see Chapter 3) the next aim was to synthesise different 
triple mutants of EcDHFR which would be able to undergo glycosylation (see Chapter 5). 
A single cysteine residue was introduced at specific sites of the DM EcDHFR via site- 
directed mutagenesis (see Section 2.6). Four different unique sites were selected. 
Positions 18 and 132 were located in the loop region, position 52 was located in the 
adenosine binding domain, and position 87 was located in the hinge region between the 
adenosine binding and loop domain of EcDHFR (Figure 4.1). These four exposed 
selected position was selected using the X-ray crystal structure of EcDHFR [107].
Loops are common secondary structural elements which are also defined by a 
contiguous segment of polypeptide. They lack regular dihedral angles and hydrogen 
bonding patterns and allow the protein backbone to reverse direction in three-dimensional 
space [173, 174]. They are variable in length and composition and are usually situated 
near the surface of proteins where they can play a role in ligand interaction and biological 
recognition. As has been pointed out by Leszczynski and co-workers, loops are excellent 
candidates for protein engineering studies [173].
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D132C
N18C
Figure 4.1: Structural overview of EcDHFR. The four unique sites are labeled in red. 
Folate and NADP+ are drawn in stick format and indicated in blue and yellow 
respectively in the ternary complex (1RA2). The structure is oriented so that the co-factor 
nicotinamide ring is in the plane of paper [78, 108].
According to X-ray crystallographic studies, the Met20 loop is one of the most 
mobile structural element in the entire enzyme molecule. Three conformations of the 
protein have been observed during the protein catalysis [107]. The central section of 
Met20 loop, residues 16-20, is disordered in the apoenzyme and the NADP+-holoenzyme 
crystal structures, generating an opening of the active-site cavity to solvent. The binding 
of ligands (i.e. folate, NADPH/NADP+) causes the disordered segment of the loop to 
move as a result of stabilizing hydrogen bonds between residues in the Met20 and the F- 
G loops (See Section 1.7). The backbone nitrogen atoms of these loops displayed high 
dynamic mobility in NMR relaxation experiments, which has been interpreted to suggest 
a connection between the dynamic properties of these loops and the catalytic behaviour
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of DHFR [138, 175].
Previous studies by site-directed mutagenesis at position 121, a highly mobile 
residue located in the middle of the F-G loop over 19 A from the active site have shown 
that the replacement of the glycine (Gly) residue, with valine (Val) or leucine (Leu) 
slowed the hydride transfer rate changed dramatically and also reduced the affinity of the 
protein for NADPH [77, 176, 177]. In addition, previous studies by Benkovic and co- 
workers have shown that attachment of a large hydrophobic moiety on the surface of the 
Met20 loop altered the kinetic activity of the protein [126].
We therefore proposed to study the four EcDHFR triple mutants because their 
point mutation sites are exposed to the surface in order to see if glycosylation on this 
position will have any influence on the protein as compared to the observed results with 
DM and WT EcDHFR. This chapter presents a detailed description of the entire study of 
DM-N18C, DM-R52C, DM-D87C, and DM-D132C EcDHFR mutants for obtaining 
results that will be taken as reference values in the following chapters, where site- 
selective glycosylation is involved.
4.2 Expression and purification of the EcDHFR mutants
The four EcDHFR triple mutants (DM-N18C, DM-R52C, DM-D87C and DM- 
D132C) were constructed by oligonucleotide site-directed mutagenesis. To synthesize 
these proteins, a single E. coli BL21(DE3) colony containing DM-N18C, DM-R52C, 
DM-D87C or DM-D132C EcDHFR was expressed for protein. The expressed mutant 
enzymes were purified according to the protocol used for the wild-type protein (Sections
3.2 and 3.3). The recombinant EcDHFR triple mutants have calculated masses between
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17,932 and 17,990, therefore within the SDS-PAGE analysis of the purified EcDHFR 
triple mutants showed a single band of similar mass to WT EcDHFR (see Figure 3.2). 
The concentration of the mutants was determined using the methotrexate (MTX) titration 
method (Section 2.8.7.3).
4.3 Characterisation and thermal denaturation of EcDHFR mutants
CD spectroscopy was used to investigate the structure of the four mutant enzymes 
by comparison with WT EcDHFR. The far-UV CD spectra of the mutants showed some 
differences. While the overall shape of the spectra were similar the molar ellipticity at
9 I222 nm measured for the four mutants varied between -6,718 and -7,695 deg cm dmol' 
(Figure 4.2 and Table 4.1) From the observed values for each of the EcDHFR triple 
mutants at 222 nm, they are comparable to the WT EcDHFR. This suggests that while the 
secondary structure of the mutant may be similar to that of the wild-type protein, but the 
packing might be slightly different.
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Figure 4.2: Far-UV spectra of DM-N18C, DM-R52C, DM-D87C, DM-D132C and WT 
EcDHFRs. All protein concentration were 10 pM  and the spectra were recorded using 
Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength of 1 mm in 
5 mM KjP04 (pH 7.0).
The thermal stability of the EcDHFR triple mutants was studied according to the 
protocol used for the WT and DM proteins. Thermal denaturation of the four triple 
mutant proteins was reversible from 20 to 80 °C at a temperature gradient of 24 °C h'1 
(Figure 4.3). The CD transitions recorded for DM-N18C, DM-R52C, and DM-D132C 
EcDHFR were similar and their midpoints were within the experimental error of 
measurements (Table 4.1). Interestingly, DM-D87C has a lower thermal denaturation 
temperature by ~9 °C compared to WT EcDHFR, even though there is no highly 
significant difference in its secondary structure to the wild-type protein [159]. This 
suggested that replacement of cysteine residues of EcDHFR in a specific site may affects 
the protein thermal stability. Therefore, when position 87 is replaced with the 
hydrophobic side chain of a cysteine residue, the thermal stability of the protein is
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reduced compared to the wild-type protein. This mutation might have generated a local 
conformational change that affects the thermal stability of the protein.
Previous studies on WT EcDHFR using molecular dynamics (MD) simulations 
against high temperatures at 500 K, have showed that the adenosine binding domain 
unfolds earlier than other parts of EcDHFR [77, 178]. Therefore, when we introduce a 
cysteine residue at the position 87, a decrease in melting temperature may be observed 
due to the change of environment from hydrophilic to hydrophobic side-chain residue.
WT EcDHFR 
DM-D87C EcDHFR 
DM-N18C EcDHFR 
DM-R52C EcDHFR 
DM-D132C EcDHFR r 
60
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Figure 4.3: Thermal denaturation of DM-N18C, DM-R52C, DM-D87C, DM-D132C and 
WT EcDHFRs. All protein concentrations were 10 pM and the spectra were recorded 
using a Applied Photophysics Chirascan CD spectrometer from 20 to 80 °C with a 
pathlength of 1 mm in 5 mM KiPQ4 (pH 7.0), and the scan rate was 24 °C h'1.
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Table 4.1: Structural parameters for WT and DM EcDHFR, and the four triple mutants.
EcDHFR [0 ] 2 2 2  deg cm2 dmol'1 Tm (°C)
WT -7,399 ± 182 50.7 ± 0.2
DM -7,689 ± 84 50.9 ± 0.9
DM-N18C -7,398 ± 123 50.5 ±0.4
DM-R52C -7,695 ± 17 49.7 ±0.5
DM-D87C -6,718 ±50 40.9 ±0.3
DM-D132C -7,417 ± 37 50.7 ±0.3
4.4 Effects of site-directed mutagenesis on catalysis by the EcDHFR 
triple mutant
In order to further investigate the influence of the four mutations on EcDHFR, the 
steady-state rate and the hydride transfer rate for the catalysed by the four EcDHFR triple 
mutants were measured and compared to DM and WT EcDHFR.
4.4.1 Steady-state kinetic studies
The kcat value of each mutant was measured by absorbance spectroscopy under 
conditions of excess substrate and cofactor (Section 3.6). KmNADPH was determined 
instead of KmH2F, because NADPH is more stable than H2F, and the presence of 
impurities such as folate within the H2F solution leads to inaccuracies in the 
determination of the H2F concentration which is problematic when determining the Km 
value.
112
From the observed results in Table 4.2, the mutant of DM-N18C has a similar 
kcat/KMNADPH value to the DM and wild type protein. The DM-R52C, DM-D87C, and 
DM-D132C mutants have a lower kcat/KMNADPH value than the DM and wild type protein. 
The difference catalytic efficiency values of each protein are due to the individual protein 
having a high K m NADPH value or low catalytic constant rate of reaction.
At 25 °C, the R52C mutant showed a ~2-fold decrease in the steady state rate; 
however there is not much difference in the K m NADPH value when compared with the 
wild-type protein (Table 4.2). Mutations at position 87 and 132 showed similar steady 
state rate as the wild type protein, however they had a lower catalytic efficiency because 
their Km value is affected (Table 4.2). The mutants of DM-87C and DM-D132C showed 
two to three times lower affinity towards NADPH. It interesting to observe a lower 
catalytic efficiency for DM-D87C and DM-D132C, since these sites were located away 
from the catalytic centre and do not have any direct contact with the co-enzyme or 
substrates. Furthermore, no alteration of the protein secondary structure has been 
observed following the introduction of cysteine at these sites (Figure 4.2). The observed 
low values of kcat or high values of Km of these mutants may due to a change of local 
conformational by introduction of cysteine at the selected sites in the protein.
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Table 4.2: Steady state kinetic parameters for WT and DM EcDHFR, and the four triple 
mutants. Kinetic measurements were carried out at 25 °C
EcDHFR NADFH / . . X y f NKm (pM) k c a i( s _1) W K M NAUffl (pM 'V1)
WT 1.6 ±0.1 12.2 ±0.7 7.6
DM 2.1 ±0.1 9.4 ±0.4 4.5
DM-N18C 1.5 ±0.1 10.4 ±1.5 6.9
DM-R52C 2.1 ±0.1 4.9 ± 0.6 2.3
DM-D87C 4.9 ± 1.7 9.1 ±0.1 1.9
DM-D132C 3.6 ±0.1 12.6 ±1.3 3.5
4.4.2. Pre-steady state kinetic studies
The hydride transfer reaction catalysed by DM-N18C, DM-R52C, DM-D87C, and 
DM-D132C were measured by stopped flow FRET at 25 °C under the conditions of 
excess H2F (Section 3.6). This methodology is very sensitive, and allows observation not 
only of the reduction of NADPH to NADP+, but also of conformational changes of the 
enzyme that will affects the distance between the two chromophores (the NADPH and the 
tryptophan). The resulting traces were fitted to a single exponential decay. The reaction 
catalyzed by the four triple mutants of EcDHFR showed very small changes in hydride 
transfer rate compared with the wild-type (Table 4.3). From the observation of the 
hydride transfer rate for the DM-R52C and DM-D132C (Table 4.2), when we introduced 
a hydrophobic residue such as the cysteine residue at that position, it has increased their 
single turn-over rates compared to DM and wild-type DHFR. The introduction of the 
cysteine residue on the loop seems have enhanced the hydride transfer rate of the triple 
mutants EcDHFR. Therefore we observed an increased of kn rate from 223 to 309 s’1 for
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the DM-R52C and DM-D132C EcDHFR. The experiment was carried out with a 
minimum of 3 repeats under the same conditions (Section 2.10.2.4).
Table 4.3: Pre-steady state kinetic parameters for the DM-N18C, DM-R52C, DM-D87C, 
DM-D132C, DM and WT EcDHFR. Kinetic measurements were carried out at 25 °C.
EcDHFR kH (s'1)
WT 223 ±5
DM 191 ±6
DM-N18C 174 ± 26
DM-R52C 305 ±8
DM-D87C 162 ±3
DM-D132C 309 ±8
4.5 Urea denaturation/equilibrium unfolding of triple mutant EcDHFRs
The equilibrium urea titrations were performed on the EcDHFRs triple mutants 
and monitored by tryptophan fluorescence emission as previously described (Section 3.8). 
The difference in free energy, as determined by global fitting of the fluorescence urea 
titration data, between the native and denatured states of the DM-N18C, DM-R52C, and 
DM-D132C mutants showed similar difference in free energy (AG°)values to the wild- 
type protein (Table 4.4)
Interestingly, DM-D87C mutant showed the lowest AG° value, 2.7 kcal mol'1 
(Table 4.3) compared to the other triple mutants and WT EcDHFR, and this value is 
about half that of the WT or DM EcDHFR [159]. This shows that the replacement of the 
cysteine residue at position 87 has an influence on the protein stability. Although we
115
observed no significant changes in the secondary structure for DM-D87C compared with 
the wild type protein via far-UV CD spectrum, the replacement of cysteine at 87 may 
have affected the protein’s tertiary conformation. As mentioned earlier, position 87 is 
located at the hinge-bending region, and the replacement of a hydrophobic residue onto 
this site may have unfavorable effects on the two domains, which may lead to early 
protein degradation. Therefore a decrease in the thermal and chemical stability of DM- 
D87C EcDHFR has been observed.
Table 4.4: Thermodynamic parameter values obtained from equilibrium urea 
denaturation for the DM-N18C, DM-R52C, DM-D87C, DM-D132C, DM and WT 
EcDHFR.
EcDHFR AG° (kcal mol*1) M (kcal mol*1 M '1) Cm (M)
WT 5.9 ±0.3 2.1 ±0.1 2.8 ±0.1
DM 5.2 ± 0.3 1.6 ±0.1 3.1 ±0.1
DM-N18C 5.3 ±0.3 2.3 ± 0.4 2.6 ±0.1
DM-R52C 5.7 ± 0.2 2.1 ±0.3 2.6 ±0.1
DM-D87C 2.7 ±0.2 1.4 ±0.2 2.1 ±0.1
DM-D132C 5.5 ±0.3 2.6 ±0.1 3.0 ±0.1
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4.6 Equilibrium dissociation constant (KD) of EcDHFR triple mutants 
complexes
Measurement of the equilibrium dissociation constants for the complexes of 
NADPH/folate with the four triple mutants of EcDHFR was performed as described for 
the wild-type protein at 25 °C and pH 7.0 (Section 3.9). From the observed results (Table 
4.5), all the EcDHFRs triple mutants have a similar Kd values for NADPH to WT 
EcDHFR. However there is a slight difference in Kd values for the proteimfolate 
complexes. From Table 4.5, DM-R52C EcDHFR showed ~3 times higher values of Kd 
(folate) compared with the wild-type protein. By observing their single-turnover 
rate/hydride transfer rate (Tables 4.2 and 4.3), all these mutants showed comparable 
results to the wild-type enzyme, and this is in agreement with their Kd (NADPH) values. 
By comparing the steady state rates of these mutant proteins (Table 4.2), DM-R52C 
mutant showed a lower steady state rate than the wild type protein. It seems, when we 
substitute position 52 with a cysteine residue, it has an influence on the protein’s affinity 
towards folate. Interestingly, no major conformational change had occured within the 
mutant protein, as noted from the far-UV CD spectrum. The binding affinity values 
between the NADPH and proteins are so low, that we are not able to conclude if there are 
any differences between the mutants of EcDHFRs. However, from the Kd binding 
between folate (homologous for H2F/H4F) and mutant proteins, we are able to observe 
that there is a correlation between the binding affinity with the steady state rate of 
reaction (Table 4.2). The mutant DM-R52C showed three times weaker binding to folate, 
compared with the DM and wild type protein, and also had the slowest turnover rate 
among the four triple mutant EcDHFRs (Tables 4.2 and 4.5).
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Table 4.5: Equilibrium dissociation constants of NADPH and folate parameter values of 
the DM-N18C, DM-R52C, DM-D87C, DM-D132C, DM and WT EcDHFRs at 25 °C and 
pH 7.0
EcDHFR KD(pM)
NADPH Folate
WT 0.10 ±0.03 2.05 ±0.05
DM 0.12 ±0.02 2.11 ±0.12
DM-N18C 0.22 ± 0.03 2.97 ±0.25
DM-R52C 0.19 ±0.05 6.32 ±0.16
DM-D87C 0.13 ±0.01 3.13 ±0.21
DM-D132C 0.17 ±0.08 2.11 ±0.01
4.7 Conclusions
Recombinant DM-N18C, DM-R52C, DM-D87C, and DM-D132C EcDHFR 
mutants have been expressed and purified. CD spectra were comparable as the wild type 
protein showing that 2° structure of the protein was not affected. Thermal denaturation 
studies showed that the DM-N18C, DM-R52C, and DM-D132C EcDHFR mutants have 
similar stability to wild type protein, whereas the DM-D87C mutant does not. It has a 
lower thermal stability by 10 °C compared to the WT protein. In addition urea 
denaturation equilibrium unfolding studies showed that DM-D87C mutant has a lower 
AG° value compared to wild type protein. This result is in agreement with values 
obtained from thermal denaturation studies using CD spectroscopy. It seems that 
introduction of a hydrophobic residue into the highly exposed site 87 altered the protein 
stability. By comparing the amino acid sequence of DHFR between other species (i.e. 
Moritella profunda, E. coli, and Enterobacter aero genes), the aspartic acid residue at
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position 87, is a conserved residue. Therefore, we assume the introduction of a 
hydrophobic residue at position 87 might generate a local conformational change that 
affects the thermal stability of the protein. As the result lower thermal and chemical 
stability values are observed.
Kinetic studies of DM-N18C, DM-R52C, DM-D87C and DM-D132C EcDHFR 
mutants showed comparable results to wild type protein. Although there is a slight change 
in the values for some of the mutants compared with the wild type protein, these changes 
are not very large.
From the X-ray crystal structure of EcDHFR, R52 is located at the adenosine 
binding domain and situated near the glutamate moiety of the substrate (i.e. folate/H2F). 
Although there was no direct evidence to show that there was an alteration of the bonding 
between R52C with the glutamate of the substrate. However, when we introduced the 
position 52 with cysteine residue, might generate a local conformational change that 
affects the postion 52 with the glutamate of the substrate. As the result, we observed a 
low binding affinity value between the DM-R52C with folate (Table 4.5). The weaker 
binding of this mutant towards folate, seems has affected the mutant catalytic rate.
This study shows that the introduction of a hydrophobic residue at a specific site 
can affect the stability and kinetic reactivity of the protein. These results will be used as a 
baseline for the investigation of whether glycosylation of those sites has any affect on the 
overall stability and kinetic reactivity of the protein.
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Chapter 5 
Synthesis and Purification of 
Glycosylated EcDHFR
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5.1 Introduction
Glycosylation is important for many molecular processes such as molecular 
recognition, degradation and stability. Surface glycoproteins act as markers in the 
communication between cells during immune responses, inflammation and microbial 
virulence [179-181]. The correct glycosylation of proteins is important for their proper 
folding in vivo [182]. The presence of sugars on proteins has been shown to modulate 
their kinetic properties and stability [183].
However the scope of studies into specific in vitro glycosylation of proteins has 
until recently been limited and complicated by the fact that natural glycoproteins 
normally occur as mixtures of glycoforms that carry different sugars in different positions 
on the same protein backbone. The biological importance of glycoconjugates and their 
increasing importance as therapeutic agents make the synthesis of homogeneous 
glycoproteins an important task.
The different properties exhibited by each glycoforms within these 
microheterogeneous mixtures present cause regulatory difficulties [184] and problems in 
determining the exact function through structure-activity relationships. It has even been 
suggested that these naturally occurring mixture of glycoforms provide a spectrum of 
activities that can be biased in one direction or another as a means of fine-tuning [185]. 
Previous studies of single glycoforms by Dwek and co-workers [185] has been successful, 
however their methodology required abundant sources and extensive chromatography. 
There is therefore an urgent need for alternative sources of homogeneous glycoproteins.
The use of natural enzymes allows the site-selective introduction of sugars but is 
limited to natural glycans and by often relatively poor yields. Chemical glycosylation
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reactions, however, which are more flexible with respect to the choice of glycan, suffer 
from limited site-selectivity. Despite significant advances in convergent synthesis using 
approaches such as native peptide ligation and ligation of a peptide with expressed 
protein fragments, the chemical synthesis of proteins is still a formidable task [186]. In 
addition, while methods for the synthesis of large structurally-defined oligosaccharides 
have recently been developed, oligosaccharide synthesis is still not routine [72].
Several methods have been described for the generation of neoglycoproteins 
(modified glycoprotein that resembles native glycoprotein) via site-selective 
glycosylation of proteins by chemical modification of biotechnologically produced 
proteins. Among the first approach was that of Flitsch and co-workers, who used the 
combination of the introduction of unique cysteine residues at the required sites, and a 
highly flexible but selective chemical derivatisation strategy (Scheme 5.1). The reaction 
of the free thiol group of a cysteine residue with a chemically-synthesized glycosyl 
iodoacetamide produces a stable linkage between the protein and the carbohydrate that 
resembles that found in the native glycosylation of asparagine residues [67, 70, 187]. 
Later this method was applied by Wong and co-workers to introduced chitotriose and a 
heptasaccharide stripped from the surface of horseradish peroxidase to bovine serum 
albumin (BSA) [69].
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Scheme 5.1: Generation of neoglycoproteins via alkylation o f cysteine-containing 
proteins with glycosyl haloacetamides (X -C l, Br, or I) [70]
For full control of glycosylation both choices of site (site selectivity) and glycans 
are needed. A combined site-directed mutagenesis and chemical modification approach 
has solved this problem [188-191]. This approach provides a general method that allows 
both region- and glycan-specific glycosylation of proteins. The strategy involves the 
introduction of cysteine as a chemoselective tag at presented positions within a given 
protein and the reaction of its thiol group with glycomethanesulfonate (glycoMTS) 
reagents or glycosyl iodoacetamide (Scheme 5.2). Previous work by Davis and co­
workers used glycoMTS reagents, which react specifically and quantitatively with thiols 
and allows the controlled formation of neutral disulfide linkage [191]. However this 
methodology does not produce high yields of homologous glycoproteins. A slight change
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of the protein conformation would affect the glycosylation by producing lower yield of 
glycosylated proteins and this has been noted by Anderson and co-workers [192].
In an impressive, recent example of site-selective glycosylation through combined 
mutagenesis and modification, Flitsch and co-workers have used their iodoacetamide 
methodology (Scheme 5.1) to glycosylate three cysteine mutants of erythroprotein (EPO) 
(Scheme 5.2) [70]. The three natural asparagine (Asn) glycosylation sites (sites 24, 38 
and 83) were mofified to cysteine residues for reaction with glycosyl iodoacetamide. 
Although the conversion rate from unglycosylated to glycosylated form is about 60% 
after 24 hours reaction time, it was possible to purify glycosylated EPO from 
unglycosylated EPO using a lectin-affinity column. This methodology is very simple and 
does not require any complex steps to synthesize and purify the end products.
Therefore it was decided to use this methodology to allow site-specific 
glycosylation of the naturally nonglycosylated enzyme, dihydrofolate reductase (DHFR). 
This chapter presents a detailed description of the glycosylation of EcDHFR.
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Protein Protein OH
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HO'
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HO
OH
glycoMTS
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OH
HO'
HO
OH
Glycosyl
iodoacetamideOH
HO'
X------
HO
OH
X = NHC(0)CH2 or S or 0(CH2)S
Scheme 5.2: Site-selective glycoprotein synthesis through a combination o f site-directed 
mutagenesis and chemical modification [70, 190, 191]
5.2 Alkylation of EcDHFR triple mutants with glycosyl haloacetamides
This section describes the methodology for alkylation of the thiol group of a
cysteine residue in EcDHFR triple mutants with glycosyl iodoacetamide. The reaction 
was first optimized with DM-D87C EcDHFR, using mass spectrometry to analyze the 
products. By comparing the molecular weight of the observed peaks in the mass spectrum 
with the non-glycosylated protein, it was possible to determine whether the protein was 
successfully glycosylated. Four different iodoacetamides were used; glucose, N- 
acetylglucosamine (GlcNAc), lactose, and maltosetriose iodoacetamide which range from 
monosaccharide to trisaccharide (Figure 5.1). These glycosyl iodoacetamides were 
synthesised and contributed by Flitsch and co-workers, and details of the synthetic work 
has been published [67].
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Figure 5.1: The four different types o f saccharides that were used: glucose (glc) 
iodoacetamide (10), GlcNAc iodoacetamide (11), lactose (lac) iodoacetamide (12), and 
maltotriose iodoacetamide (13) [67].
At pH 8.5, 25 °C, the glycosyl iodoacetamide did not react efficiently with DM- 
D87C EcDHFR. Although the reaction was incubated for 24 hours t he percentage yields 
of the conversion from the non-glycosylated protein to glycosylated protein was about 
30%. Further incubation of the mixtures for additional 24 hours increased the yield of 
glycosylated EcDHFR to 90%. However, two additional peaks were observed in the 
MALDI-TOF mass spectrum other than the mono-glycosylated EcDHFR. These peaks 
were observed at Mw~ 18,472 and Mw~ 18,743, which correspond to the attachment of an
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additional one and two units of GlcNAc acetamide, respectively. Reducing the 
temperature to 4 °C prevented unwanted glycosylation, with the reaction stopping at the 
desired monoglycosylated product. The reaction was incubated for 48 hours the 
percentage yields of the conversion from the non-glycosylated protein to glycosylated 
protein was about 90%. At 37 °C, the intensity of the peak with molecular weight 18,743 
became larger. From the observed results, the incubation mixture of temperatures greater 
than 4 °C and 48 hours, additional GlcNAc acetamides unit may react non-specifically on 
the DHFR protein (i.e lysine residue). The mass spectra of the alkylated DM-D87C 
EcDHFR with GlcNAc iodoacetamide at the three different temperatures are shown in 
Figure 5.2 and the observed molecular weight values were comparable to the calculated 
values for the glycosylated proteins. For example, non-glycosylated DM-D87C EcDHFR 
has a molecular weight (Mw) of 17,948 and after it is glycosylated with GlcNAc 
iodoacetamide at 4 °C, the molecular weight increases to 18,210.
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Figure 5.2: MALDI-TOF mass spectra o f DM-D87C EcDHFR alkylated with GlcNAc 
iodoacetamide at 4 °C (a), 25 °C (b), and 37 °C (c).
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The above experiments show temperature has an influence on the specificity of 
the alkylation reaction. Although, we have no solid evidence to show the correlation 
between the temperatures with the binding of glycosyl iodoacetamide, however from our 
experiments and observation, we conclude that the reaction between the glycosyl 
iodoacetamide with triple mutants EcDHFR is favored at 4 °C. Therefore only a single 
peak was observed in the MALDI-TOF mass spectra for the glycosylated EcDHFR 
(Figure 5.2a).
Figure 5.3 shows an example of the MALDI-TOF mass spectra for glycosylated 
DM-D87C EcDHFR with glucose, and lactose acetamide. The calculated mass for the 
glycosylated DM-D87C EcDHFR with glucose is ~ 18,170 and the glycosylated protein 
with lactose iodoacetamide is -18,332. The observed molecular masses in Figure 5.3 
were comparable to the calculated mass of the proteins. If the yield of the glycosylated 
protein was less than 90% compared with the non-glycosylated protein, then purification 
of the glycosylated protein was required. This was carried out by reacting with 2- 
[(biotinoyl)-amino]-ethyl methanesulfonate (MTSEA) and applying the solution to a 
column containing avidin resin, resulting in retention of biotinylated EcDHFR and 
elution of essentially pure mono-glycosylated proteins (Figure 5.2a) [71].
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Figure 5.3: MALDI-TOF mass spectra of DM-D87C EcDHFR glycosylated with glucose 
(a), and lactose acetamide (b). Within each spectrum, there is a mass spectrum of non 
glycosylated DM-D87C EcDHFR for comparison.
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5.3 Purification of glycosylated EcDHFR triple mutants
Production of high yields of the desired mono-glycosylated proteins was essential 
for analysis. However, as low temperatures were required to prevent bis-alkylation, 
obtaining a high percentage yield may still be a problem due to inefficient alkylation. 
When the yield of glycosylated DHFR fell below 90 % based on the observed mass 
spectrum, the glycosylated proteins were separated from sugar-free protein using affinity 
chromatography (Scheme 5.2). Initially, purification of the mixture of glycosylated 
EcDHFR was attempted using lectin-affinity chromatography, however no spectrum was 
observed for the glycosylated protein. An alternative purification method was therefore 
required, and was successfully introduced by Swanwick and co-workers [71]. Mixtures of 
glycosylated and unglycosylated proteins were treated at pH 7.5 with 2-[(biotinoyl)- 
amino]-ethyl methanesulfonate (MTSEA) to produce mixtures of DHFRs that were either 
glycosylated or biotinylated on the cysteine residue. By incubating the protein solution 
with the MTSEA reagent, most of the non-glycosylated EcDHFR was reacted with the 
thiol group of the MTSEA to form a MTSEA-DHFR. Since the glycosylated EcDHFR 
has no available thiol group to react with the MTSEA reagent, the two forms could be 
separated using avidin-affmity chromatography. Purification by affinity chromatography 
on a column containing avidin resin resulted in the retention of biotinylated protein and 
elution of essentially pure mono-glycosylated proteins (Scheme 5.2) [71].
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conditions were used to glycosylate the remaining EcDHFR triple mutants. Therefore 
using this method, homogenous samples of EcDHFR carrying glucose (glc), GlcNAc, 
lactose (lac) and maltotriose on the cysteine residue of the EcDHFR triple mutants were 
successfully prepared in good overall yields (Scheme 5.2).
Table 5.1 shows the calculated molecular weight of the tryptic peptide for DM- 
D87C EcDHFR. These data were then compared to the observed peaks in the mass 
spectrum to demonstrate the presence of the carbohydrate moiety at the desired sites of 
the mutants.
Table 5.1: Calculated molecular weights for the tryptic peptides o f DM-D87C EcDHFR 
observed in the mass spectrum. The fragment containing the introduced cysteine residue 
is indicated in bold and underlined.
Mass (Mw) Position Peptide Sequence
2460.3 13-33 VIGMENAMPWNLPADLAWFKR
2303.1 13-32 VIGMENAMPWNLPADLAWFK
2115.1 77-98 SVDEAIAAAGCVPEIMVIGGGR
2032.2 59-76 NIILSSQPGTDDRVTWVK
1635.8 45-58 HTWESIGRPLPGRK
1505.8 45-57 HTWESIGRPLPGR
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Figure 5.4: Trypsin digests o f DM-D87C EcDHFR (a) and DM-D87C EcDHFR carrying 
lactose on residue 87 (b). Mw ~ 2116.1 and 2497.5 are the singly charged ions for 
peptide contained SVDEA1AAAGCVPEIMVIGGGR, in its unglycosylated and lactose 
carrying forms, respectively. Peaks 1-4 correspond to the other tryptic peptides.
134
5.4 Conclusions
A route for the purification to homogeneity of substantial quantities of 
neoglycoprotein has been described. Site-directed mutagenesis was used to introduce 
cysteine residues in specific positions of the target protein. The mutant proteins were 
derivatised with chemically synthesized glycosyl iodoacetamides and purified through 
scavenging of the unreacted sugar free proteins by biotin containing thiosulfonates 
followed by affinity chromatography to yield essentially pure glycosylated proteins.
This methodology does not require complex purification methods, therefore it is 
very easy to synthesis and purify a homogenous glycosylated proteins. This methodology 
was applied to the four different EcDHFRs triple mutants {i.e. DM-N18C, DM-R52C, 
DM-D87C and DM-D132C) to allow studies of the effect of the carbohydrate moieties on 
the physical, chemical and kinetic activity of the protein. In addition, it should be noted 
that the present methodology is very general and should be applicable to the derivitisation 
of cysteine sidechains with electrophilic thiol specific reagents other than glycosides, 
such as spectroscopic reporter groups, to produce homogeneously labelled material [193- 
195].
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Chapter 6 
Studies of the effect of 
Glycosylation on EcDHFR
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6.1 Introduction
Chapters 4 and 5 describe the creation of four different triple mutants of EcDHFR, 
and an effective methodology of producing homogeneous glycoproteins. Here, the effect 
of the glycosylation on the triple mutants of EcDHFR, in terms of their structure, stability 
and kinetic reactivity of the protein, is described.
6.2 DM-N18C EcDHFR
Asn 18 is located in the Met20 loop, which is one of the most flexible structures 
in the entire protein (Figure 6.2) [107]. To synthesise this protein, a single E. coli 
BL21(DE3) colony containing DM-N18C EcDHFR was used in a large-scale preparation 
of the protein. Isopropyl-P-D-thiogalactoside (IPTG) was then added into the mixture for 
induction. Over expression of the DHFR protein was followed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) for visualization. The recombinant DM- 
N18C EcDHFR protein has a calculated mass about 17,947 molecular weight, therefore a 
band will be observe between the region of Mw -20,000-14,000 which indicated by the 
protein markers at the SDS gel (Figure 6.1). The purification steps for the DHFR protein 
were then carried out using a column containing methotrexate (MTX) resin. After 
extensively dialysis the protein solution in 5 mM KiPC>4 (pH 7.0) buffer to decreases the 
NaCl concentration and then applied to a column containing diethylaminoethyl (DEAE) 
resin for further purification.
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Mw -18,000 
EcDHFR
Figure 6.1: SDS-PAGE fo r  large-scale expression o f  EcDHFR. Lane 1 indicates the 
protein standard molecular weight; Lane 2 indicates the cells growth before induction 
with IPTG; and Lane 3-5 indicate the cells after induce with IPTG fo r  duration 1, 3, and 
4 h o f incubation.
Fragm ents o f proteins solution contained  the least folate was determ ined using 
U V -spectrophotom eter at 280 nm. A fter that, we extensively w ashed the protein solution 
in 5 m M  K 1PO 4  (pH  7.0) buffer to  decreases the N aC l concentration. The DM -N18C 
EcD H FR protein was purified  and its concentration was determ ined as the wild type 
EcD H FR (see Section 2.8.5-7 and C hap ter 3).
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Figure 6.2: Structural overview of EcDHFR. Position 18 is indicated in red. Folate and 
NADP+ are drawn in stick format and indicated in blue and yellow respectively in the 
ternary complex (1RA2). The structure is oriented so that the nicotinamide ring of the co­
factor is in the plane of paper [78, 108].
The purified protein was then alkylated with glycosyl haloacetamides and purified 
as described above (Sections 2.9 and 5.3). The concentration of the glycosylated protein 
was determined using the MTX titration method (Sectiom 2.8.7.3) and determined the 
presence of mono-glycosylated EcDHFR via MALDI-TOF spectroscopy (Figure 6.3).
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Figure 6.3: MALDI-TOF mass spectrum of DM-N18C EcDHFR and its glycoyslated 
form with Glc acetamide. The mass of the glycosylated form is in agreement with the 
calculated mass ofDM-N18C carrying one GlcNAc unit.
6.2.1. Characterisation and thermal denaturation studies
CD spectroscopy was used to investigate the secondary structure of glycosylated 
DM-N18C EcDHFR. As DM EcDHFR. is comparable to WT EcDHFR in terms of 
structure, stability and kinetic reactivity (see Chapter 3), all the EcDHFR triple mutants 
and their glycosylated forms were compared directly to WT EcDHFR. Substrate and 
cofactor were not bound to any enzyme, therefore the spectra represented the enzymes in 
their native form (apoenzyme). The CD spectrum for the glycosylated forms of DM- 
N18C EcDHFR had a minimum at 222 nm and a maximum of 195 nm (Figure 6.4), 
which is similar to the unglycosylated DM-N18C and WT EcDHFR. No significant 
difference in the CD spectra were observed, showing that glycosylation at position 18 did 
not have a significant effect on the secondary structural elements of EcDHFR (Figure 6.4; 
Table 6.1).
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Figure 6.4: Far-UV spectra of WT EcDHFRs, DM-N18C EcDHFR, and its glycoylated 
forms. All protein concentrations were 10 pM  and the spectra were recorded by using a 
Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength of 1 mm in 
5 mM K[P04 (pH 7.0).
Thermal stability of the glycosylated forms of DM-N18C EcDHFR was 
determined by monitoring the change in the CD signal at 222 nm as a function of 
temperature. The temperature dependencies of the CD profile of glycosylated DM-N18C 
EcDHFR exhibited a small linear variation of the signal between 20 and 35 °C, 
corresponding to the native baselines, followed by a cooperative loss of secondary 
structure between 35 and 57 °C (Figure 6.5). Thermal denaturation of DM-N18C 
EcDHFR and its glycosylated forms were reversible from 20 to 80 °C at a temperature 
gradient of 24 °C h'1. The CD transitions recorded for DM-N18C EcDHFR and its 
glycosylated forms were similar and their midpoints were within the experimental error 
of measurements (Table 6.1). The addition of glycans on the DM-N18C EcDHFR 
therefore caused no significant difference to the thermal stability.
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Figure 6.5: Thermal denaturation of WT EcDHFR, DM-N18C EcDHFR, and its 
glycosylated forms. All protein concentrations were 10 pM and the spectra were recorded 
by using a Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength 
of 1 mm in 5 mM KjP04 (pH 7.0).
Table 6.1: Structural parameters for the WT, DM-N18C and its glycosylated forms of 
EcDHFR
EcDHFR / Glycan [0]222 (cleg cm2 dmol"1) Tm (°C)
WT -7,399 + 182 50.7 + 0.2
DM-N18C -7,398 ± 123 50.5 + 0.4
Glucose -7,121 + 149 50.5 + 0.3
GlcNAc -6,899 ± 23 51.0 + 0.1
Lactose -7,264 + 230 50.6 + 0.9
Maltotriose -7,467 ± 221 51.0 + 0.7
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6.2.2. Effects of glycosylation on DM-N18C catalysis
In order to examine the effect of site-selective glycosylation on DM-N18C 
EcDHFR catalysis, the hydride transfer rate and the steady-state rate for the reaction for 
the four different glycan derivatives were measured and compared to the wild-type 
protein.
6.2.2.1 Steady state kinetic studies of glycosylated DM-N18C EcDHFR
The velocity of the DHFR-catalysed tum-over rates of NADPH and H2F were 
measured by UV spectroscopy at 340 nm. Glycosylation seems to affect the tum-over 
rate of the DM-N18C EcDHFR, leading to a slight decrease in kcat values at 25 °C (Table 
6.2). As the size of the carbohydrate moiety is increased at the surface of DM-N18C 
EcDHFR, the kcat value is lowered compared with WT EcDHFR. When a trisaccharide is 
attached to DM-N18C EcDHFR, the kcat value is decreased about two fold compared with 
WT EcDHFR.
Interestingly, K m NADPH values were unaffected by glycosylation. It seems 
glycosylation on the position 18 of EcDHFR does not affect the Michaelis constant of the 
protein but it might affect the product release step. The attachment of a carbohydrate 
moiety on the Met20 loop may have affected the movement of the loop, therefore leading 
a decrease in kcat value as the size of the carbohydrate moiety is increased. Due to the 
decrease of the kcat value, the calculated catalytic efficiency (kcat/KMNADPH) of the 
glycosylated DM-N18C EcDHFR also shows lower values compared to the DM-N18C 
and WT EcDHFR (Table 6.2). The experiment was carried out with a minimum of three 
repeats under the same conditions (Section 2.10.2.3).
143
Table 6.2: Steady state kinetic parameters for WT EcDHFR, DM-N18C EcDHFR and its
glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kcat (s ) v  NADPH ( A/Pk , rfjr NADPH ,  -1 llA/rvkKm (pM) kcat/KM (s pM) )
WT 12.2 + 0.7 1.6 + 0.1 7.6
DM-N18C 10.4+1.5 1.5+ 0.1 6.9
Glucose 8.9 + 0.4 1.4+ 0.3 6.3
GlcNAc 7.6+ 0.5 1.1 +0.1 6.9
Lactose 6.2+ 0.7 1.4+ 0.0 4.4
Maltotriose 4.8 + 0.5 1.3+0.6 3.7
6.2.2.2 Pre-steady state kinetic studies for glycosylated DM-N18C EcDHFR
The hydride transfer rate catalysed by DM-N18C EcDHFRs and its glycosylated 
forms were measured by stopped-flow FRET at 25 °C under the conditions of excess H2F 
(Section 3.6). The resulting time course traces were fit to a single exponential decay and 
the rates are shown in Table 6.3. The reaction catalysed by the glycosylated DM-N18C 
showed a minor decrease in hydride transfer rate (Table 6.3). The addition of 
carbohydrate moiety on the Met20 loop may have disrupted the bonding between the 
Met20 loop and the backbone carbonyl oxygen of H45 in the helix. Therefore, the 
increased size of glycan on the Met20 loop may have delayed the complex formation. As 
the result, a lower value of single turn over rate for the protein compared with WT 
EcDHFR has been observed (Table 6.3). Interestingly, these values do not affected by the 
size of the carbohydrate moiety. The experiment was carried out with a minimum of 3 
repeats under the same conditions (Section 2.10.2.4).
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Table 6.3: Pre-steady state kinetic parameters for the WT EcDHFR, DM-N18C EcDHFR
and its glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kH (s' )
WT 223 + 5
DM-N18C 174 ± 26
Glucose 179 + 9
GlcNAc 160+19
Lactose 132 + 23
Maltotriose 156 + 8
6.2.3 Urea denaturation/ equilibrium unfolding of DM-N18C EcDHFR and its 
glycosylated forms.
Equilibrium urea titrations were performed on the glycosylated DM-N18C 
EcDHFR and monitored by tryptophan fluorescence emission as previously described 
(Section 3.8). The difference in free energy, as determined by global fitting of 
fluorescence urea titration data, between the native and denatured states of the 
glycosylated DM-N18C EcDHFR is similar to that for WT EcDHFR (Table 6.4). 
Glycosylation at position 18 therefore seems to have no influence on the protein stability. 
This is comparable with the results from CD spectroscopy studies which showed no 
difference in secondary structure and thermal stability (Section 6.2.1).
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Table 6.4: Thermodynamic parameters obtained from equilibrium urea denaturation for 
WT EcDHFR, DM-N18C EcDHFR and its glycosylated forms.
EcDHFR / Glycan AG ° (kcal mol'1) m (kcal mol^M'1) Cm (M)
WT 5.9 + 0.3 2.1 ±0.1 2.8 ±0.1
DM-N18C 5.3 ±0.3 2.3 ± 0.4 2.6 ±0.1
Glucose 5.7 ±0.1 1.9 ± 0.1 2.7 + 0.2
GlcNAc 5.5 ±0.2 1.8 ±0.1 2.7+ 0.1
Lactose 5.6 ±0.3 2.0 ±0.1 2.5 + 0.2
Maltotriose 5.3 ±0.3 2.1 ±0.1 2.3 +0.1
6.2.4 Equilibrium dissociation constants (Kd) of glycosylated DM-N18C EcDHFR 
complexes.
Equilibrium dissociation constant studies for the complexes of NADPH and folate 
with the glycosylated DM-N18C EcDHFR were performed at 25 °C and pH 7.0 as 
described previously (Sections 3.9 and 4.6). The KDNADPH values for the glycosylated 
DM-N18C EcDHFRs (Table 6.5) are very small, therefore it is difficult to conclude that 
glycosylation has affected the protein affinity towards NADPH. Glycosylation on the 
Met20 loop therefore does not appear to show any influence on the KD for NADPH 
binding with the protein. The Kd values with folate, on the other hand, increase slightly 
upon glycosylation (Table 6.5) and these values are significantly different to the WT and 
DM-N18C EcDHFRs. Glycosylation at position 18 of EcDHFR has showed an increased 
of about 1 pM for KDFolate value. However this effect does not correlate to the size of the 
carbohydrate moiety. On attachment of GlcNAc on the DM-N18C EcDHFR, its KoFolate 
value showed no significant difference to that of the protein glycosylated with lactose and 
maltotriose (Table 6.5). The relatively increased value of KoFolate of the glycosylated
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protein may have direct affect on the kcat and kn of the protein. Therefore we were 
observed a minor changed of kcat and kH values of the protein along the increasing of the 
size of the glycan (Table 6.2 and Table 6.3).
Table 6.5: Equilibrium dissociation constants o f the complexes of NADPH and folate 
with WT EcDHFR, DM-N18C EcDHFR, and its glycosylated forms at 25 °C and pH 7.0
EcDHFR / Glycan Kd (pM)
NADPH Folate
WT 0.10 + 0.03 2.05+0.05
DM-N18C 0.22 + 0.03 2.97 + 0.25
Glucose 0.36 + 0.01 3.30 + 0.44
GlcNAc 0.34 + 0.07 4.39 + 0.19
Lactose 0.30 + 0.06 4.2 + 0.42
Maltotriose 0.36 + 0.07 5.03 + 1.35
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6.3 DM-R52C EcDHFR
As mentioned previously, site 52 is located on the adenosine binding domain and 
is located near of the glutamate moiety of the folate/^F/FLF (Figure 6.6). To synthesized 
this protein, a single E. coli BL21(DE3) colony containing DM-R52C EcDHFR was used 
to prepare a large-scale expression of the protein. Isopropyl-p-D-thiogalactoside (IPTG) 
was then added for induction. Over expression of the DHFR protein was followed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for visualization. 
The recombinant DM-R52C EcDHFR protein has a calculated mass about 17,990 
molecular weight, therefore a band will be observe between the region of Mw -20,GOO- 
14, 000 which indicated by the protein markers at the SDS gel. A similar observation for 
SDS gel as for previous triple mutants or WT EcDHFR will be observed (see Figure 6.1). 
The purification steps for the DHFR protein were then carried out using a column 
containing methotrexate (MTX) resin. After extensively dialysis the protein solution in 5 
mM KiPC>4 (pH 7.0) buffer to decreases the NaCl concentration and then applied to a 
column containing diethylaminoethyl (DEAE) resin for further purification.
The protein has purified and glycosylated as described previously (Sections 
2.8.7.3, 2.9 and 4.2). The concentration of the glycosylated protein determined using the 
MTX titration method (Section 2.8.7.3) and determined the presence of mono­
glycosylated EcDHFR using MALDI-TOF spectroscopy (Figure 6.7).
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Figure 6 .6 : Structural overview of EcDHFR. The position 52 is indicated in red. Folate 
and NADP+ are drawn in stick format and indicated in blue and yellow respectively in 
the ternary complex (1RA2). The structure is oriented so that the co-factor nicotinamide 
ring is in the plane of paper [78, 108].
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Figure 6.7: MALDI-TOF mass spectra o f DM-R52C EcDHFR and its glycoyslated form 
with Glc acetamide. The mass of the glycosylated form is in agreement with the 
calculated mass of DM-R52C carrying one Glc unit.
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6.3.1. Characterisation and thermal denaturation studies
The CD spectra of glycosylated DM-R52C EcDHFRs were compared to those of 
its un-glycosylated form, and of WT EcDHFR. The CD spectra for the glycosylated 
forms of DM-R52C EcDHFR had a minimum at 222 nm, with a MRE values between - 
6,967 and -7,695 deg cm2 dmol'1 (Table 6.6) and these values are comparable to those of 
the WT EcDHFRs (Figure 6.8).
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Figure 6.8: Far-UV spectra of WT EcDHFR, DM-R52C EcDHFR, and its glycoylated 
forms. All protein concentrations were 10 pM  and the spectra were recorded by using a 
Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength of 1 mm in 
5 mMKiP04 (pH 7.0).
Thermal denaturation of DM-R52C EcDHFR and its glycosylated forms was 
reversible from 20 to 80 °C at a temperature gradient of 24 °C h'1. The CD transition 
recorded for DM-R52C EcDHFR and its glycosylated forms were similar and their 
midpoints were within the experimental error of measurements (Figure 6.9) Values for the
■ WT EcDHFR
• R52C EcDHFR
* R52C-glucose 
▼ R52C-GlcNAc
♦ R52C-iactose
< R52C-maltotriose
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glycosylated forms were similar to those of the DM and WT EcDHFR. This shows that 
the addition of glycans to the DM-R52C EcDHFR caused no significant difference in 
thermal stability (Table 6.6).
-3 .0 -
-4 .0 -
-5 ,0 -
- 6 .0 - WT EcDHFR 
R52C EcDHFR 
R52C-glucose 
▼ R52C-GlcNAc 
♦ R52C-lactose 
« R52C-maltotriose- 8 .0 -
Temperature °C
Figure 6.9: Thermal denaturation of WT EcDHFR, DM-R52C EcDHFR and its 
glycosylated forms. All protein concentrations were 10 pM and the spectra were recorded 
by using a Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength 
of 1 mm in 5 mM KjP0 4  (pH 7.0).
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Table 6.6: Structural parameters for WT EcDHFR, DM-R52C EcDHFR and its
glycosylated forms.
EcDHFR / Glycan
----■" ™i---------------------
[0 ] 2 22 (deg cm dmol* ) Tm (°C)
WT -7,399 + 182 50.7+0.2
DM-R52C -7,695 ± 17 49.7 + 0.5
Glucose -7,366+ 129 49.9 + 0.2
GlcNAc -6,967 + 45 50.2 + 0.9
Lactose -7,629 + 15 51.6 + 0.1
Maltotriose -7,260 + 140 49.8 + 1.0
6.3.2. Effects of glycosylation on DM-R52C EcDHFR catalysis
In order to examine the effect of site-selective glycosylation on DM-R52C 
EcDHFR catalysis, the hydride transfer rate and the steady-state rate for the reaction for 
the four different glycan derivatives were measured and compared to the wild-type 
protein.
6.3.2.1 Steady state kinetic studies for glycosylated DM-R52C EcDHFR
The DM-R52C EcDHFR showed an improvement in rate back towards that of the 
wild type protein with increasing glycan size, with an increased of kcat values from 4.9 to
12.2 s'1 which was similar to that of the WT EcDHFR (Table 6.7). Interestingly, the Km 
for NADPH for the glycosylated protein showed a comparable result to that of the WT 
ECDHFR. It seems that this is not significantly affected by site-selective protein 
glycosylation.
The catalytic efficiency (kca/KM) of the glycosylated DM-R52C EcDHFR also
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showed an improvement from 2.3 to 7.3 s'1 pM'1 and this value is similar as the WT 
EcDHFR (Table 6.7). Glycosylation on DM-R52C EcDHFR, appears to improve the 
catalytic efficiency of the protein and reformed the catalytic power of the DM-R52C 
EcDHFR similar to that of the wild type protein.
Table 6.7: Steady state kinetic parameters for WT EcDHFR, DM-R52C EcDHFR and its 
glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kcat (S ) NADPH / ’ w x ....., T tr  NADPH ,  -1 „ w - KK m  (pM) kcat/KM (s pM )
WT 12.2 + 0.7 1.6 + 0.1 7.6
DM-R52C 4.9 + 0.6 2.1 +0.1 2.3
Glucose 7.1 +0.1 1.6 + 0.5 4.4
GlcNAc 9.2 + 0.2 1.3 +0.0 7.0
Lactose 12.2+1.5 2.1 +0.4 5.8
Maltotriose 11.6 + 0.3 1.6+ 0.0 7.3
63.2.2 Pre-steady state kinetic studies for glycosylated DM-R52C EcDHFR
The hydride transfer rate catalysed by DM-R52C EcDHFR and its glycosylated 
forms were measured by stop flow FRET at 25 °C under the conditions of excess H2F 
(Section 3.6). The resulting time course traces were fit to a single exponential decay and 
the rates are shown in Table 6.8. The reaction catalysed by the glycosylated DM-R52C 
showed a relatively small change in hydride transfer rate upon the increasing size of 
glycan, however these values are comparable with the wild type protein (Table 6.8). 
Although the non-glycosylated protein has a higher hydride transfer rate compared with 
the wild type protein, upon glycosylation the hydride transfer rate seems to shows similar
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results to those of wild type protein. By introducing a hydrophilic compound (i.e. glycan 
moiety) at DM-R52C EcDHFR may have aided the protein in reaching a stable 
conformation with the glutamate moiety of the substrate.
Table 6.8: Pre-steady state kinetic parameters for WT EcDHFR, DM-R52C EcDHFR and 
its glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kH (s'1)
WT 223 + 5
DM-R52C 305 + 8
Glucose 235 + 24
GlcNAc 266+ 18
Lactose 175 + 5
Maltotriose 169 + 32
6.3.3 Urea denaturation/ equilibrium unfolding of DM-R52C EcDHFR and its 
glycosylated forms.
Equilibrium urea titrations were performed on the glycosylated DM-R52C 
EcDHFR and monitored by tryptophan fluorescence emission as previously described 
(Section 3.8). The difference in free energy, as determined by global fitting of 
fluorescence urea titration data, between the native and denatured states of the 
glycosylated DM-R52C EcDHFR is similar to that for WT EcDHFR with a value 
between 5.4 to 5.5 kcal mol'1 (Table 6.9). From the observed results, glycosylation at 
position 52 seems has no influence on the protein stability and it is comparable with the 
results from CD spectroscopy studies (Section 6.3.1).
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Table 6.9: Thermodynamic parameter values obtained from equilibrium urea
denaturation for WT EcDHFRs, DM-R52C EcDHFR and its glycosylated forms
EcDHFR / Glycan AG ° (kcal mol'1) m (kcal mol^M'1) Cm (M)
WT 5.9 ±0.3 2.1 ±0.1 2.8 ±0.1
DM-R52C 5.7 ±0.2 2.1 ±0.3 2.6 ±0.1
Glucose 5.5 ±0.2 1.9 ±0.1 2.7 ±0.1
GlcNAc 5.4 ±0.2 1.6 ±0.1 2.8 ±0.1
Lactose 5.5 ±0.2 1.6 ± 0.1 2.6 ±0.1
Maltotriose 5.4 ±0.1 1.9 ±0.2 2.9 ±0.1
6.3.4 Equilibrium dissociation constants (K©) for glycosylated DM-R52C EcDHFR 
complexes.
Equilibrium dissociation constant studies for NADPH and folate with the 
glycosylated DM-R52C were performed at 25 °C and pH 7.0 as described for the WT and 
DM-R52C EcDHFRs (Section 3.9 and Section 4.6). The KD values for NADPH with the 
glycosylated DM-R52C EcDHFRs are very small, therefore it is very difficult to 
conclude there is any significant difference among the proteins (Table 6.10). From the X- 
ray crystal structure, although position 52 is located on the adenosine binding domain, it 
does not make any direct contact with the NADPH structure. Therefore, we may not see 
any changes or influences on the K© for NADPH binding. The K© values for folate, on 
the other hand, decrease slightly with the size of the glycans (Table 6.10). However these 
changes are not significantly different to the unglycosylated DM-R52C EcDHFR. The 
relatively decreased value of the K© for folate of the glycosylated protein may be due to 
formation of a stable conformation between the glutamate moiety of the folate and the
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glycan moiety on the protein; therefore an improvement in the protein affinity towards 
folate, and the catalytic reactivity is observed (Table 6.6).
Table 6.10: Equilibrium dissociation constants of NADPH and folate parameter values of 
WT EcDHFR, DM-R52C EcDHFR, and its glycosylated forms at 25 °C and pH 7.0
EcDHFR / Glycan Kd (pM)
NADPH Folate
WT 0.10 + 0.03 2.05 + 0.05
DM-R52C 0.19 + 0.05 6.32 + 0.16
Glucose 0.24 + 0.09 7.25+0.46
GlcNAc 0.26 + 0.03 6.59 + 0.15
Lactose 0.33+0.01 5.54 + 0.16
Maltotriose 0.32 + 0.05 2.67+0.39
6.4 DM-D87C EcDHFR
As mention previously, site 87 is a solvent exposed residue within the hinge 
region that connects the adenosine binding and loop domains (Figure 6.10). To synthesis 
this protein, a single E. coli BL21(DE3) colony containing DM-D87C EcDHFR was used 
to prepare a large-scale expression of the protein. Isopropyl-p-D-thiogalactoside (IPTG) 
was then added for induction. Over expression of the DHFR protein was followed by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for visualization. 
The recombinant DM-D87C EcDHFR protein has a calculated mass about 17,948 
molecular weight, therefore a band will be observe between the region of Mw -20,GOO- 
14,000 which indicated by the protein markers at the SDS gel. A similar observation for
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SDS gel as for previous triple mutants or WT EcDHFR would be observed (see Figure 
6.1). The methodology for purifying this mutant was similar as for the other triple 
mutants and WT ECDHFR (see Section 2.8.7.3, 3.3, 6.2, and 6.3). The purified protein 
was then alkylated with glycosyl haloacetamides and purified as described above 
(Sections 2.9 and 5.3). The concentration of the glycosylated protein determined using 
the MTX titration method (Sectiom 2.8.7.3) and verified the production of mono­
glycosylated protein using MALDI-TOF spectroscopy for determined the presence of 
carbohydrate moiety on the protein (Figure 6.11).
Figure 6.10: Structural overview o f EcDHFR. The position 87 is labelled in and 
indicated in red. Folate and NADP+ are drawn in stick format and indicated in blue and 
yellow respectively in the ternary complex (1RA2). The structure is oriented so that the 
co-factor nicotinamide ring is in the plane of paper [78, 108J.
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Figure 6.11: MALDI-TOF mass spectra ofDM-D87C EcDHFR and its glycoy slated form 
with Glc acetamide. The mass of the glycosylated form is in agreement with the 
calcidated mass ofDM-D87C carrying one Glc unit.
6.4.1. Characterisation and thermal denaturation studies
CD spectroscopy was used for determined the secondary structure of DM-D87C 
EcDHFR. The far-UV CD spectrum of the protein was compared to those of its 
glycosylated forms and WT EcDHFR. The CD spectra for the glycosylated forms of DM- 
D87C EcDHFR had a minimum at 222 nm with a MRE value between -6,854 and -7,643 
deg cm2 dmol1, and this is similar and comparable to the WT EcDHFRs (Figure 6.12; 
Table 6.11).
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Figure 6.12: Far-UVspectrum ofWTEcDHFR, DM-D87C EcDHFR, and its glycoylated 
forms. All protein concentrations were 10 pM  and the spectra were recorded by using a 
Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength of 1 mm in 
5 mM KiP04 (pH 7.0).
Thermal denaturation of DM-D87C EcDHFR and its glycosylated forms were 
reversible from 20 to 80 °C at a temperature gradient of 24 °C h'1. Previous studies have 
shown the hinge region appears to lose its native structure relatively early in the 
temperature-induced unfolding process [77, 178]. Therefore, changes in Tm for the DM- 
D87C EcDHFR were observed when a hydrophobic residue was introduced at that site 
(Section 4.3, Table 6.11). The CD transitions showed an improvement in Tm for the 
glycosylated protein (Figure 6.13 and Table 6.11). Glycosylation at C87 has also 
increased the cooperativity of unfolding of the mutant protein. Although there is no 
significant difference in their secondary structure compared with the wild type protein, 
the addition of a glycan moiety at C87 has improved the protein thermal stability by
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introducing a polar hydrophilic environment on that site. Previous studies on WT 
EcDHFR using molecular dynamics (MD) simulations against high temperatures at 500 
K, have showed that adenosine binding domain will be initially unfolds compared other 
part of the EcDHFR [77, 178]. Therefore, when we introduce a cysteine residue at the 
position 87, might generates a local conformational change that affects the thermal 
stability of the protein. Glycosylation of residue 87 on the other hand reversed this effect 
most likely through increased solvation. However, the stability increased gained through 
glycosylation was significantly higher than observed for the un-glycoyslated protein in 
the presence of high concentration of maltose (Table 6.11).
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Figure 6.13: Thermal denaturation o f WT EcDHFR, DM-D87C EcDHFR and its 
glycosylated forms. All protein concentrations were 10 pM and the spectra were recorded 
by using a Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength 
of 1 mm in 5 mM KiP04 (pH 7.0).
160
Table 6.11: Structural parameters for WT EcDHFR, DM-D87C EcDHFR, and its
glycosylated forms
EcDHFR / Glycan
. _ ....................... .................... ...
[G] 2 2 2  (deg cm dmol' ) Tm (°C)
WT -7,399+ 182 50.7 + 0.2
DM-D87C -6,718 + 50 40.9 + 0.3
Glucose -6,869+ 15 47.1+0.3
GlcNAc -6,661+39 49.6+1.1
Lactose -7,171+50 46.8 + 2.1
Maltotriose -7,660 + 26 50.5 + 0.3
+ 0.5 M Maltose -7,029+ 131 43.4 + 0.4
6.4.2. Effects of glycosylation on DM-D87C EcDHFR catalysis
In order to examine the effect of site-selective glycosylation on DM-D87C 
EcDHFR catalysis, the hydride transfer rate and the steady-state rate for the reaction for 
the four different glycan derivatives on DM-D87C EcDHFR were measured and 
compared to the wild-type protein.
6.4.2.1 Steady state kinetic studies for glycosylated DM-D87C EcDHFR
The steady-state rate of the reduction of H2F by NADPH catalysed by the 
glycosylated DM-D87C EcDHFRs at pH  7.0 was determined by measuring the specific 
activity of the enzymes at saturating condition for substrate and cofactor via UV 
spectroscopy at 340 nm. Upon glycosylation on DM-D87C EcDHFR, the kcat values of 
the proteins were comparable to the WT EcDHFR. However the K m NADPH values for the 
proteins are higher than the wild type protein from 4.4 to 10.5 pM, leading to the lower
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calculated catalytic efficiency (kcat/KM) values of the proteins (Table 6.12). A decreased 
catalytic efficiency (kcat/KM) values from 1.9 to 0.7 s'1 M '1. Interestingly, glycosylation on 
the position C87 of the protein, which has no direct contact with NADPH according to 
the X-ray crystal structure (Figure 6.10), has an influence on the Km for NADPH but no 
correlation with sugar size.
Table 6.12: Steady state kinetic parameters for WT EcDHFR, DM-D87C EcDHFR, and 
its glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kcat (S ) IT NADPH /Km (pM) W K mnau|,h (s 1 pM '1)
WT 12.2 + 0.7 1.6+ 0.1 7.6
DM-D87C 9.1 +0.1 4.9+ 1.7 1.9
glucose 7.3 + 0.9 10.5 + 1.5 0.7
GlcNAc 7.4 ±0.1 6.3+ 1.3 1.2
lactose 6.1 +2.4 7.0+ 1.8 0.9
maltotriose 8.0 + 0.5 4.4 + 0.7 1.8
6.4.2.2 Pre-steady state kinetic studies for glycosylated DM-D87C EcDHFR
The hydride transfer rate catalysed by DM-D87C EcDHFR and its glycosylated 
forms were measured by stopped-flow FRET at 25 °C under the conditions of excess H2F 
(Section 3.6). The resulting time course traces were fit to a single exponential decay and 
the rates are shown in Table 6.13. The reaction catalysed by the glycosylated DM-D87C 
protein showed a comparable hydride transfer rate upon glycosylation from 157 to 147 s'1 
(Table 6.13). Interestingly, the position 87 is located in a solvent-exposed region and is 
away from the catalytic centre of the enzyme, yet has an effect on the protein catalytic
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reactivity. On introduction of a cysteine residue at position 87, a decreased of the hydride 
transfer rate is observed. When we glycosylated this site, there is not much changes in the 
hydride transfer rate compared with the EcDHFR triple mutants. Glycosylation at 
position 87 seems have affected the catalytic reactivity of the DM-D87C EcDHFR, 
leading to lower catalytic efficiency values (Table 6.12) and hydride transfer rate 
compared with WT EcDHFR.
Table 6.13: Pre-steady state kinetic parameters for WT EcDHFR, DM-D87C EcDHFR, 
and its glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kH (s'1)
WT 223 + 5
DM-D87C 162 + 3
Glucose 157 + 18
GlcNAc 149 + 7
Lactose 147 + 19
Maltotriose 154+12
6.4.3 Urea denaturation/ equilibrium unfolding of DM-D87C EcDHFR and its 
glycosylated forms
Equilibrium urea titrations were performed on the glycosylated DM-D87C 
EcDHFR and monitored by tryptophan fluorescence emission as previously described 
(Section 3.8). The difference in free energy, as determined by global fitting of 
fluorescence urea titration data, between the native and denatured states of the 
glycosylated DM-D87C EcDHFR shows an improvement in the protein stability from 2.7 
kcal mol'1 (DM-D87C) to 5.3 kcal mol'1 (DM-D87C-maltotriose) with increasing size of
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the glycan moiety (Table 6.14). From the observed results, glycosylation at position 87 
seems to have a positive influence on the protein stability. This is comparable with the 
results from the thermal denaturation studies which showed increased protein thermal 
stability upon glycosylation (Section 6.4.1).
Table 6.14: Thermodynamic parameters obtained from equilibrium urea denaturation for 
WT EcDHFR, DM-D87C EcDHFR, and its glycosylated forms
EcDHFR / Glycan AG° (kcal mol'1) M (kcal mol^M'1) Cm(M)
WT 5.9 + 0.3 2.1 +0.1 2.8 + 0.1
DM-D87C 2.7 + 0.2 1.4 ±0.2 2.1 +0.1
Glucose 4.2+  0.1 1.6 + 0.1 2.0+ 0.1
GlcNAc 4.3+0.3 1.6 + 0.1 2.0 + 0.2
Lactose 5.1 +0.1 1.8 + 0.1 2.1 +0.2
Maltotriose 5.3+ 0.3 1.9 + 0.1 2.2+ 0.2
6.4.4 Equilibrium dissociation constants (Kd) of glycosylated DM-D87C EcDHFR 
complexes
Equilibrium dissociation constant studies between NADPH and folate with the 
glycosylated DM-D87C were performed at 25 °C and pH 7.0 as described for the WT and 
DM-D87C EcDHFRs (Section 3.9 and Section 4.6). The KD values for the complexes of 
glycosylated DM-D87C EcDHFRs with NADPH (Table 5.15) are very similar to that of 
the wild type protein. Although the glycosylated DM-D87C protein has a relatively poor 
Km for NADPH compared with WT EcDHFR, but it does not have any effect on the 
binding affinity between the protein and the NADPH. The Kd values for the complex of 
folate with the glycosylated proteins are also comparable to the wild type protein.
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Interestingly, the Kd values for the complexes changes between the proteins and NADPH, 
does not match with the large values of KMNADPH. Glycosylation at position 87 has no 
effect on the protein affinity towards the NAPDH and folate.
Table 6.15: Equilibrium dissociation constants o f NADPH and folate parameters ofW T  
EcDHFR, DM-D87CEcDHFR, and its glycosylated forms at 25 °C and pH 7.0
EcDHFR / Glycan Kd (pM)
NADPH Folate
WT 0.10 + 0.03 2.05 + 0.05
DM-D87C 0.13+0.01 3.13+0.21
Glucose 0.23 + 0.11 2.56 + 0.25
GlcNAc 0.26 ± 0.04 3.05+0.06
Lactose 0.22 + 0.02 2.92 + 0.09
Maltotriose 0.33 + 0.03 3.99 + 0.89
6.5 DM-D132C EcDHFR
Position 132 is located in the end of the F-G loop of the protein (Figure 6.14). The 
mutant enzyme was produced in E. coli BL21(DE3) and purified according to the 
protocol used for WT EcDHFR (see Section 2.8.7.3 and 3.3). SDS-Page analysis of 
purified DM-D132C EcDHFR showed a single band of similar molecular weight to WT 
and the other EcDHFRs triple mutants (see Figure 6.1). The purified protein is then 
alkylated with glycosyl haloacetamides and purified as describe above (Sections 2.9 and 
5.3). The concentration of the glycosylated protein is determined using the MTX titration 
method (Sectiom 2.8.7.3) and verified using MALDI-TOF spectroscopy (Figure 6.15).
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Figure 6.14: Structural overview o f EcDHFR. The position 132 is indicated in red. Folate 
and NADP+ are drawn in stick format and indicated in blue and yellow respectively in 
the ternary complex (1RA2). The structure is oriented so that the co-factor nicotinamide 
ring is in the plane o f paper [78, 108].
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Figure 6.15: MALD1-TOF mass spectra o f DM-D132C EcDHFR and its glycoyslated 
form with Glc acetamide. The mass o f the glycosylated form is in agreement with the 
calculated mass of DM-D132C carrying one Glc unit.
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6.4.1. Characterisation and thermal denaturation studies
CD spectroscopy was used to investigate the secondary structure of DM-D132C 
EcDHFR and its glycosylated forms and the thermal denaturation of the proteins. The far- 
UV CD spectrum of the EcDHFR triple mutants was compared to those of its 
glycosylated forms and WT EcDHFR. The CD spectrum for the glycosylated forms of 
DM-D132C EcDHFR had a minimum at 222 nm with a MRE value between -7,104 and - 
7,780 deg cm2 dmol'1, and this is comparable to WT EcDHFR (Figure 6.16; Table 6.16).
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Figure 6.16: Far-UV spectrum of WT EcDHFR, DM-D132C EcDHFR, and its 
glycosylated forms. All protein concentrations were 10 pM  and the spectra were recorded 
by using a Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength 
o f l  mm in 5 mM KiPQ4 (pH 7.0).
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Thermal denaturation of DM-D132C EcDHFR and its glycosylated forms was 
reversible from 20 to 80 °C at a temperature gradient of 24 °C h'1. The CD transitions 
recorded for DM-D132C EcDHFR and its glycosylated forms were similar and their 
midpoints were within the experimental error of measurements (Figure 6.17 and Table 
6.16). This shows that addition of glycans to the DM-R132C EcDHFR caused no 
significant difference in thermal stability.
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Figure 6.17: Thermal denaturation of WT EcDHFR, DM-D132C EcDHFR, and its 
glycosylated forms. All protein concentrations were 10 pM and the spectra were recorded 
by using a Applied Photophysics Chirascan CD spectrometer at 25 °C with a pathlength 
of 1 mm in 5 mM K,P04 (pH 7.0).
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Table 6.16: Structural parameters for WT EcDHFR, DM-D132C EcDHFR, and its
glycosylated forms.
EcDHFR / Glycan
ry |
[G]2 2 2  (deg cm dmol' ) Tm (°C)
WT -7,399+ 182 50.7 + 0.2
DM-D132C -7,417 + 37 50.7 + 0.3
Glucose -7,424 + 38 52.8 + 0.9
GlcNAc -7,766 + 95 52.1 + 1.6
Lactose -7,104+126 51.2 + 0.7
Maltotriose -7,780 + 7 52.4 + 0.6
6.5.2. Effects of glycosylation on DM-D132C catalysis
In order to examine the effect of site-selective glycosylation on DM-D132C 
EcDHFR catalysis, the hydride transfer rate and the steady-state rate for the reaction for 
the four different glycan derivatives on DM-D132C EcDHFR were measured and 
compared to the wild-type protein.
6.5.2.1 Steady state kinetic studies for glycosylated DM-D132C EcDHFR
Upon glycosylation of DM-D132C EcDHFR, the catalytic efficiency (kcat/KM) of 
the glycosylated DM-D132C EcDHFR improves compared with the non glycosylated 
DM-D132C EcDHFR from 3.5 to 7.5 s '1 pM 1 (Table 6.17). The kcat values of the 
glycosylated proteins were not highly different to the WT EcDHFR, and the K m NADPH 
values for the glycosylated proteins (except D132C-glucose) were similar to the wild type 
protein, thereby increasing the catalytic efficiency of the protein and comparable to WT
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EcDHFR. From the X-ray crystal structure, position 132 is located at the end of the F-G 
loop, with no direct contact with the ligands, however a change in the Km values for 
NADPH is observed. Introduction of a hydrophobic residue into that region seems have 
disfavored the protein in catalytic reactivity which might due to local conformational 
change on the protein. However, when a carbohydrate moiety (hydrophilic compound) is 
introduce into that area, the KM values for NADPH of the glycosylated protein is 
improved from 3.6 to 1.4 pM.
Table 6.17: Steady state kinetic parameters for WT EcDHFR, DM-D132C EcDHFR, and 
its glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kcat ( s  ) K m ™  (pM) ( s 1 pM -1)
WT 12.2 + 0.7 1.6 + 0.1 7.6
DM-D132C 12.6 ± 1.3 3.6+ 0.1 3.5
Glucose 10.2 + 0.8 2.7 + 0.3 3.8
GlcNAc 9.7 + 0.4 1.4+ 0.0 6.9
Lactose 10.7 + 0.4 1.6+ 0.4 6.7
Maltotriose 11.3 ±0.3 1.5+ 0.2 7.5
6.5.2.2 Pre-steady state kinetic studies for glycosylated DM-D132C EcDHFR
The hydride transfer rate catalysed by DM-D132C EcDHFR and its glycosylated 
form were measured by stopped-flow FRET at 25 °C under the conditions of excess H2F 
(Section 3.6). The resulting time course traces were fit to a single exponential decay and 
the rates are shown in Table 6.18. There is a slight decrease of hydride transfer rate for 
the glycoyslated proteins compared with the non-glycosylated DM-D132C EcDHFR
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from 309 to 217 s 1, which is comparable to that of the wild type protein (Table 6.18). 
Glycosylation at site 132 seems to have no large effects on the protein catalytic reactivity, 
therefore we did not observe a highly significant changes of the rates for the glycosylated 
proteins and WT EcDHFR.
Table 6.18: Pre-steady state kinetic parameters for WT EcDHFR, DM-D132C EcDHFR, 
and its glycosylated forms. Kinetic measurements were carried out at 25 °C
EcDHFR / Glycan kH (s’1)
WT 223 + 5
DM-D132C 309 + 8
Glucose 229 + 7
GlcNAc 252 + 22
Lactose 254+15
Maltotriose 217 ± 18
6.5.3 Urea denaturation/ equilibrium unfolding of DM-D132C EcDHFR and its 
glycosylated forms
Equilibrium urea titrations were performed on the glycosylated DM-D132C 
EcDHFR and monitored by tryptophan fluorescence emission as previously described 
(Section 3.8). The difference in free energy, as determined by global fitting of 
fluorescence urea titration data, between the native and denatured states of the 
glycosylated DM-D132C EcDHFR, is similar to that for WT EcDHFR (Table 6.19). 
From the observed results, glycosylation at position 132 seems has no influence on the 
protein stability and it is comparable with the results from the thermal denaturation 
studies using CD spectroscopy (Section 6.5.1).
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Table 6.19: Thermodynamic parameters obtained from equilibrium urea denaturation for
WT EcDHFR, DM-D132C EcDHFR, and its glycosylated forms
EcDHFR/Glycan AG ° (kcal mol'1) m (kcal mol^M'1) Cm (M)
WT 5.9 + 0.3 2.1 ±0.1 2.8 ±0.1
DM-D132C 5.5 +0.3 2.6 ±0.1 3.0 ±0.1
Glucose 5.3 +0.2 2.2 ± 0.2 2.8 ±0.1
GlcNAc 5.2 ± 0.3 1.8 ±0.2 2.7 ± 0.2
Lactose 5.4 ±0.3 1.7 ±0.2 2.9 ±0.1
Maltotriose 5.1 ±0.2 1.7 ±0.2 2.5 ±0.1
6.5.4 Equilibrium dissociation constants (Kd) for glycosylated DM-D132C EcDHFR 
complexes.
Equilibrium dissociation constant studies between NADPH and folate with 
glycosylated DM-D132C were performed at 25 °C and pH 7.0 as described for the WT 
and DM-D132C EcDHFRs (Section 3.9 and Section 4.6). The KD values for the 
glycosylated DM-D132C EcDHFRs with NADPH and folate were comparable to those 
of the wild type protein (Table 6.20). Although the observed KD values for the protein 
glycosylated with lactose and maltotriose towards NADPH and folate were higher than 
the WT EcDHFR, these values were comparable to the WT EcDHFR. Position 132 is 
remote from the binding sites of both compounds. This would explain why glycosylation 
at 132 has no major influence on the Kd for either NADPH or folate.
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Table 6.20: Equilibrium dissociation constants o f NADPH and folate parameters of WT
EcDHFR, DM-D132C EcDHFR and its glycosylated forms at 25 °C and pH 7.0
EcDHFR / Glycan Kd (|iM)
NADPH Folate
WT 0.10 + 0.03 2.05+0.05
DM-D132C 0.17+0.08 2.11 +0.01
Glucose 0.32 + 0.04 2.28 + 0.08
GlcNAc 0.29 + 0.04 2.23 + 0.02
Lactose 0.37 + 0.01 2.97+0.16
Maltotriose 0.48+0.13 2.80 + 0.18
6.6 Conclusions
DM-N18C, DM-R52C, DM-D87C, and DM-D132C EcDHFR have been 
successfully glycosylated, and their secondary structures were analyzed by CD 
spectroscopy, showing similar results to the wild type protein. Thermal and urea 
denaturation studies showed that glycosylation does stabilized the protein. However these 
effects are dependent on the specific site of glycosylation. For example, the thermal 
stability of the DM-D87C EcDHFR is increased upon glycosylation. The stability gained 
through glycosylation was significantly higher than that observed for unglycosylated 
DM-D87C EcDHFR in the presence of high concentrations of maltose. The presence of
0.5 M maltose increased the melting temperature of all proteins examined by only 
approximately 3 °C. The increased stability frequently observed with naturally 
glycosylated proteins might therefore not simply be a nonspecific effect arising from 
changes in the solvation properties of the enzymes [53]. Site-specific effects can clearly
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also contribute to the overall thermal stabilization of proteins, at least in the case of 
DHFR. All the results that observed for glycosylated DM-D87C EcDHFR have been 
published by our group [196].
At selected sites, the introduction of a carbohydrate moiety onto a protein has an 
effect on its catalytic reactivity. For example, the catalytic efficiency of the DM-R52C 
EcDHFR is increased upon glycosylation. However, glycosylation at position 18 does not 
increase the catalytic efficiency of the protein. Previous studies by Benkovic and co­
workers on position 18 by attaching a large hydrophobic compound {i.e. Alexa 488) have 
showed similar results [126]. The increasing mass of the carbohydrate moiety attached at 
the central region of the Met20 loop has disrupted its flexibility in movement during 
complex formation within the protein. Therefore, glycosylation at the position 18 does 
have an effect of the protein dynamics. As a result, there is a decrease of its catalytic 
efficiency.
From our observed results, glycosylation seems to play an important role in 
protein stability and kinetics. However these effects were only observed at certain sites 
on EcDHFR.
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Chapter 7 
General Conclusions
Glycosylation is one of the major naturally occurring modifications of the 
covalent structure of proteins. Although much is known about the structure and 
biosynthesis of oligosaccharides in glycoproteins, the central question of how 
glycosylation contributes to the glycoprotein structure and function is not entirely clear. 
Studies on native glycosylated, carbohydrate-depleted, and recombinant non-glycosylated 
proteins have revealed such effects as stabilization of protein conformation, protection 
from proteolysis, protection from thermal denaturation, control of catalytic activity, and 
enhancement in nascent polypeptide solubility, but no effect was consistently observed 
for all glycoproteins. One method to study the effects of glycosylation systematically is 
the ‘artificial’ incorporation of glyeans into proteins. The overall aim of this project was 
to use such an approach to determine the effect of site-specific glycosylation on the 
stability and kinetic reactivity of.DHFR, a naturally unglycosylated enzyme
The studies of glycosylated proteins required a substantial quantity of 
homologous glycoprotein, therefore an effective methodology was required. The method 
used combined site-directed mutagenesis to introduce cysteine residues in specific 
positions and subsequent derivatisation with chemically synthesized glycosyl 
haloacetamides (chloro or iodo). For purification, an innovative methodology was 
developed that uses scavenging of the unreacted sugar-free proteins by biotin-containing 
thiosulfonates followed by affinity chromatography yielding essentially pure glycosylated 
proteins. This is an efficient route for the synthesis of specifically glycosylated proteins 
to facilitate the study of the physical, chemical and biological effects of protein 
glycosylation.
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The importance of site-specific glycosylation in stabilization of proteins against 
thermal denaturation was revealed clearly in our work. In the case of DM-D87C 
EcDHFR, site-selective glycosylation dramatically increased the resistance of the protein 
to thermal denaturation. The protein’s melting temperature was increased significantly 
through the site-selective attachment of simple glycans by 6.0 to 9.0 °C. Glycosylation 
also stabilized DM-D87C EcDHFR against urea denaturation, increasing the free energy 
of unfolding value by 2.6 kcal mol'1. However, this dramatic stabilization effect was not 
observed in the other three mutants of EcDHFR. The DM-N18C, DM-R52C, and DM- 
D132C mutants of EcDHFR showed little change in their observed thermal stability or 
resistance to urea denaturation upon glycosylation. This lack of effect on resistance to 
thermal denaturation has previously also been observed in DM-E120C [71]. Glu 120 is 
located on the water-exposed face of a surface loop next to Gly 121, which appears to be 
crucial for the activity of the enzyme. Thermal stability of DM-E120C EcDHFR was 
increased only slightly by the site-selective attachment of simple glycans. From these 
results, in general the changes of thermal stability of the proteins due to glycosylation is 
of the same order of magnitude as the decrease observed upon deglycosylation of 
naturally glycosylated proteins such as yeast external invertase, bovine serum fetuin and 
glucoamylase by 3.4, 4.0 and 1.9 °C, respectively [47]. Our data suggest that in certain 
circumstances significant increases in the thermal stability of proteins can be achieved 
even with the small carbohydrates used in the study, rather than with the often much 
larger oligosaccharides found in naturally glycosylated proteins. Resistance toward 
thermal denaturation due to glycosylation was only observable at specific sites on the 
protein.
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The site-selectively glycosylated mutants of EcDHFRs showed similar kinetic 
activity (kcat/KMNADPH) and hydride transfer rates to the wild-type protein. This suggests 
that the structures of the proteins were essentially unaltered. DM-R52C and DM-D132C 
EcDHFR showed slight improvement in their kinetic activity following site-selective 
glycosylation, while the kinetic activity of DM-N18C EcDHFR slightly decreased upon 
site-selective glycosylation and that of DM-D87C EcDHFR did not show any change. 
This is interesting because the mutation site at 87 is far from the active site (Asp 27) and 
hence has no direct contact with either the substrate or cofactor. The lack of effect on the 
kinetic activity values due to site-selective glycosylation has also been observed in the 
DM-E120C EcDHFR [71].
Although there were some improvements on kinetic activity values of the selected 
mutants of EcDHFR, the values were not significantly different to those of the wild-type 
protein. Interestingly, in four of the five cases studied, site-selective glycosylation does 
not show any large effects on the naturally nonglycosylated EcDHFR. There are several 
possible conclusions; the first is that the size of the carbohydrate moiety attached to the 
surface of the protein is too small for any large effects to be observed. Alternatively, the 
large effects shown by the carbohydrate moiety on glycoprotein in terms of stability and 
catalytic effects may only observe in natural glycoproteins. Finally, the increase in 
thermal stability upon site-selectively glycosylation on DM-D87C EcDHFR may be due 
to the specific interactions of the carbohydrate moiety at certain points on the protein. 
This final suggestion is supported by the fact that DM-D87C EcDHFR showed a large 
effect whereas the other four mutants did not. This suggests that the increase in resistance 
to thermal denaturation observed for proteins in sugar solutions is also due to binding of
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the sugars to specific sites on the protein.
In conclusion, an effective method for the synthesis of homologous glycosylated 
and non-glycosylated proteins has been developed and applied to the site selective 
glycosylation of EcDHFR. While only minor effects on the kinetic properties of EcDHFR 
were observed, site-specific interactions between the proteins and the carbohydrate 
moieties led to significant effects on the stability of the protein.
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Scheme 1. Alkylation of site-selectively introduced cysteine mutants of DHFR;[ll,6! n  =  0-3.
Glycosylation is important for many molecular processes such 
as molecular recognition, degradation and stability. While it 
has long been established that the native conformation of 
many proteins can be stabilised against thermal denaturation  
through glycosylation,1, 31 the mechanism of such stabilisation 
is less clear. The removal of carbohydrates from naturally gly­
cosylated proteins through the use of glycosidases*41 or by mu­
tagenesis of glycosylation sites*5,61 can lead to  decreased ther­
mal stability of the protein. This is often accom panied by an in­
creased tendency towards protein aggregation. Due to  the  
heterogeneous nature of protein glycosylation both in vivo 
and in vitro, a com prehensive study o f its effect on thermal 
stability has been elusive. However, studies o f the stability of 
several unglycosylated proteins in the presence o f high con­
centrations of saccharides such as glycerol, glucose, sucrose, 
galactose and a,a-trehalose have led to the conclusion that 
these glycans stabilise the folded protein due to  preferential 
binding of the native state.*7-101 Such observations su ggest that 
glycosylation of natural proteins could establish a microenvir­
onm ent that resembles that o f unglycosylated proteins in solu­
tions of high carbohydrate content.
The scope of studies into specific in vitro glycosylation of 
proteins has until recently been limited. The use o f natural en ­
zymes allows the site-selective introduction o f sugars but is 
limited to natural glycans and by often relatively poor yields. 
Chemical glycosylation reactions, however, which are more 
flexible with respect to  the choice of glycan, suffer from limit­
ed site-selectivity. Such shortcomings have been overcom e  
through a combination of the introduction o f unique cysteine  
residues at required sites and a highly flexible but selective  
chemical derivatisation strategy (Scheme i).lll-,6) This m ethod­
ology allowed us to study the effect o f site-specific glycosyla­
tion on the thermal stability of the naturally nonglycosylated  
enzyme, dihydrofolate reductase (DHFR), systematically.
DHFR is a major target for antibacterial and anticancer drugs 
and has long served as a paradigm for the study o f enzym e ki­
netics, protein dynamics and stability. DHFR has a com pact
[a] D r .  R . 5. S w a n w i c k ,  L - H .  T e y , P r o f .  R .  K . A l l e m a n n  
S c h o o l  o f  C h e m i s t r y ,  C a r d i f f  U n i v e r s i t y
P a r k  P l a c e .  C a r d i f f  C F 1 0  3 A T  ( U K )
F a x :  ( + 4 4 ) - 2 9 2 0 - 8 7 9 0 1 4  
E - m a i l :  a l l e m a n n r k @ c a r d i f f . a c . u k
[b] D r .  R .  S .  S w a n w i c k ,  P r o f .  R . K  A l l e m a n n  
S c h o o l  o f  C h e m i s t r y ,  U n i v e r s i t y  o f  B i r m i n g h a m  
E d g b a s t o n ,  B i r m i n g h a m ,  B 1 5  2 T T  ( U K )
[c] D r .  A  M .  D a i n e s ,  P r o f .  S .  L  F l i t s c h
S c h o o l  o f  C h e m i s t r y ,  U n i v e r s i t y  o f  E d i n b u r g h
K i n g ' s  B u i l d i n g s ,  W e s t  M a i n s  R o a d ,  E d i n b u r g h ,  E H 9  3 J J  ( U K )
folded form (Figure 1), which is comprised of two domains, the 
adenosine binding and loop domains. These domains are con­
nected by a short polypeptide stretch centred around amino
NADP'
G l u l 2 0
Figure 1. Diagram of the structure of £  c o l i  DHFR indicating the positions 
of the two loop residues Asp87 and Glu120. The positions of dihydrofolate 
(H2F) and cofactor (NADP+) are shown in the space-filling models.1171
acid residues 86 and 87, known as the hinge region. Large- 
scale m ovem ents of external loops control access of the cofac­
tor to  the active site and propagation through the catalytic 
cycle.*17'191 Here w e report dramatic increases in the thermal 
stability o f E. coli DHFR as a result of site-selective glycosylation 
of individual surface residues.
Loop residues 87 and 120, located on opposite sides of the 
protein (Figure 1), were chosen for selective glycosylation. 
G lul20 is positioned on the water-exposed face of a surface 
loop next to Glyl21, which appears to be crucial for the activi­
ty of the enzym e. Mutation o f residue 121 significantly reduces 
the catalytic performance of DHFR through local conformation­
al changes that affect the properties of the enzyme global­
ly.*20-261 Asp87 is a solvent exposed residue within the hinge 
region that connects the adenosine binding and loop domains. 
The hinge region appears to  lose its native structure relatively 
early in the temperature-induced unfolding process.*20,271 Site- 
selective glycosylation of positions 120 and 87 of DHFR was 
achieved through the replacement o f Glu120 and Asp87 with 
cysteine by site-directed m utagenesis of the cysteine free 
double mutant DHFR-C85A/C152S (DM), which has folding, sta­
bility and kinetic properties very similar to those of the wild- 
type protein.*281 DM-E120C and DM-D87C were derivatised by
1 3 3 8  © 2005 Wiley-VCH Verlag GmbH&Co. KGaA, W einheim DOI: 10.l002/cbic.200500103 ChemBioChem 2005, 6, 1338-1340
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treatment with the iodoacetam ides of N-acetyl glucosam ine, 
glucose, maltose, lactose and maltotriose (O-a-D-glucopyrano- 
syl-(1 —►4)-0-a-D-glucopyranosyl-(l —»4)-o-glucose) and purified 
as described previously.1161
CD-spectroscopy indicated no significant differences be­
tween the structures of wild-type DHFR, DM-E120C and DM- 
D87C and their glycosylated forms (Figure 2). However, when
1 0 -
0 ■ ■
-10
270230190 210 250
XJn m  ►-
Figure 2. Representative CD-spectra for DHFR, DHFR mutants and their gly­
cosylated forms. CD-spectra of DHFR (brown dots), DM (black dots), DM- 
D87C (red squares), DM-E120C (blue squares) and DM-D87C-lactose-acet- 
amide (green triangles). All other glycan-carrying proteins described in the 
text exhibited CD-spectra that were essentially identical to the ones shown 
here. All protein concentrations were 10 pM and the spectra were recorded 
by using a JASCO-810 spectrometer at 25 “C with a path length of 1 mm in 
10 mM KP„ pH 7.0. Mean residue ellipticities [ 0 ] ,  are reported in units of 
10*degcm2dmol_'.
the thermal stabilities of the proteins were investigated by 
measuring their CD-spectra as a function of temperature, the  
presence of the glycans led to  significant stabilisation o f the  
protein folds (Table 1). Glycosylation of Cys120 led to a small 
but significant increase in the melting temperature of the pro­
tein. Interestingly, the extent o f stabilisation observed for dis­
accharides was about twice that seen for m onosaccharides.
Table 1. Melting temperatures [°C] of DM, DM-E120C and DM-D87C and 
their glycosylated forms. The thermal stabilities of nonglycosylated DM 
and DM-D87C in the presence of 0.5 m maltose are also indicated. The 
melting temperatures were determined from the denaturation curves ob­
tained from the dependence of the mean residue ellipticity at 222 nm 
[6?]lji2 on temperature. All protein concentrations were 10 pM and the 
spectra were recorded on a JASCO-810 spectrometer with a path length 
of 1 mm in 10 mM KP„ pH 7.0.™ The melting temperature for wild-type 
DHFR is 50.7 ± 0 2 °C.
Glycan DM DM-E120C DM-D87C
none 50.8 ±0.3 50.8 ± 0 .4 40.9 ±0 .3
glucose 51.8 ±0 .2 47.1 ±0 .3
GlcNAc 52.5 ±0.1 49.6 ±1 .1
lactose 54.1 ±0.1 46.8 ±2.1
maltose 54.2 ±0 .3 n.d.
maltotriose n.d. 47.5“
acetamide 51.3“ 39.6 ±1 .2
+ 0 .5 m maltose 52.9 ± 0 .4 n.d. 43.4 ± 0 .4
[a] Single measurement.
Glycosylation of Cys120 with lactose or maltose stabilised the 
protein by approximately 3°C.
The steady-state kinetic parameters measured for DM-E120C 
and its glycosylated forms were similar to those measured for 
DM and indeed the wild-type enzym e1291 (Table 2). This sug­
Table 2. Steady state kinetic parameters of DHFR mutants and their gly­
cosylated forms. Kinetic measurements were carried out at 25 °C as previ­
ously described.™ The kinetic parameters for DHFR are K ' ^ d p h  =  2.8±  
0.3 pM and k a t  =  8 .8±0 .2  s-1.
DM
Glycan [ s ~ ' ]
[PM]
DM-E120C
k a ,  [S-’l C ™
[pM]
DM-D87C 
Acat IS’ 1] C ™
[pM]
None 7.0 ± 0 .4  2.7 ± 0 5
Glucose
GlcNAc
Lactose
Maltose
6.4 ±  1.4 2.3 ±  1.0 
7.8 ±1.1 3.7 ±  1.4 
5.3 ±1 .7  3.9 ±2.1  
7.1 ± 2 .0  1.9 ±  1.7 
7.7 ±  1.9 6.8 ±  1.6
9.1 ±0.1 4.9 ±  1.7
7.3 ±0 .9  10.5 ±1 .5
7.4 ±0.1 6.3 ±1 .3
6.1 ±2 .4  7.0 ±1 .8  
n.d. n.d.
gests that the structures were essentially unaltered. The sur­
face FG loop, which contains Glu120, is connected through hy­
drogen bonds and van der Waals interactions to the M20 loop, 
which exists in tw o conformations depending on the state of 
the catalytic cycle.117,301 M ovements of the M20 loop, which dis­
play rates similar to  that of the steady-state turnover, regulate 
ligand binding.1231 The similar reaction rates o f DM-E120C and 
its glycosylated forms suggest that these conformational 
changes are not significantly affected by the presence of gly­
cans in the FG loop. This could indicate a coordinated move­
m ent o f the FG and M20 loops and is in agreement with re­
sults obtained by molecular mechanics simulations.123,24,311
While replacing Glu120 with Cys had no effect on the stabili­
ty o f the protein, DM-D87C displayed significantly reduced sta­
bility com pared to  DM (Table 1). The melting temperature of 
DM-D87C was lowered by almost 10°C and the thermally in­
duced unfolding reaction displayed som ewhat reduced coop- 
erativity (Figure 3). However, the CD-spectrum of DM-D87C at 
2 5 °C was comparable to that o f DM (Figure 2); this suggests 
that no major conformational changes had occurred as a con­
sequence of the amino acid change. Derivatisation of DM- 
D87C with glycosyl iodoacetam ides dramatically increased the 
stability o f the protein. Alkylation with A/-acetyl glucosamine 
com pletely reversed the destabilising effect o f Cys87, and the 
glycosylated protein displayed thermal stability that was identi­
cal to that o f the parent protein (Table 1). The shape of the 
melting curve observed for glycosylated forms of DM-D87C 
was comparable to  that of DM (Figure 3). As had been ob­
served for glycosylated DM-E120C, the steady-state kinetic 
properties o f the DM-D87C and its glycosylated forms at 25 °C, 
were similar to  those observed for DM (Table 2). Together with 
the unaltered CD-spectra of the glycosylated proteins, the re­
sults suggested  that the altered thermal stabilities of the pro­
teins were not a consequence of global conformational 
changes, but due to the site-specific presence of glycans. Alky­
lation of DM-E120C and DM-D87C with nonglycosylated iodo- 
acetam ide alone did not lead to a significant increase of the
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CHEMBIOCHEM
lOb
-3
-3 5
-4
-4 5
-5
-5.5
-6
-6.5
-7
-7.5
> ; c
10 30 50 70 90
T tC
Figure 3. Representative melting curves for DHFR mutants and their glycosy­
lated forms. The mean residue ellipticity at 222 nm was measured as a func­
tion of temperature for DM-D87C (black squares), DM-D87C carrying glucose 
(green squares) and N-acetylglucosamine (blue dots), DM-E120C carrying N -  
acetylglucosamine (purple squares) and lactose (red squares) by using a gra­
dient of 20°Ch~'. Conditions are as in Figure 2. Mean residue ellipticities at 
222 nm are reported in units of 103 degcm2d m o r \
proteins' melting temperatures (Table 1). This indicated that 
the glycans were responsible for the increased stability o f the  
glycoproteins. The unnatural linkage betw een the proteins and 
the glycans was clearly not the cause of their enhanced stabili­
ty.
Asp87, which is located in the hinge region betw een the ad­
enosine binding and loop domain of DHFR, contains on e  of 
the most solvent exposed side chains o f the protein. Replace­
ment of the polar carboxylate group of Asp87 with the hydro- 
phobic side chain of cysteine might generate a local conforma­
tional change that affects the thermal stability o f the protein. 
Glycosylation of residue 87 on the other hand reversed this 
effect most likely through increased solvation. However, the  
stability increase gained through glycosylation was significantly 
higher than that observed for the unglycosylated protein in 
the presence of high concentrations of maltose. The presence  
of 0.5 m maltose increased the melting temperature of all pro­
teins examined by only approximately 3°C (Table 1). The in­
creased stability frequently observed with naturally glycosylat­
ed proteins, might therefore not simply be a nonspecific effect 
arising from changes in the solvation properties o f the en- 
zymes.1101 Site-specific effects can clearly also contribute to  the  
overall thermal stabilisation of proteins, at least in the case of 
DHFR.
Our results show that site-selective glycosylation of DHFR 
can dramatically increase the resistance of the protein against 
thermal denaturation. The protein's melting temperature could  
be increased significantly through the site-selective attachm ent 
of simple glycans. It should be noted that the increase in ther­
mal stability observed in our studies is o f the sam e order of 
magnitude as the decreases observed upon deglycosylation of 
naturally glycosylated proteins, which were 3.4, 4.0 and 1.9°C 
for yeast external invertase, bovin serum fetuin and glucoamy- 
lase, respectively.141 Our data suggest that significant increases 
in the thermal stability of proteins can be achieved even with
the small carbohydrates used in this study, rather than with 
the often much larger oligosaccharides found in naturally gly­
cosylated proteins.
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Coupling of protein motions and hydrogen transfer during catalysis by 
Escherichia coli dihydrofolate reductase
Richard S. S W A N W IC K * ,  Giovanni M A G L IA t ,  La i-hock T E Y *  and Rudolf K. A L L E M A N N *1
' S c h o o l  o f  C hem istry , C ard iff U n iv e rs ity , M a in  B u ild in g , P ark  P la c e , C a rd iff  C F 1 0  3AT, U .K ., and  tS c h o o l of C h e m is try , U n iv e rs ity  of B irm in g h a m , E d g b asto n , B irm in g h a m  B 15  2TT , U .K .
The enzyme DHFR (dihydrofolate reductase) catalyses hydride 
transfer from NADPH to, and protonation of, dihydrofolate. The 
physical basis of the hydride transfer step catalysed by DHFR 
from Escherichia coli has been studied through the measurement 
of the temperature dependence of the reaction rates and the kinetic 
isotope effects. Single turnover experiments at pH 7.0 revealed 
a strong dependence of the reaction rates on temperature. The 
observed relatively large difference in the activation energies for 
hydrogen and deuterium transfer led to a temperature dependence 
of the primary kinetic isotope effects from 3.0 +  0.2 at 5°C to 
2.2 ± 0 .2  at 40 °C and an inverse ratio of the pre-exponential 
factors of 0.108 ±0 .04 . These results are consistent with theo­
retical models for hydrogen transfer that include contributions 
from quantum mechanical tunnelling coupled with protein mo­
tions that actively modulate the tunnelling distance. Previous work 
had suggested a coupling of a remote residue, G ly121, with the 
kinetic events at the active site. However, pre-steady-state experi­
ments at pH 7.0 with the mutant G121V-DHFR, in which G ly121 
was replaced with valine, revealed that the chemical mechanism 
of DHFR catalysis was robust to this replacement. The reduced 
catalytic efficiency of G 121 V-DHFR was mainly a consequence 
of the significantly reduced pre-exponential factors, indicating the 
requirement for significant molecular reorganization during 
G 121 V-DHFR catalysis. In contrast, steady-state measurements at 
pH 9.5, where hydride transfer is rate limiting, revealed temper­
ature-independent kinetic isotope effects between 15 and 35 °C 
and a ratio of the pre-exponential factors above the semi-classical 
limit, suggesting a rigid active site configuration from which hy­
drogen tunnelling occurs. The mechanism by which hydrogen 
tunnelling in DHFR is coupled with the environment appears 
therefore to be sensitive to pH.
Key words: dihydrofolate reductase, dynamics, hydrogen transfer, 
kinetics, protein motions, tunnelling.
INTRODUCTION
It has long been accepted that electrons can be transferred in chemi­
cal reactions by quantum mechanical tunnelling with energies 
of activation deriving from heavy-atom motions [1], However, 
only recently have several cases of hydrogen tunnelling been des­
cribed where the probability of tunnelling was modulated by 
environmental dynamics and protein motions [2-15], Several 
theoretical models that incorporate environmental motions have 
been developed to describe hydrogen transfer reactions [5,16-19]. 
The model proposed by Kuznetsov and Ulstrup [19] and devel­
oped further by Knapp and Klinman [5,13] for enzymatic trans­
formations, which separates the faster e~ and H co-ordinates from 
the environmental co-ordinate, distinguishes between passive 
motions that influence the probability of the formation of an 
active site configuration conducive to hydride transfer, and active 
protein motions that modulate the tunnelling distance and hence 
the reaction rate.
DHFR (dihydrofolate reductase) has long served as a paradigm 
for the study of issues relating to enzyme structure, dynamics and 
catalysis. DHFR catalyses the reduction of H2F (7,8-dihydro- 
folate) to H4F (5,6,7,8-tetrahydrofolate) with the concurrent oxi­
dation of NADPH. DHFR is essential for maintaining intracellular 
levels of H4F, a cofactor involved in the biosynthesis of several 
amino acids, purines and thymidylate. DHFR from Escherichia 
coli is a monomeric enzyme comprising an eight-stranded f i-sheet 
and four a-helices connected by flexible loop regions (Figure 1). 
The M20, /3F-/3G and /3G-/3H loops have been implicated in 
catalysis [20], In the reactive ternary complex, when both H2F and
NADPH are bound, the M20 loop adopts the closed conformation, 
which is stabilized through hydrogen bonds between residues in 
the M20 and the /JF-/JG loops [21], The backbone atoms of the 
/1F-/IG loop display high dynamic mobility in NMR relaxation 
experiments, which has been interpreted to suggest a connection 
between the dynamic properties and the catalytic behaviour of 
DHFR [22-25],
The complete kinetic scheme for DHFR from E. coli has been 
determined [26,27]. The reaction rate is strongly dependent on 
the pH of the solution. The chemical step, in which the pro-R hy­
drogen is transferred from C-4 of NADPH to C-6 of H2F and 
N-5 of the substrate is protonated, is characterized by a single 
pA'a of approx. 6.5 with a rate variation of almost two orders of 
magnitude. This p /fa can most likely be attributed to protonation 
of the substrate in the ternary enzyme complex [28]. At physio­
logical pH, the overall rate of the conversion of H2F into H4F is 
limited by product release, while the chemical step is fast and es­
sentially irreversible [26]. However, atpH  values of9.5 and above, 
hydrogen transfer is much slower and fully rate-determining.
Several computational studies using combined QM/MM (quan­
tum mechanical and molecular mechanical) and free-energy per­
turbation approaches have shed some light on the mechanism of 
the hydride transfer step in DHFR catalysis [28-35]. QM/MM 
simulations and genomic sequence analysis identified a network 
of hydrogen bonds and van der Waals interactions in DHFR from 
E. coli between the surface /IF-/3G loop and the active site that 
may influence protein dynamics and promote catalysis [18,36]. 
Replacement of G ly121, a highly mobile residue located in the 
middle of the /1F-/3G loop over 19 A (1 A =  0.1 nm) from
Abbreviations used: DHFR. d ihydrofo late reductase; DTT, dithiothreitol; H2F, 7,8-dihydrofolate; H4F, 5,6,7,8-tetrahydrofolate; KIE, kinetic isotope effect; 
NADPD. (4R)-[2H]NADPH; QM/MM, quantum m echanical and molecular mechanical.
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The PDB file 1RA2 [21] was used to generate the diagram. The 0F-/3G and the M20 loops as 
well as the position of the catalytically important loop residue Gly121 are indicated.
the active site (Figure 1), with valine or leucine slowed the hydride 
transfer rate dramatically and weakened binding of NADPH [37]. 
Experimental and theoretical results suggested that this reduction 
in the rate of hydride transfer was due to significant differences in 
the stability of the tertiary structural elements surrounding the site 
of the mutation [22,33,38].
Two previous experimental studies suggested a coupling be­
tween protein dynamics and DHFR catalysis. Pre-steady-state 
measurements with DHFR from Thermotoga maritima indicated 
that protein fluctuations were coupled with hydride transfer which 
at low temperature displayed a significant contribution from tun­
nelling [8]. Steady-state experiments at the non-physiological pH 
value of 9, where hydride transfer is largely rate-determining 
for the E. coli enzyme, suggested a relatively rigid active site 
geometry and hydride transfer by extensive tunnelling, modulated 
b y  passive dynamics [2].
Here, we report measurements of the hydride transfer catalysed 
b y  DHFR from E. coli and the G 121 V-DHFR mutant, in which 
valine replaced the loop residue Gly121. While hydride transfer 
was slowed by almost two orders of magnitude in the mutant at 
physiological pH, hydrogen transfer was actively coupled with 
the environment for both proteins. The mechanism by which 
hydrogen transfer coupled with the environment was dependent 
on pH.
MATERIALS AND METHODS  
Substrates and cofactors
H2F was prepared by dithionite reduction of folate (Sigma) 
as described previously [39]. NADPH was purchased from 
Sigma. NADPD ((4R)-[2H]NADPH) was prepared by reduction 
of NADP+ (Sigma) using the NADP+-dependent alcohol de­
hydrogenase from Thermoanaerobium brokii (Sigma) and puri­
fied by anion-exchange chromatography on Mono Q™ HR 5/5 
(Amersham Biosciences). NADPH and NADPD concentrations 
were determined spectrophotometrically using a molar absorp­
tion coefficient (e) at 339 nm of 6200 M _1 • cm-1. Similarly, the
concentration of H2F was measured assuming an e of 28 000 M“1 • 
cm-1 at 282 nm for pH 7.4.
Protein purification
BL21(DE3) Star (Stratagene) cells were used for the production of 
DHFR from E. coli and its G 121V mutant from a pETl lc  derived 
plasmid (Novagen) containing the respective coding regions es­
sentially as described in [38]. Cells were grown in LB (Luria- 
Bertani) medium containing 0.27 mM ampicillin at 37 °C to an 
optical density at 600 nm of 0.6. Expression was induced by the 
addition of isopropyl /3-thiogalactoside to a final concentration of 
0.4 mM. Cells were harvested by centrifugation and resuspended 
in lysis buffer [25 mM potassium phosphate, pH 7.0,0.5 M NaCl, 
1 mM EDTA, 10 % , v/v, glycerol and 1 mM DTT (dithiothreitol)]. 
The suspension was sonicated for 5 min on ice and centrifuged at 
50 000 g  for 45 min. The supernatant was applied to a metho­
trexate column (10 ml; Sigma) pre-equilibrated with lysis 
buffer. The resin was extensively washed (~  300 ml) with the 
same buffer and elution of bound protein was achieved with 
100 mM sodium borate (pH 8.3), 0.5 M NaCl, 10%  glycerol and 
3 mM folic acid. The eluted protein was dialysed extensively 
against lOmM  potassium phosphate (pH 7.0) containing 1 mM 
DTT. The dialysate was applied to a DEAE-Sepharose 
column (20 ml; GE Healthcare) previously equilibrated with 
10 mM potassium phosphate (pH 7.0) containing 1 mM DTT and 
5 mM EDTA. The bound protein was eluted with a gradient 
from 0 to 1 M NaCl in potassium phosphate (pH 7.0), 5 mM 
EDTA and 1 mM DTT and dialysed to remove salt. The protein 
concentrations were measured spectrophotometrically assuming 
an s of 31100 M -1 • cm -1 at 280 nm and by titration with metho­
trexate.
P re-steady-state kinetic m easurem ents
Pre-steady-state kinetic experiments were performed on an A p­
plied Photophysics stopped-flow spectrophotometer essentially 
as described before [8]. Hydride transfer rates were measured 
following the fluorescence resonance energy transfer from the 
protein to reduced NADPH in potassium phosphate for optimal 
pH stability over the temperature range. The sample was excited at 
292 nm and the emission was measured using an output filter with 
a cut-off at 400 nm. In a typical experiment for DHFR, the enzyme 
(40 fxM,  final concentrations) was preincubated with NADPH or 
NADPD (20 /xM) in 100 mM potassium phosphate (pH 7.0) and 
100 mM NaCl for at least 15 min to avoid hysteresis. The reaction 
was started by rapidly mixing with H2F (200 /xM) in the same 
buffer. For G121 V-DHFR, the enzyme (20 /xM) was preincubated 
with NADPH or NADPD (10 /xM) and the experiments were run 
as above. The hydride transfer rates did not change when the 
concentration of NADPH was reduced to 5 /xM or doubled to 
20 /xM.
Steady-state kinetic m easurem ents
All steady-state kinetic experiments were performed in MTEN 
buffer (50 mM MES buffer, 25 mM Tris, 25 mM ethanolamine 
and 100 mM NaCl) at pH 9.5. The pH was carefully adjusted at 
the experimental temperature with the relevant calibration buffers 
[borate (pH 10; Fisher Chemicals) and phosphate (pH 7; Fisher 
Chemicals)] at that temperature. DHFR (50 nM) was preincubated 
with NADPH/NADPD (50 /xM) for 10 min at the experimental 
temperature prior to the addition of excess H2F (100 /xM) to 
initiate the reaction. The steady-state rate was determined from 
the linear decrease in the absorbance of the reduced cofactor at 
340 nm with time using a molar absorbance change for the DHFR
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figure 2 Fluorescence energy transfer during DHFR catalysis
Measurement of the rate of H- (light grey dots) and D- (dark grey) transfer catalysed  by DHFR in 
I  single turnover experiment m easured by stopped-flow  fluorescence resonance energy transfer 
lorn DHFR to the reduced cofactor at 25  °C . The relative intensity of fluorescence above 400  nm 
n s  m easured after excitation at 292 nm. The fits to a  double-exponential m odel for decreasing  
luorescence intensity are a lso  indicated. DHFR w as preincubated with NADPH or NADPD and 
l e  reaction started through the addition of H2F. Final concentrations were: DHFR, 40  ^ M ; 
educed  cofactor, 20 f iM  and H2F, 200 n M .  The dead tim e of the  experim ents w as approx. 
1002 s.
reaction o f 11800 M "1 • cm -1 [40]. Each data point was m easured 
at least six times.
RESULTS AND DISCUSSION
Temperature dependence of hydride transfer and KIEs 
(kinetic isotope effects) for DHFR catalysis
The rate o f hydride transfer (kH) from NADPH to H2F was m ea­
sured at pH 7 and 25 °C in single-turnover experiments by m oni­
toring fluorescence resonance energy transfer from DHFR to the 
reduced cofactor in the presence of excess enzym e [26,37]. 
The decrease o f the fluorescence intensity was best described by a 
double exponential (Figure 2). The rate constant o f the slow step 
(~6 .5  s-1) was independent o f the concentration o f NADPH and 
did not depend on whether NADPH or NADPD was used as the 
cofactor. It most likely represented the slow release o f cofactor 
and/or product. At 25 °C, the rapid decrease in fluorescence inten­
sity preceding this slow step occurred with a first-order rate 
constant of 203.7 ±  7.4 s_l (see Supplementary Table 1 at http:// 
www.BiochemJ.org/bj/394/bj3940259add.htm) in good agree­
ment with previously published values o f 220 s-1 [26,37] and 
222.8 ±  1.3 s-1 [8]. The slight variation is m ost likely a con­
sequence o f the different buffers used in these experiments. In the 
experiments reported here potassium phosphate was used because 
of its good pH stability over wide ranges o f temperature. W hen 
NADPD was used as the cofactor, the rate constant was reduced 
to 75.1 ±  5.4 s-1, resulting in a KIE o f 2.7 ±  0.2. This value was 
identical with the value o f 2.8 that has been predicted com pu­
tationally [31] and the published experimental value o f 2.9 +  0.2 
at ambient temperature [41].
To evaluate whether hydride transfer during catalysis by DHFR 
was coupled to protein motions, the rate o f the chemical step was 
measured at pH 7.0 as a function o f the temperature between 5 and 
40 °C for both 'H  (H)- and 2H (D)-transfer. The temperature de­
pendence o f the rates was fitted to the em pirical Arrhenius 
equation (In k =  In A — EJRT, where it is a first-order rate 
constant, A is the pre-exponential factor and EA is the experimental 
activation energy) to obtain the activation energy and the pre­
exponential factor (Figure 3). The reaction rates showed a 
relatively strong dependence on the temperature, resulting in
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Figure 3 Arrhenius plots for H- and D-transfer during DHFR and G121V- 
DHFR catalysis at pH 7.0
Temperature dependence  of the  H- (O ) and D -transfer ( • )  rate constants for the reactions 
catalysed by DHFR (A) and  G121V-DHFR (B) is show n. Each data point is the average 
of at least six m easurem ents: the  error bars are obscured  by the sym bols. Fitting the 
average rate value for every tem perature to the Arrhenius equation yields the following 
param eters: DHFR, £ AH =  29 .9  ±  0.6  kJ • m o l- 1 , Ah =  3 .3  ±  0.8  x  107 s -1 and £ AD =  37.7 ±  
0 .6  k J -  m o l-1, A 0 =  3 .07  +  0 .80  x  108 s - 1 ; G121V-DHFR, £ AH=  23.3 ±  0.3 kJ - m o l-1. 
Ah =  2 .2  ±  0 .2  X 103 s - 1 and  £ AD =  39 .0  ±  0 .6  kJ • m ol- 1 , A0 =  8.1 ±  2.0  x  105 s - 1 .
activation energies o f  EAH o f 29.9 +  0.6 kJ • m ol-1 and EAD of 
37.7 ±  0.7 kJ • m ol-1, leading to an inverse pre-exponential factor Ah/Ad o f 0.108 +  0.04 (AH =  3.3 + 0 .8  x  107 s-1; AD =  3.07 +  
0.81 x  108 s-1). The activation energy for H-transfer reported here 
was very sim ilar to that measured previously in a different buffer 
but under identical conditions otherwise (28.2 +  0 .9 k J-m o l-1) 
[8]. The relatively large difference in the activation energies 
for H- and D-transfer led to a temperature dependence of the 
prim ary KIEs (Figure 4). The KIE varied from 3 .0 +  0.2 at 
5°C to 2 .2 +  0.2 at 40  °C. The inverse ratio of the pre-exponen­
tial factors, which was well below the lower limit for the 
semi-classically calculated value o f 0.71 [2,42], suggested a 
contribution from quantum mechanical tunnelling. Within a 
model o f tunnelling through a rigid barrier, the temperature- 
dependent KIEs together w ith the observed values for AH/AD and Eah/d suggest a m oderate am ount o f tunnelling [43]. Two recent 
com putational studies o f  hydrogen transfer during catalysis by 
DHFR from E. coli suggested that the barrier for hydrogen transfer 
was significantly lowered through the inclusion of quantum 
mechanical effects [31,36]. Garcia-Viloca et al. [31] obtained 
an overall quantum  mechanical correction o f 13 .4k J-m o l-1 to 
the classical activation energy for hydrogen transfer. Most o f this
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Figure 4 Temperature dependence of the KIEs for H- and D-transfer from 
NADPH/NADPD to HZF
(A) R esults from pre-steady-state m easurem ents a t pH 7.0 for catalysis by DHFR ( • )  and 
G121 V-DHFR (O ). The best fit through the data yielded A f AH/0 of 7.83 ± 0 .9 8  kJ - m o M  
and Ah/A d of 0 .1 0 9 ± 0 .0 4 3  for DHFR and A F AH/0 of 1 5 .8 3 ± 0.44 kJ • m o M  and A H/A D 
of 0.0024 +  0.0004 for G121V-DHFR. (B) Steady-state m easurem ents for DHFR catalysis  at 
pH 9 .0  and 5.0. The best fit through the data between 15 and 35 °C  is indicated and  yields 
a £ a h/0 of 1.11 ± 0 .7 9  kJ • m o l-1 and A H/A D of 1.81 +  0.19.
correction was attributed to quantization o f nuclear vibrations, 
while only 2.9 kJ • mol-1 derived from hydrogen tunnelling. From 
the inverse ratio of the pre-exponential factors measured here, 
a previously proposed static model would predict moderate 
hydrogen tunnelling [43,44]. However, within the formalism of 
this model, elevated KIEs would be predicted in contrast with 
the rather small values measured here. The hydride transfer 
reaction catalysed by DHFR can therefore only be described 
adequately if protein motions coupled with hydrogen transfer are 
taken into account. Several theoretical approaches to hydrogen 
transfer models have been proposed that treat the hydrogen co­
ordinates as fully quantum mechanical and incorporate various 
degrees of heavy atom motions to modulate the tunnelling 
barrier [16,17,45-47]. In one such model, a distinction was made 
between motions that actively modulate the tunnelling barrier 
and passive motions that merely help bring the substrates into 
reactive configurations (reviewed in [5,13]). This model predicts 
that when active dynamic motions are dominant and generate 
a temperature-dependent tunnelling distance, the KIEs become 
so temperature-dependent that the ratio o f the pre-exponential 
factors is inverse. The experimentally observed inverse AhM d and 
the temperature dependence of the KIEs suggest that at pH 7.0, 
DHFR actively modulates the tunnelling distance and hence the 
reaction rates [48]. Such active motions result in temperature-
dependent KIEs and an inverse ratio o f the pre-exponential factors, 
because the ideal tunnelling distance is different for the two 
isotopes. Such actively promoted tunnelling has been called rate- 
prom oting vibrations [14,49,50], environmentally coupled tun­
nelling [13,43], and vibrationally enhanced ground state tunnell­
ing [51]. The results reported here may also support the recent 
proposal o f a correlation o f changes in structural characteristics 
within DHFR from  E. coli along the reaction pathway of hydrogen 
transfer through a network of hydrogen bonds and van der Waals 
interactions spanning the entire enzyme [18].
Steady-state kinetics of DHFR at pH 9 .5
In a previous study, the temperature dependence of the deuterium 
and tritium isotope effects at pH 9.0, which was measured under 
steady-state conditions, also revealed environmentally coupled 
hydrogen transfer [2]. However, in contrast with the results pre­
sented here, for H-transfer at pH 7.0, the KIEs were independent 
o f temperature. The rates for hydride transfer in DHFR catalysis 
have been shown to decrease steeply with increasing pH [26]. 
However, the rate o f product release, which is rate-determining 
at physiological pH, is pH-independent; hence hydride transfer 
becom es rate lim iting at elevated pH and, at pH 9.5 and above, the 
steady-state rate reflects the rate o f the chemical step only [2,26]. 
Since at pH 9.0 the chem ical step is not fully rate-determining, hy­
dride transfer rates were measured under steady-state conditions 
at pH 9.5 to exclude kinetic complexity at pH 9.0 as a basis for the 
observed difference in the temperature dependence of transfer at 
elevated and physiological pH. We have therefore determined 
the tem perature dependence o f the steady-state turnover rates 
for the reduction o f H2F  with NADPH and NADPD during DHFR 
catalysis at pH 9.5 [26] from the decrease in the absorbance at 
340 nm due to the oxidation o f the cofactor. At 25 °C, the rates 
for H- and D -transfer were 0.927 ±  0.012 and 0.341 +  0.008 s_l, 
resulting in a K IE o f 2.72 ± 0 .1  (see Supplementary Table 2 at 
http://www.Biochem J.org/bj/394/bj3940259addd.htm). The KIE 
measured here was essentially identical to that calculated in a pre­
vious study [KIE (H/D) =  2.92 +  0.076] from the measured HA' 
and D A  KIEs at pH 9.0 [2].
W ithin the tem perature range o f 15 and 35 °C the KIEs re­
m ained constant w ithin the error o f the experiment (Figure 4), 
while below 15°C the KIEs decreased sharply. Fitting the KIEs 
between 15 and 35 °C to the Arrhenius equation resulted in a very 
small difference in the activation energy for H- and D-transfer 
(A £ ah/d =  1.11 ±  0.79 kJ • m ol-1) and an isotope effect for the 
pre-exponential factor AHM D of 1.81 +  0.19, larger than the upper 
sem i-classical lim it o f 1.41 [42]. A similar temperature depen­
dence and enhanced KIE for the pre-exponential factors had been 
observed previously for the H A  and D A  KIEs at pH 9.0 [2]. A 
larger value for AhM d o f 4 .0 +  1.5 has been reported previously 
in steady-state experim ents at pH 9.0 [2], While an + hM d ratio 
outside the sem i-classical range has widely been accepted as an 
indication for quantum  m echanical tunnelling, a recent compu­
tational study resulted in a ratio o f pre-exponential factors of 1.9 
[52], identical w ithin error with the results reported here. Inter­
estingly, a larger value was obtained when the tunnelling contri­
butions were omitted.
The tem perature-independent KIEs at elevated pH were in sharp 
contrast w ith the strong temperature dependence of the KIEs at 
pH 7 and suggested a relatively rigid active site configuration 
from which hydrogen transfer occurs with a contribution from 
environm entally coupled hydrogen tunnelling. Within the model 
linking catalysis and dynam ics proposed by Klinman and co­
workers [43], the elevated value for /4hM d together with the tem­
perature-independent KIEs suggested contributions from passive
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dynamics that do not actively modulate the tunnelling distance. 
This is in sharp contrast with the behaviour o f DHFR at physio­
logical pH, where hydrogen transfer is facilitated by active 
modulation o f the tunnelling barrier. It is interesting to point out in 
this context that a recent computational study o f DHFR catalysis 
revealed a small but significant temperature variation o f the KIEs 
as a consequence of two competing tem perature effects [53]. It 
is perhaps not surprising that in such a system the tem perature 
dependence varies with reaction conditions.
DHFR has evolved an active site structure that is organized 
to support hydrogen tunnelling and to use active dynam ics to 
promote hydrogen transfer at physiological pH. Relatively small 
increases in the pH of the solution, however, lead to a stiffening 
of the active site that no longer allows DHFR to actively prom ote 
hydrogen transfer, resulting in a reduction o f  the reaction rate by 
i more than one order of magnitude. Interestingly, at pH  9.5, DHFR 
displays a temperature dependence o f the reaction rates sim ilar to 
that o f the structurally more rigid DHFR from the therm ophilic 
bacterium T. maritima [8]. Both enzymes appear to rely on passive 
motions only to generate active site configurations conducive 
to hydrogen transfer. In addition, the hydride transfer rates for 
the thermophilic DHFR at pH 7 and for the mesophilc DHFR at 
! pH 9.5 were similar in the experimentally accessible tem perature 
range [8,39]. These observations may suggest an evolutionary 
pattern in which catalysis progressed from a relatively rigid 
active site structure of DHFR from the ancient therm ophile T. maritima to a more flexible and kinetically more efficient structure 
in E. coli that actively promotes hydrogen transfer at physio­
logical pH.
Temperature dependence of hydride transfer and KIEs 
for catalysis by G121 V-DHFR
Although residue 121 in the /JF-/JG loop o f DHFR is on the ex­
terior o f the protein and approx. 19 A from the centre o f the 
enzyme, experimental studies have shown that mutations o f G ly121 
can reduce the rate o f hydride transfer by up to 163-fold [20,37]. 
Together with NMR and computational studies, these results have 
been interpreted as evidence for the existence o f a network o f 
coupled dynamic motions that include residues in exterior loops 
of DHFR and promote hydride transfer [ 18]. It has been postulated 
that mutation o f G ly121 disrupts this network of coupled m otions 
leading to the observed reduction in the reaction rate and altered 
dynamic properties o f the enzyme [52]. The rate o f the hydride 
transfer from NADPH to H2F catalysed by G121 V-DHFR was 
measured at pH 7.0 in pre-steady-state experiments. The decrease 
in the fluorescence intensity was best described by a double ex­
ponential. A first event was observed that occurred with a rate con­
stant of approx. 3.5 s-1 at 25 °C and did not show a KIE when 
NADPD replaced NADPH. This process had previously been 
interpreted as a conformational change associated with a re­
arrangement o f the reduced nicotinamide ring into the enzym e’s 
active site [20]. Surprisingly, this fast isotopically insensitive step 
had not been observed under similar conditions in a previous study 
of G 121 V-DHFR catalysis, perhaps due to the different buffers 
used in the two studies [37]. This initial step was followed by a 
slow decrease in the fluorescence intensity, the rate o f which did 
not change when the concentration o f NADPH was varied. The 
slow step was therefore most likely due to the oxidation o f the co­
factor that occurred with a first-order rate constant o f 0.171 ±  
0.004 s- ' at 25 °C (see Supplementary Table 3 at http://www. 
BiochemJ.org/bj/394/bj3940259add.htm). This rate constant is 
somewhat lower than that published previously [37], m ost likely 
as a consequence of the different reaction conditions. In the pre­
sent study, potassium phosphate, which shows little variation o f
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pH with changing temperature, was used rather than the amine- 
based M TEN buffer. At 25 °C, a KIE o f 1.450 ±  0.042 was mea­
sured when NADPD was used instead o f NADPH.
Sim ilar to the wild-type enzyme, a relatively strong temperature 
dependence o f the hydride transfer rates and the KIEs was ob­
served between 5 and 35 °C (Figures 3 and 4). The rates increased 
almost 3-fold in the temperature range leading to activation 
energies o f  EAH o f 23.3 +  0.3 and EAD of 39.0 ±  0.6 kJ ■ m ol-1 
for H- and D -transfer respectively. The activation energy for 
H-transfer catalysed by G 121 V-DHFR was smaller than that 
measured for the wild-type, indicating that the reduced catalytic 
efficiency o f the m utant was a consequence of a smaller pre­
exponential factor (A« =  2.2 ±  0.2 x  103 s-1; AD =  8 .1 + 2 .0 x  
103 s-1). The difference in activation energies (A £ a =  EAH — EAD) 
o f — 15.7 kJ • m ol-1  was twice that observed for wild-type DHFR, 
leading to  more strongly inverse pre-exponential factors AH/AD of 
0.0025 +  0.0007. These data are consistent with a model in which 
the reaction occurred with a significant contribution from quantum 
m echanical tunnelling coupled with active dynamic motions.
The results presented here indicate that, while replacing residue 
121 in DHFR w ith valine leads to a significant reduction in the 
rate o f hydrogen transfer, the general mechanism by which the re­
action is coupled with the environment is unaltered, at least in a 
qualitative sense. M olecular dynamics, CD and fluorescence ex­
perim ents had suggested that the reduced catalytic efficiency of 
the m utant may arise from  structural effects on the overall fold 
o f  the protein [38]. NM R experiments indicated that in G121V- 
DHFR the closed conform ation, in which hydrogen transfer 
occurs in the wild-type, was destabilized [22]. Geometric con­
straints im posed by the bulky isopropyl group in G 121 V-DHFR 
m ay be transm itted to the active site to produce a lower number 
o f active site configurations favourable for hydride transfer. In 
agreem ent with this explanation, a computational study by Thorpe 
and Brooks [33] suggested that H2F and NADPH populate 
preferentially a region o f configuration space of DHFR that is 
conducive to the reaction, while substrate and cofactor become 
trapped in unproductive configurations in G 121 V-DHFR. The 
results presented here indicate, however, that once NADPH and 
H2F  are bound in the reactive configuration, both mutant 
and wild-type actively prom ote hydride transfer.
The reduced catalytic efficiency o f G 121 V-DHFR was mainly a 
consequence o f the significantly reduced pre-exponential factors. 
The Eyring interpretation o f the temperature dependence of the 
reaction rates relates activation energy and pre-exponential factor 
to activation enthalpy and entropy, A 77* and AS*. The activation 
enthalpies and entropies for hydride transfer by DHFR and 
G 121 V-DHFR were obtained by fitting the temperature depen­
dence o f the reaction rates to the Eyring equation [k/T = kB/h exp 
(AS*//?) exp(— AH*/RT), where A: is a first-order constant, kB the 
Boltzm ann constant and h the Planck constant; R is the universal 
gas constant]. W hile the activation enthalpy favoured hydride 
transfer by G121 V-DHFR by 6.3 ±  0.2 kJ • m ol-1, the activation 
entropy strongly favoured the reaction catalysed by the wild-type 
enzyme. An increase in the activation entropy (— TAS*) for the 
mutant indicated that a significantly higher molecular reorgan­
ization was required to reach the transition state in G 1 2 1 V- 
DHFR (TAS*g.2iv =  -  56.4 ±  0.8 kJ • m ol-1) than in the wild 
type enzym e (T AS*yrr =  — 32.9 +  0.8 kJ • m ol-1).
In summary, our results suggest that the mechanism by which 
hydrogen transfer in DHFR is coupled with protein fluctuations, 
depends on the pH of the environment. Under physiological con­
ditions, DHFR increases the reaction rate through optimization 
o f the coupling o f  environm ental dynamics with quantum mech­
anical tunnelling. Only relatively small changes in pH lead to 
a stiffening o f the active site and a loss o f active promotion of
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hydrogen transfer. On the other hand, the m echanism is relatively 
robust towards mutation o f residue 121, the identity o f which 
is known to be critical for efficient hydride transfer. Like in the 
wild-type enzyme, the tunnelling distance is m odulated by active 
dynamics in the kinetically com prom ised mutant G 121 V-DHFR. 
The reduced hydride transfer rates o f this mutant are therefore 
not the consequence o f altered dynamics, but most likely o f geo­
metric constraints [33,38] that lead to a higher entropic cost for the 
formation of active site conformations conducive to the reaction.
This w ork w as su p p o rted  by the  BBSRC (B io techno logy  a n d  B io log ical S c ie n c e s  R esearch  
Council) and Cardiff University.
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Protein m otions during ca ta ly sis  by 
dihydrofolate re d u c ta ses
R udolf K. A llem ann1’*, R hiannon M . E van s1, L ai-hock Tey1, Giovanni M aglia2, 
Jiayun P an g1,2, R obert R odriguez1,2, P aul J. Shrim pton2 
and R ichard S. Sw anw ick11 School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff CF10 3AT, UK 2School of Chemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
D ihydrofolate reductase (D H F R ) m ain ta ins th e  in tracellu lar pool o f  te trahydrofo la te  th rough  catalysis 
o f hydrogen transfer from  reduced  n ico tinam ide  adenine d inucleo tide  to  7 ,8-dihydrofolate. We repo rt 
results for pre-steady-state kinetic stud ies o f  the  tem p era tu re  dep en d en ce  o f  the rates and the 
hydrogen/deuterium -kinetic isotope effects fo r the  reactions catalysed by the enzym es from  the 
m esophilic Escherichia coli and  the  hyperthe rm oph ilic  Thermatoga maritima. We propose an  evolutionary 
pa tte rn  in  w hich catalysis p rogressed from  a relatively rigid active site s tru c tu re  in  the ancient 
therm ophilic D H F R  to  a m ore flexible an d  kinetically m ore  efficient s tru c tu re  in  E. coli th a t actively 
prom otes hydrogen transfer a t physiological p H  by  m odu la ting  th e  tunnelling  distance. T h e  E. coli 
enzym e appeared  relatively robust, in  th a t kinetically severely com prom ised  m u tan ts  still actively 
propagated  the reaction. T h e  reduced  hydrogen  transfer rates o f  the  extensively s tud ied  G lyl21V al 
m u tan t o f  D H F R  from  E. coli w ere m ost likely d u e  to  sterically unfavourab le long-range effects from  the  
in troduction  o f  the  bulky isopropyl group.
Keywords: hydrogen  transfer; k ine tic  iso to p e  effects; p ro te in  dynam ics; catalysis; enzym es
1. INTRODUCTION
5 ,6 ,7 ,8 -T etrahyd ro fo la te  (H 4F ) is req u ired  fo r th e  
biosynthesis o f  thym idylate, purines and  several am ino  
acids. Its in tracellular levels are m ain ta ined  th ro u g h  
th e  n ic o tin a m id e  ad e n in e  d in u c leo tid e  p h o sp h a te  
(N A D P H )-dependen t reduction  o f  7 ,8-d ihydrofolate 
(H 2F) catalysed by  the ub iquitous enzym e dihydrofolate 
reductase (D H F R ; figure 1). T h is  enzym e has therefore 
been a long-standing pharm acological target an d  hence 
has been studied  extensively by X -ray crystallography, 
nuclear m agnetic resonance (N M R ) spectroscopy and  
com putation  (Sawaya & K rau t 1997; C asaro tto  et al. 
1999; Feeney 2000; Radkiewicz & Brooks 2000; Agarwal et al. 2002a,b; S hrim pton  & A llem ann 2002; Benkovic & 
H am m es-Schiffer 2003; G arcia-Viloca et al. 2 003a,b; 
Shrim pton et al. 2003; T h o rp e  & Brooks 2003 , 2004; 
Venkitakrishnan et al. 2004; M cElheny et al. 2005; P u  et al. 2005). W hile structural studies o f enzym es have 
significantly influenced o u r view o f catalysis, the  static 
three-dim ensional p ictures provided by  these studies do  
no t incorporate the wide range o f  dynam ical m otions th a t 
occur in  proteins. D H F R  has recently  served as a 
paradigm  for the developm ent and  testing o f  concepts 
tha t relate the enorm ous catalytic pow er o f enzym es to  
their dynam ic properties.
Several studies o f  D H F R  have indicated  th e  im p o rt­
ance o f its dynam ic properties for catalysis. D H F R  from  Escherichia coli (E cD H F R ) is a m onom eric enzym e 
consisting o f  four a-helices, eight fl-sheets and  four
* Author for correspondence (allemannrk@cardifF.ac.uk).
One contribution of 16 to a Discussion Meeting Issue ‘Quantum  
catalysis in enzymes—beyond the transition state theory paradigm’.
m obile loops (figure 2). T h e  enzym e is separated  in to  tw o 
dom ains, th e  adenosine b ind ing  dom ain  and  the loop 
dom ain . P revious studies have ind icated  the central role 
o f  the  M 2 0 , the  F G  (residues 116-132) and the G H  
(residues 1 4 2 -150 ) loops for the  catalytic activity and  
m echan ism  o f  D H F R . T h e  M 20  loop adopts the  closed 
con fo rm ation  in  the  reactive te rnary  com plex w hen b o th  
H 2F  and  N A D P H  are b o u n d  (Sawaya & K rau t 1997). 
T h is  co n fo rm atio n  is stabilized th rough  hydrogen bonds 
betw een  residues in  the  M 20  an d  the F G  loops. T h e  
backbone n itro g en  atom s o f  these loops displayed high 
dynam ic m obility  in  N M R  relaxation experim ents, w hich 
has b een  in te rp re ted  to  suggest a connection  betw een the 
dynam ic p ro p ertie s  o f  these loops and  the catalytic 
behav iour o f  D H F R  (Epstein  et al. 1995; O sborne et al. 
2001). T h e  rela tionsh ip  betw een  m ovem ents o f these 
loops and  catalysis has been  p ro b ed  by site-directed 
m utagenesis. R ep lacem en t o f  G ly  121, a highly m obile 
residue located  in  the  m iddle o f  the  F G  loop over 19 A 
from  th e  active site, w ith  Val o r L eu  slowed the hydride 
transfer ra te  dram atically  and  w eakened the b inding o f 
N A D P H  (C am ero n  & Benkovic 1997). W hile being 
strictly conserved  in  all p rokaryotic D H F R s, Gly 121 
does n o t ap p ear to  fo rm  any in teractions w ith other 
residues. M o le c u la r  dynam ic (M D ) sim ulations o f 
E c D H F R  revealed  a strong  correla tion  betw een the 
m ovem ent o f  th e  catalytically im p o rtan t M 20  and  F G  
loops (R adkiew icz & Brooks 2000). T hese  correlated 
m otions w ere observed  only  in  reactive com plexes o f the 
enzym e a n d  ab sen t in  the  p ro d u c t com plex. M ixed 
q u an tu m  m echan ica l m olecu lar m echanic sim ulations 
and  genom ic sequence analysis have identified a netw ork
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Figure 1. DHFR catalyses the transfer of H-Re from 
nicotinamide adenine dinucleotide phosphate (NADPH) to 
7,8-dihydrofolate (H2F).
Figure 2. Sketch of the structures of (a) EcDHFR and (6) 
TmDHFR. The active site of EcDHFR is located between 
the ABD and the LD. Substrate, cofactor, and the position of 
Glyl21 in the FG loop of EcDHFR are indicated.
of hydrogen bonds and van der Waals contacts from 
Asp 122 on the surface of the protein to the active site 
(Agarwal et al. 2002b). T his network may facilitate 
hydride transfer, suggesting a direct link between the 
motion of the FG  loop and the catalytic events in  the 
active site. In good agreem ent with the kinetic m easure­
ments, com putation revealed a significant increase in the 
energy barrier for the hydride transfer o f the Gly 121 to 
Val m utant (EcD H FR -G 121V ) relative to the wild-type 
enzyme (D H FR; Watney et al. 2003).
2. RESULTS AND DISCUSSION
(a) H ydride transfer in DHFR fr o m  T. m aritim a  
and  E. coli
T he m easurem ent of the tem perature dependence o f the 
kinetic isotope effects (KIEs) o f the hydride transfer
Phil. Trans. R. Soc. B (2006)
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Figure 3. Temperature dependence o f the kinetic isotope effects 
for hydrogen transfer catalysed by Tm DHFR (Maglia & 
Allemann 2003).
catalysed by D H F R  is a sensitive m ethod to probe the 
influence o f pro tein  dynam ics on the chem istry of the 
reaction. H ere, we report the results o f such m easure­
m ents for the m onom eric D H F R  from  E. coli, its 
catalytically com prom ised G 121V -m utant and D H F R  
from  Thermatoga maritima (T m D H F R ). Unlike its 
m esophilic  hom ologue , th is the rm oph ilic  enzym e, 
which unfolds at ca 80 °C— alm ost 30 °C above the 
m elting tem perature o f E cD H F R  (Maglia etal. 2003)— is 
the only dim eric D H F R  known at present (figure 2; 
D am s et al. 2000). M utan ts that increase the proportion 
o f  the  m onom er o f T m D H F R  display significantly 
reduced therm al stability (Rodriguez & Allemann 2006, 
unpublished data). T h e  dim erization interface involves 
the catalytically im portan t M 20 and  the F G  loops and the 
steady state turnover rate o f T m D H F R  is reduced by 
approxim ately 1 order o f m agnitude relative to  the 
enzyme from  E. coli at their respective physiological 
tem peratures (M aglia et al. 2003).
T h e  hydride transfer rates for the reduction o f H 2F  
during  T m - and  E cD H F R  catalysis were m easured as a 
function  o f  tem pera tu re  by fluorescence resonance 
energy tran sfe r from  the  p ro te in  to  the reduced  
nico tinam ide m oiety  o f N A D P H . F or T m D H F R , a 
biphasic tem p era tu re  dependence was observed at pH  
7.0 w ith a b reak  p o in t at approxim ately 25 °C (figure 3; 
M aglia & A llem ann 2003; M aglia 2004). Below 25 °C 
the K IE  increased w ith decreasing tem perature, while 
above 25 °C the K IE  was tem peratu re-independen t, at 
least w ithin the relatively narrow  range o f experim en­
tally accessible tem peratu res. T h e  ratio o f the A rrhe­
nius pre-exponentia l factors, w hich was obtained from 
the ex trapolation  o f  the tem peratu re  dependence o f the 
K IE , was inverse for the lower tem perature range 
(AH/AD =  0 .0 0 2 ) an d  close to  u n ity  above 25 °C 
(AH/AD =  1-56). T h e  activation energies o f hydride 
and deu tride transfer were ob ta ined  from  the tem pera­
tu re dependence o f the reaction  rates to the em pirical 
A rrhenius equation . F o r the tem peratu re  range from  25 
to 65 °C E j  and  E °  for hydride and deuteride transfer 
were similar (E^ =  53.5 kJ m ol-1 ; E® =  56.0 kJ mol *), 
while below 25 °C the difference o f  the activation energies 
increased owing to  an  increased activation energy for 
deuteride transfer.
Several theoretical approaches to hydrogen transfer 
have been proposed  th a t trea t the hydrogen coordinate
M20-loop
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Figure 4. Comparison of the T-dependence of hydrogen 
transfer of EcD H FR and EcDHFR-G121V at pH  7.0 
(Swanwick et al. 2006).
com pletely  q u a n tu m  m echanically  an d  in c o rp o ra te  
various degrees o f heavy a tom  m otions th a t m o d u la te  
the tunnelling barrier (B runo & Bialek 1992; Borgis & 
H ynes 1996; Agarwal et al. 2002b). In  one such  m odel, a 
d istinction was m ade betw een m otions th a t actively 
m odulate the tunnelling  barrier and  passive m otions th a t 
m erely help b rin g  th e  su b stra tes  in to  th e  reactive  
configurations (Kuznetsov & U lstrup  1999; K n ap p  & 
K linm an 2002; K linm an 2003). T h is  m odel p red ic ts th a t 
when active dynam ic m otions are dom inan t and  generate  
a tem perature-dependent tunnelling  distance, th e  K IE s 
becom e highly tem peratu re-dependen t and  the ratio  o f 
the pre-exponential factors becom es inverse. W ith in  the  
fram ew ork o f  th is m ode l, the  experim ental resu lts  
observed for T m D H F R  catalysis suggest th a t a t low 
tem perature, T m D H F R  actively m odulates the tu n n e l­
ling distance and  hence the reaction rates. H ow ever, a t 
higher tem peratures, the  rigidity o f  the  enzym e necessary  
to  ensure its therm al stability appears to  p revent such  
active tunnelling, and  only passive m otions th a t generate  
reactive configurations o f substrate and  cofactor p rom ote  
the reaction. I t is perhaps n o t surprising th a t low- 
frequency pro tein  m odes becom e m ore im p o rtan t for 
the reaction a t lower tem peratures as they m ay be excited 
a t tem peratures well below  the C - H  stretching m ode, 
the excitation o f which is m uch  m ore tem peratu re- 
dependent. A  m olecular dynam ical sim ulation o f  the 
T m D H F R  catalysed reaction  a t 5, 25 and  65 °C using  
ensem ble-averaged variational transition  sta te  theo ry  
w ith m ultid im ensional tunnelling  confirm ed significant 
contribu tions from  H -tunnelling  a t all tem p era tu res , 
w ith the  relative con tribu tions to  the overall reaction  
rate  decreasing w ith increasing tem peratu res (Pang et al. 2006).
H  and  D  tran sfe r  ca ta lysed  by th e  m esoph ilic  
E c D H F R  a t p H  7 .0  revealed  a m o n o p h a sic  an d  
relatively s trong  d ep e n d en c e  o f  th e  rea c tio n  ra tes 
on  the tem perature resulting in activation energies o f 
=  29.9 kJ m ol-1 and  E% =  37.7 kJ m o l"  1 lead ing  
to  an inverse pre-exponentia l fac to r ^hA i4d= 0-108 
and  tem peratu re-dependen t prim ary  K IE s (figure 4; 
Swanwick et al. 2006). W ith in  the  dynam ic m odel 
proposed by K napp  & K linm an (2002), the  inverse Ah/Ad and  the  tem perature dependence o f  the  K IEs 
observed here suggest a dynam ic active site for E c D H F R  
at p H  7.0 tha t, unlike th e  active site o f T m D H F R ,
actively m odula tes the  tunnelling  distance and hence the 
reaction  rates in  the  physiological tem perature range.
E c D H F R  appears to  have evolved an active site 
s tru c tu re  th a t  is o rg an iz ed  to  s u p p o r t h y d rogen  
tunne lling  an d  to  use active dynam ics to  p rom ote 
hydrogen  tran sfe r a t physiological p H . Relatively small 
increases in  th e  p H  o f  th e  so lu tion , how ever, lead to  a 
stiffening o f  th e  active site th a t no  longer allows D H F R  
to  actively p ro m o te  hydrogen  transfer, resulting  in  a 
red u c tio n  o f  th e  reac tio n  ra te  by m ore th an  1 order o f 
m a g n itu d e . A bove  p H  9 , E c D H F R  d isp layed  a 
te m p era tu re  dep en d en ce  o f  the  reaction  rates sim ilar 
to  th a t o f  th e  s truc tu ra lly  m ore rig id  D H F R  from  the  
th e rm o p h ilic  b ac te riu m  T. maritima (K napp  & K linm an 
2002 ; S ikorski et al. 2 0 04 ), suggesting th a t they b o th  
relied  on  passive m o tions only to  generate active site 
configurations conducive to  hydrogen  transfer. T hese  
observa tions m ay suggest an  evolu tionary  p a tte rn  in 
w hich  catalysis p rog ressed  from  a relatively rigid active 
site s tru c tu re  o f  D H F R  from  the  anc ien t therm ophile  T. maritima to  a m ore  flexible an d  kinetically m ore 
efficient s tru c tu re  in  E. coli th a t actively prom otes 
hydrogen  transfe r a t physiological p H .
(b) B asis o f  redu ced  a c tiv ity  o f  EcDHFR-G121V
G ly 121 in  th e  F G  loop  o f  D H F R  is on  the ex terio r o f 
th e  p ro te in  a n d  approxim ately  19 A  from  th e  cen tre o f 
th e  enzym e. Several stud ies have show n th a t rep lace­
m e n t o f  th is residue can  lead  to  significant reductions o f 
th e  hy d rid e  tran sfe r rates. T ogether w ith  N M R  and  
co m p u ta tio n a l stud ies, these  resu lts have b een  in ter­
p re te d  as evidence for the  existence o f  a netw ork  o f 
co u p led  dynam ic  m o tio n s th a t inc lude residues in 
ex terio r loops o f  D H F R  an d  p ro m o te  hydride transfer. 
R ep lacem en t o f  G ly l2 1  has b een  p ro p o sed  to  lead  to  
a ltera tions in  th e  ne tw ork  o f  coup led  m otions and  
alte red  dynam ic  p ro p ertie s  o f  th e  enzym e resulting  in  a 
red u c tio n  o f  its cataly tic efficiency (W atney et al. 2003).
S im ilar to  th e  w ild-type E c D H F R , a relatively strong 
te m p e ra tu re  d ep e n d en c e  o f  the  hydride  transfer rates 
an d  th e  K IE s w as observed  betw een  5 and  35 °C for 
catalysis by  th e  m u ta n t (Sw anw ick et al. 2006). T h e  
ra tes inc reased  a lm ost th reefo ld  in  the  tem peratu re  
range lead in g  to  activation  energies o f  E^ =23.3 and  Ea = 39 .0  kJ m o l-1 for H -  an d  D -transfe r, respectively, 
an d  te m p e ra tu re -d e p e n d e n t K IE s (figure 4). Together 
w ith  th e  s tro n g ly  in v e rse  p re -e x p o n e n tia l fac to rs (Ah/Ad = 0 .0 0 2 5 ), these  resu lts suggested  th a t the 
reac tion  o cc u rre d  w ith  a significant co n tribu tion  from  
th e  q u a n tu m  m ech an ica l tunne lling  coupled  to  active 
dynam ic m o tio n s.
O u r  o b serva tions in d ica ted  th a t, w hile replacing 
residue 121 in  D H F R  w ith  Val leads to  a significant 
red u c tio n  in  th e  ra te  o f  h ydrogen  transfer, the  general 
m ech an ism  by w h ich  th e  reac tion  is coupled  to  the  
en v iro n m en t is u n a lte red , a t least in  a qualitative sense. 
T h is  w as in  g o o d  ag reem en t w ith  M D  sim ulations and  
C D  an d  fluo rescence experim en ts w hich h ad  suggested 
th a t co n fo rm atio n a l changes th a t have been  trans­
m itted  to  th e  active sites as a consequence o f the 
geom etric  co n s tra in ts  im posed  by the bulky isopropyl 
g roup  in  E c D H F R -G 1 2 1 V  m ay be the  reason for the 
red u ced  cata ly tic  efficiency o f  th e  m u ta n t (Swanwick et al. 2004 ; T h o rp e  & B rooks 2004).
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T h e  pre-steady-state  m easu rem en ts  o f  th e  hyd ride  
transfer event in  E c D H F R -G l 21V catalysis revealed  an  
isotope insensitive step  before hyd ride  tran sfe r th a t 
occurred  w ith a rate  co n s tan t o f  app rox im ate ly  3 .5  s -1  
a t am bien t tem peratu re  and  cou ld  be  in te rp re te d  as a 
conform ational change (C am eron  & B enkovic 1997; 
Swanwick et al. 2006). T h o rp e  an d  B rooks suggested  
previously th a t substra te  an d  co fac to r an d  N A D P H  
populate  preferentially a region o f  configu ration  space 
o f E c D H F R  from  w hich th e  reac tion  can  take p lace  
(T h o rp e  & B rooks 2 0 0 4 ) . In  E c D H F R -G 1 2 1 V , 
however, N A D P H  an d  H 2F  are p o stu la ted  to  beco m e 
trapped  in  unp roductive  configurations (Sw anw ick et al. 2004). T h e  te m p era tu re  d ep en d en ce  o f  th e  
hydride transfer indicates th a t once N A D P H  an d  H 2F  
are bound  in  the reactive configuration, b o th  m u ta n t and  
wild-type actively p rom ote  hydride transfer.
In  sum m ary, analysis o f  hom ologous D H F R s an d  
their m u tan ts has provided evidence th a t hydrogen  
transfer occurs to  a significant am oun t by  q u an tu m  
m echanical tunnelling  p rom oted  by  the environm ent. 
S tructural changes as a consequence o f m utations o f  
E cD H F R  appear to  give rise  to  changes in these  
prom oting m otions leading to  reduced  hydrogen transfer 
efficiencies as a consequence o f  gready changed ratios o f 
pre-exponential factors. O n  the  o ther h an d , in  the  
hypertherm ophilic D H F R  from  T. maritima, the necess­
ary stability against therm al denatu ration  appears to  
result in a rigid and hence less efficient enzyme.
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